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ABSTRACT 
 
Design and Syntheses of Dyes for Biological Applications. 
(May 2011) 
Cliferson Thivierge, B.S., Florida Atlantic University 
Chair of Advisory Committee: Dr. Kevin Burgess 
 
The challenges in modern biological imaging applications are two-fold: (i) to develop 
better methods of imaging, and (ii) to develop dyes that are suitable for these methods.  
This dissertation deals with the design and synthesis of dyes mainly by modification of 
known dyes to make them suitable for modern biological applications. 
Towards this aim, novel ways of derivatizing BODIPY dyes are explored.  One 
method involves extending the conjugation via phenyl acetylene units, pushing 
fluorescence wavelengths near 600 nm.  A different approach deals with C-H 
functionalization of BODIPY in which the fluors are functionalized with acrylate units, 
extending their fluorescence to the red.  The BODIPY dyes developed are then 
incorporated in through-bond energy transfer cassettes.  We examine the factors 
affecting energy transfer efficiencies by synthesizing analogs of the cassettes and also 
studying the electrochemical behavior of the donor and acceptor parts. 
The concept of through-bond energy transfer is incorporated into conjugated polymers 
by random incorporation of BODIPY dyes into polyfluorenes.  The ideal ratio of 
fluorene to BODIPY parts was found to be 4:1.  The BODIPY doping agents result in 
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dispersed emissions when excited at the polyfluorene donors.  Concurrently, the 
polyfluorene backbone acts as an energy harvester for the BODIPY dyes, in effect 
increasing their molar absorptivities. 
Finally the use of BODIPY dyes as photodynamic therapeutic agents was examined.  
We found that BODIPY dyes are efficient at producing reactive oxygen species when 
halogens are attached directly on the BODIPY core.  Furthermore, the mechanism of cell 
death by using such agents was elucidated.  Attachment of the most promising agent to 
polyglutamic acid is done to promote the EPR effect.  Lastly we develop a potentially 
new type of PDT agent that absorbs strongly above 800 nm, permitting its use in deep 
tissue PDT.  
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1 
CHAPTER I 
INTRODUCTION 
 
The importance of fluorescent probes in research is ever growing as demonstrated by 
the 2008 Nobel Prize in Chemistry being awarded to Drs. Osamu Shimomura, Martin 
Chalfie, and Roger Y. Tsien for the development of bioluminescent tools that exploit the 
phenomena in the studies of biological systems.  The first fluorescent compound 
discovered was quinine, a naturally occurring blue fluorescent organic dye responsible 
for the slight blue tinge of tonic water.1  Ever since, a number of synthetic and naturally 
occurring fluorescent dyes have been described.   These types of organic fluorescent 
dyes have found widespread applications including: biological molecule labeling, cancer 
treatments, OLED, and paper additives. 
 
1.1 Fluorescence 
Dyes, molecules that absorb light, are ubiquitous in everyday life.  Their modus 
operandi is depicted in the Jablonski diagram in Figure 1.1.  Generally a dye has a pair 
of electrons in the singlet ground state, S0.  Upon absorption of a photon of energy equal 
to the difference in energy between its ground state and an excited state, an electron is 
promoted to an excited state, preserving its spin in the process. Quick relaxation to the 
ground vibrational energy level of S1 usually occurs through a process called internal 
____________ 
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conversion.  This process occurs in the order of 10-12 s and is faster than most radiative 
processes.  The dye then dissipates the energy and the electron returns to a vibrational 
level in S0. 
So
S1
S2
0
1
2
3
0
1
2
3
0
1
2
3
h!absorbance
10-15 s
internal
conversion
10-12 s
h!fluorescence
10-8 s
T1
intersystem
crossing
h!phosphorescence
 
Figure 1.1. Jablonski diagram depicting the processes of absorbance and common 
radiative relaxations. 
 
In the case of fluorescent dyes, the energy is lost, at least partially, by the emission of 
a photon through a transition from S1 to a vibrational state in S0.  This process usually 
occurs in the order of 10-8 s.  A slower relaxation pathway also exists through 
intersystem crossing to the triplet state T1 where the unpaired electrons in T1 and S0 have 
the same spin.  This is a forbidden transition and is therefore much slower than 
fluorescence.  Relaxation back to the ground state through emission is known as 
phosphorescence and is rare especially for organic dyes because of the time required for 
intersystem crossing to occur.  Introduction of heavy atoms can expedite transitions to 
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the triplet state and addition of bromine and iodine are common modifications to 
enhance such transitions in organic dyes. 
An important characteristic of fluorescence is that the emitted photon is of lesser 
energy than the one absorbed.  As mentioned above, this is because fast internal 
conversion occurs to the lowest vibrational level of S1.  A measure of the difference in 
energy between the absorbed and emitted photons is known as a Stokes shift and is 
usually expressed in wavenumbers (cm-1). 
Not all dyes undergo fluorescence efficiently.  In fact, very rarely do all photons 
absorbed by a dye solution result in the same number being emitted.  There are a number 
of ways relaxation from S1 to S0 can occur such as vibrational energy losses and 
molecular collisions.  A measure of the efficiency a dye can fluoresce is known as its 
quantum yield (Φf; commonly shortened to Φ or even φ) and is defined as the ratio of 
photons emitted to the number absorbed.  A dye with a quantum yield of 0.5 for example 
would emit half as many photons as it absorbs.  This is usually measured in a relative 
fashion using a dye of known quantum yield:  the amount of absorbance and 
fluorescence area of the known and unknown dyes can be compared in order to estimate 
the unknown’s quantum yield.  Quantum yields ranging from  0.1 - 0.8 are common for 
dyes considered “fluorescent” although dyes of higher quantum yields are also 
commonly encountered.  Another useful property of fluorescent dyes is their overall 
brightness and is defined as the product of the quantum yield and the molar absorptivity 
(ε). 
! 
brightness ="#$  
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General cellular imaging applications require certain criteria from fluorescent dyes.  
Typically dyes should fluoresce to the red to near-IR regions to avoid emission overlap 
with endogenous cellular fluorophores.  The fluors should be bright; typically quantum 
yields higher than 0.10 and molar absorptivities (ε) larger than 40,000 cm-1M-1 are 
preferred.  The fluorophores should be photostable to withstand the powerful lasers used 
in modern microscopy.  Quenching can be problematic in cell imaging; it is therefore 
practical to use dyes that are less prone to aggregation and have fluorescence 
characteristics that are independent from the local environment of the dye. 
Dyes for in vivo imaging have the added challenges of water solubility and targeting.  
The necessity of red emitting dyes is even greater for in vivo imaging due to poor tissue 
penetration of wavelengths below ca 600 nm.2  Tissue penetration is also an important 
factor for the excitation laser, so a dye should not only emit but also absorb to the red.  
In fact, lasers that are closer to the blue and ultra-violet regions can damage tissue.  One 
relatively new way to overcome this problem is to use two-photons to promote the 
fluorophores to an excited state.3    In this method, two photons are simultaneously 
absorbed by the dye to promote the chromophore from the ground electronic state to an 
excited one (Figure 1.2). The two-photons are of lower energy than the 1-photon process 
but do not necessarily need to correspond to half the energy of the one photon process.  
In typical 2-photon setups, high intensity lasers are employed to increase the chances of 
simultaneous two-photon absorption; this is necessary because the TPA process is 
nonlinear and thus heavily dependent in the laser intensity.  A measure of the probability 
a dye will undergo Two Photon Absorption (TPA) is known as its two-photon cross-
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section and is usually expressed in cm4 s photon-1 or simply GM (GM = 10-50  
cm4 s photon-1). 
So
S1 0
1
2
3
0
1
2
3
h! h!'
h!'
h!emission
 
 
Figure 1.2. Illustration of one-photon (blue) and two-photons (red) absorption processes. 
 
To summarize some of the criteria discussed, ideal fluors should: 
(i) fluoresce in the red to near-IR regions  
(ii) be bright; have quantum yields higher than 0.10 and molar absorptivities 
greater than 40,000 cm-1M-1 
(iii) be photostable 
(iv) not be prone to aggregation 
(v) have fluorescence characteristics that are independent from the local 
environment of the dyes 
Criteria (i) appears simple, it is well known that extending the conjugation of a dye 
pushes its absorbance and emission wavelengths to the red.1  From a design standpoint, it 
is usually more practical to derivatize a known fluor in order to extend its conjugation 
than to design a whole new type of fluorescent dye.  A common method is by the 
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introduction of a “push-pull” system where one area of the dye has high electron density 
while another has low electron density, with the two being electronically conjugated.  
The difficulty however lies in the synthetic accessibility of such modifications. 
Criteria (ii) defined brightness as a critical factor for imaging because of the difficulty 
in observing low fluorescence signals in biological systems.  A common way of 
improving the molar absorptivity of a dye is by extending its conjugation and an 
approach that is congruent with criteria (i) could be used.  Increasing the quantum yield 
however first requires an analysis of the dye to determine why its quantum yield is low.  
Non-radiative decay, usually through rotational energy losses, is a common cause of low 
fluorescent quantum yields and approaches that minimize the rotational freedom of the 
dye are effective in this regard.1  Indeed, rigid dyes tend to have higher quantum yields 
than ones with many modes of rotation.  Of course quenching is also a common reason 
for low quantum yields and steps to reduce quenching are also helpful. 
The photostability of criteria (iii) can be ambiguous and increasing this parameter can 
be a result of trial and error.  Unfortunately, the exists no general principal to predict 
photostability of a fluor.1 
 Aggregation (iv) of dyes can be problematic because the photophysical properties of 
the dyes can change upon aggregation, e.g. the quantum yields can be lowered and the 
spectral maxima shifted.  The addition of water solubilizing groups such as carboxylic 
acids, ethers, and amines for example tend to alleviate aggregation. 
Finally dyes that are impervious to their microenvironments are desired unless the 
sensitivity is required for a specific application such as sensing.  These sensitivities can 
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be caused by the protonation (or deprotenation) of functional groups directly attached to 
the dye core, which alter the electronic properties of the dye.  Avoiding these types of 
functional groups is the best strategy. 
Of course in addition to these general guidelines, others that are specific for certain 
applications may also be desirable.  For example, single molecule microscopy generally 
requires dyes that have a low tendency to photo-blink.♦  Another example that was 
already discussed are dyes used for in vivo imaging needing to absorb in the red region 
and/or have high two-photon cross-sections to allow tissue penetration of the excitation 
source. 
 
1.2 Resonance Energy Transfer 
When two dyes are in close proximity a different type of relaxation from the excited 
state is possible.4  Resonance Energy Transfer (RET) is a process whereby a donor dye 
absorbs a photon in the usual manner but relays the energy an acceptor dye resulting in 
excitation of the acceptor.  A requirement for this process is that the emission of the 
donor dye overlaps with the absorbance of the acceptor dye.  The energy is transferred 
through a dipole-dipole interaction and does not involve the emission of photons from 
the donor. 
                                                
♦ Photo-blinking is a process whereby a dyes excited by a laser source ceases to emit 
photons and essentially enters an “off-state”.  The process is usually reversible so is not 
a problem when imaging a population of dyes although problems occur in single 
molecule imaging.   
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The efficiency of energy transfer is also dependent on the distance between the donor 
and acceptor dyes.  The rate of RET (kT) is given as 
! 
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where τD is the lifetime of the donor in the absence of the acceptor and r is the distance 
between the donor and acceptor.  R0 is called the Förster distance and is the distance at 
which 50 % of the energy from the donor transfers to the acceptor.  R0 not only 
dependent on the spectral overlap between the donor and acceptor mentioned above but 
also on an orientation factor in which R0 becomes larger in circumstances where the 
transition dipoles of the donor and acceptors are “head-to-tail”.  In cases where the 
transition dipoles are perpendicular to each other, R0 becomes zero and RET does not 
occur.  Overall, the efficiency of energy transfer (E) for a donor and acceptor at a fixed 
distance is 
! 
E =
R
0
6
R
0
6
+ r
6
 
 
The distance between the donor and acceptor is thus crucial for efficient energy 
transfer to occur.  Typical Förster distances range from 30 to 60 Å.  For this reason RET 
is a commonly used tool to detect bimolecular interactions where one biomolecule is 
labeled with the donor and a second is labeled with the acceptor.  If the biomolecules 
interact then the proximity of the donor and acceptor becomes favorable for RET and the 
interaction is easily detected through fluorescence spectroscopy. 
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1.3 Multiplexing 
It is often desirable to study biomolecules through means of multiplexing where each 
biomolecule is tagged with different fluorescent labels that are excited simultaneously by 
a laser.  The advantage of this “high-throughput” method is that multiple biomolecules 
can be observed simultaneously (Figure 1.3).  Decreases in sensitivity complicate the 
method as dyes absorb further away from the excitation source.  For this reason, a 
practical limit exists that restricts the amount of concurrent dyes that can be 
simultaneously resolved. 
A B C D
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Figure 1.3. a. Typical arrangement for multiplexing of biomolecules.  b. Dyes that 
absorb away from the excitation wavelength absorb less light and incur a loss of 
sensitivity.  The problem is more pronounced as more dyes are used (c). 
 
a 
b c 
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Combinations of donor and acceptor dyes that maximize the occurrence of RET is a 
common way of lessening the sensitivity loss.  In these arrangements, a dye absorbing 
the laser efficiently is used as the donor and covalently linked to acceptor dyes in a way 
to keep them close enough for RET to occur.  Acceptors are chosen so that their 
absorbance overlaps with the emission of the donor dye, a requirement of RET (see 
above).  Acceptors are also selected to ensure well resolved emissions are obtained.  
Only a partial improvement in sensitivities using RET are obtained however due to the 
donor-acceptor overlap requirement in RET.  As the donor-acceptor overlap becomes 
smaller, the energy transfer through RET becomes less efficient as a loss in sensitivity 
occurs. 
 
1.4 Through-bond Energy Transfer 
As discussed above, the requirements of RET are: (i) good overlap between donor 
emission and acceptor absorbance; and, (ii) favorable transition dipole orientations  
These requirements make RET difficult to use in certain situations, especially when the 
donor and acceptors absorb far away from one another.  A different type of energy 
transfer occurs when two dyes (again, a donor and acceptor) are coupled together in 
through-bond energy transfer (TBET) cassettes (Figure 1.4).  In TBET cassettes the 
donor and acceptor dyes are attached together in a way where the donor and acceptor are 
twisted and therefore not acting a one entity.  The twist can be induced by a conjugated 
linker between the two dyes or can be provided by steric interactions if the donor and 
acceptor are to be directly coupled together.  The dyes retain their individual 
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photophysical properties because the twist prevents them from being electronically 
conjugated.  In TBET, there is no known requirement of spectral overlap between the 
donor and acceptor.  It is therefore possible to create dye dyads with large virtual Stokes 
shifts. 
through-bond
energy transfer
hv
donor acceptor
hv'
energy transfer through 
bonds facilitates production 
of systems with large 
apparent Stokes shifts
through space
energy transfer
hv
donor acceptor
hv'
energy transfer through 
space: limited apparent 
Stokes shifts
RET TBET
 
 
Figure 1.4. Differences between RET and TBET. 
 
TBET systems have been investigated in materials research5,6 and to model 
photosynthetic systems;7-9 Theories describing TBET are vague; TBET may really be a 
summation of several means of transferring energy (i.e. dexter10, superexchange11, 
resonance energy transfers, etc…), although transfer rates in TBET are usually faster 
than those of just RET; this is conducive to more efficient transfer of energy. 
Besides the usefulness of large virtual Stokes shifts in multiplexing applications, 
TBET cassettes have several other valuable attributes for biotechnology.  Quenching of 
an acceptor dye in RET systems usually results in a “turned-off” state where no 
fluorescence is observed from either the donor or acceptor.  This is because energy 
transfer still occurs to the quenched acceptor.  In TBET, the donor can fluoresce even in 
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cases where the acceptor is quenched, thus affording “always-on” probes.  Finally, if the 
donor is prone to photobleaching it may be less so in TBET cassettes due to the fast 
energy transfer from donor to acceptor that often precedes photobleaching processes 
such as intersystem crossing to T1 (Figure 1.5) 
 
 
 
Figure 1.5. Example of fast through-bond energy transfer from a fluorescein donor to a 
rosamine acceptor leading to an increase in photostability of the fluorescein. (ISC = 
Intersystem Crossing, ET = Energy Transfer) 
 
Elegant investigations carried out by Lindsey in the 1990s to model energy transfer in 
photosynthesis serve as the pioneering work in the area of TBET.  Lindsey’s seminal 
contribution was to study BODIPY✠-porphyrin molecular photonic wire 1 (Figure 1.6) 
where the energy was absorbed by a BODIPY unit and transferred step-wise from 
porphyrin to porphyrin and finally to the free base porphyrin that emitted the energy.9  In 
this arrangement, the BODIPY is considered the donor, Zn-porphyrin complexes the 
                                                
✠ BODIPY dyes, short for BoronDIPYrromethene or 4,4-difluoro-4-bora-3a,4a-diaza-s-
indacene, will be covered in detail in Chapter II. 
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linker, and the free-base porphyrin the acceptor.  An important observation in the work 
was that photophysical properties of the donor and porphyrins were preserved.  Most 
interestingly, nearly all of the emission occurred from the porphyrin acceptor (92 %), 
with minimal occurring from the BODIPY (3 %) and the Zn-porphyrin complexes (5 %).  
The overall energy transfer efficiency from donor to acceptor was 76 %, 13 times higher 
than would be predicted of RET in a similar system. 
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Figure 1.6. Lindsey’s TBET systems to study photosynthesis.  The BODIPY donors 
(blue) absorb energy and relay it through bonds to porphyrin acceptors (red). 
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Figure 1.6 Continued. 
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Lindsey investigated the potential of systems like 1 as “optoelectronic gates” where 
the fluorescence of the system could be modulated from an “on/off” state by altering the 
oxidation state of Mg-porphyrins.8  Systems 2 and 3 have properties similar to 1 where 
good energy transfer efficiencies (> 80 %) occur from the BODIPYs to the free base 
porphyrins.  Upon oxidation, the Mg-porphyrin quenched the fluorescence of the 
adjacent free base porphyrin and minimal emissions (3 %) were observed from the 
acceptors. 
Further work by Lindsey examined the effect of multiple donors to a single acceptor (4 
– 7).8  Systems containing one and two BODIPY donors exhibit efficient energy transfer 
to the acceptor (> 95 %) while system 7 with eight BODIPY donors shows a slightly 
lower albeit still very high (> 85 %) efficiency.  In a subsequent publication, Lindsey 
gives some design guidelines to maximize efficient energy transfer: 12 
(i) linker should be placed in areas of high HOMO electron density on the donor 
and acceptor 
(ii) shorter linkers should be used 
(iii) slight twists between the donor/acceptor with the linker are better 
The criteria can conveniently be applied to potential systems through design and 
molecular modeling even before synthesis begins.  Criteria iii is interesting because it 
suggests that although a twist is needed for TBET systems to operate complete electronic 
decoupling between the donor and acceptor actually slows down the energy transfer 
process. 
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Although Lindsey conducted the investigation described above to study energy 
transfer in photosynthesis systems, the efficiency of energy transfer in addition to the 
large virtual Stokes shift involved appeared ideal for multiplexing applications.  With 
this aim in mind the Burgess group looked to design TBET cassettes for high-throughput 
biological applications such as the detection of protein-protein interactions and DNA 
sequencing. 
 
TBET Cassettes for Multiplexed Detection of Protein-Protein Interactions 
The approach undertaken for multiplexed detection of protein-protein interactions is 
depicted in Figure 1.7.  In order to find which partner(s) protein 1 interacts with, it is 
labeled with a fluorescent dye, preferably of high molar absorptivity.  Potential binding 
partners to protein 1 are labeled with different TBET cassettes consisting of the same 
donor that is chosen to optimize RET from the dye labeling protein 1.  The acceptors of 
the cassettes are chosen to have sharp, resolved emissions and high quantum yields.  In 
the example shown in Figure 1.7, upon interaction with protein 1 proteins B and D will 
be in close enough proximity to 1 for RET to occur between the label on protein 1 and 
the donors of cassettes on B and D.  The energy will then be transferred to the acceptors 
via TBET and the respective emissions will identify the interacting proteins, in this case 
B and D. 
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Figure 1.7. Theoretical experimental setup to employ multiplexing to detect protein-
protein interactions. 
 
Cassette 8 (Figure 1.8) was constructed to determine if BODIPY-BODIPY cassettes 
could undergo efficient TBET similar to the ones observed by Lindsey; model 
compound 8 has no functionality to attach biomolecules.13 The incorporated BODIPYs 
preserved their photophysical properties with absorption maxima matching closely to 
those of the free dyes.  Efficient energy transfer was observed from the donor to the 
acceptor.  Encouraged by this, the authors synthesized derivatives 9-11 incorporating 
carboxylic acid functionalities.  Acceptors emitting from 545 to 652 nm were used and 
energy transfers greater than 90 % were measured for these cassettes.  The advantages of 
systems 9-11 over porphyrin based systems are obvious: BODIPYs have high quantum 
yields and their emission wavelengths can be tuned by varying the substitution on the 
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BODIPY.  Although 9-11 have ideal photophysical properties, their use as biomolecular 
labels is precluded by their inherent hydrophobicities.   
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Figure 1.8. First-generation TBET cassettes produced by the Burgess group. 
 
Fluorescein and rhodamine dyes are water soluble under particular conditions and this 
motivated the development of cassettes 12-15 (Figure 1.9) containing xanthene donors 
and hydrophilic rosamines derivatives as acceptors.14  Remarkably, these cassettes 
display nearly quantitative energy transfer efficiencies and can conveniently be excited 
by Argon lasers at 488 nm.  Furthermore, dispersed emission wavelengths of 78 nm 
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were achieved in the series.  As discussed previously in Figure 1.5, the xanthene donor 
showed improved photostability when incorporated in the cassettes.  Unfortunately, 
despite the addition of cationic functionality, the cassettes again proved too hydrophobic 
for the detection of protein-protein interaction although they did find use as DNA label 
(vide infra). 
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FIGURE 1.9. Xanthene-rosamine cassettes. 
 
Cassette 16 is a water soluble version of 13 that was made by the incorporation of 
tetraacids on the rosamine part.15  The absorbance maximum at 556 nm is markedly red-
shifted compared to 13 perhaps due to the presence of the acid on the phenyl group 
attached to xanthene which is known to equilibrate between a closed-lactone and open 
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forms.  This equilibrium is affected by pH and consequently the photophysical properties 
of 16 are pH dependent.  The emission maximum is 579 nm and an ETE of 80 % was 
reported in pH 8.0 buffer.  Mouse acyl-coenzyme A binding protein (ACBP) was labeled 
with 16.  The cassettes did not impede natural binding of or misfold the protein.  The 
photophysical properties of the cassette did change upon binding to ACBP, an indication 
that the photophysical properties of 16 are affected by its microenvironment.  An ACPB-
16 conjugate was imported inside COS-7 cells via Chariot carrier.  The energy transfer 
in cells appeared to be good with little fluorescence from the donor and intense emission 
from the acceptor when exciting at xanthene.  Although 16’s water solubility is a 
remarkable improvement over previous TBET cassettes, the pH sensitivity coupled with 
the lack of clear strategies to obtain series of similar cassettes with dispersed emission 
wavelengths make it difficult to employ for multiplexing. 
 
TBET Cassettes for Other Biological Applications 
TBET cassettes have been used for other biotechnological applications besides 
multiplexing.  Akkaya has developed cassettes that act as metal sensors.  Cassette 17 
(Figure 1.10) displayed near quantitative ETE in organic solvents.16  The emission 
wavelength of the acceptor shifted from 680 to 630 nm upon addition of Ag(I) while 
other metals such as Mn(II), Fe(II), Hg(II), and Co(II) had no such effect.  The shifts in 
emission wavelengths made it possible to ratiometrically detect metal concentrations 
through calibration curves.  Interestingly, the energy transfer of the cassette remained 
high even in the presence of Ag(I).   
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Figure 1.10. Akkaya’s Ag(I) 17 and Hg(II) 18 sensing TBET cassettes and Diederich’s 
BODIPY donor and acceptor TBET cassette. 
 
Cassettes 18 were designed as Hg(II) sensors.17  Similar modulations in photophysical 
properties as 17 occurred upon binding to mercury, mainly a hypsochromic shift from 
670 to 600 nm in emission wavelength of the acceptors.  Unfortunately a slight, albeit 
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significant, response to Ag(I) was also obtained although sensitivity to Hg(II) was ca 7 
times greater; no other metals had appreciable effects on the fluorescence of 18.   Also 
notable is the decrease in ETE from 94 % to 85 % of 18b compared to 18a respectively, 
resulting from the increase in the length of the phenylacetylene linkers.  This seems to 
corroborate Lindsey’s criteria (see above) that longer linker lengths tend to impede 
efficient TBET.  Akkaya et al. assert that the energy transfers in 17 and 18 occur through 
RET although such an exclusive transfer pathway is unlikely. Water-soluble versions of 
these systems would be more desirable but hydrophilic systems are considerably more 
challenging to synthesize. 
The observed drop in energy transfer efficiency concurrent with linker length increases 
corroborates work by Diederich et al. on cassettes 19.18  The authors correlated the 
decrease in ETE with length between the donors and acceptors as measured by the 
boron-boron distances.  Cassette 19a showed an excellent ETE of 98 % at a donor-
acceptor distance of 19 Å while 19b had an ETE of 85 % at 32 Å.  Amazingly, in the 
case of 19c, the ETE dropped to a mere 35 % at a donor-acceptor distance of 53 Å.  In 
the same manuscript, the authors used these findings to design an elegant light activated 
molecular switch although this work is beyond the scope of a discussion on TBET since 
the switch did not represent a TBET cassette. 
TBET cassettes have also been explored as fluorescent tags for DNA.  There are 
numerous advantages in tagging DNA in such a way; the absorbance wavelengths of the 
tagged bases are red-shifted away from the unlabeled bases, the molar absorptivities of 
the bases increase as a result of the added conjugation, and finally acceptors that emit far 
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from the excitation source can be used thus simplifying the detection process.  Cassettes 
20-22 feature extended thymidine donors and xanthene acceptors (Figure 1.11).  First a 
deoxynucleoside analog of 20 was made.19  This analog showed an absorption maximum 
from the donor at 320 nm in contrast with thymidine that absorbs near 260 nm.  The 
energy transfer efficiency to the acceptor was near 100 % and fluorescence from the 
acceptor occurred at 520 nm.  Oligonucleotides incorporating 20 were synthesized by 
solid phase syntheses20 and the cassette was not significantly quenched in either single or 
double stranded conformations.  Thermal denaturation studies showed that the presence 
of 20 in ds-oligonucleotides did not significantly decrease the stability of the chains, less 
so in fact than A-A mismatches.  Circular dichroism studies also demonstrated that 20 
did not perturb the ds-oligonucleotide B-form.  Dideoxythymidine triphosphate-cassette 
conjugates were constructed from compounds 20-22.21  Taq polymerase was used in an 
attempt to incorporate the modified nucleotides into DNA.  The rate of incorporation 
was ddTTP > 6-TAMRA-ddTTP > ddTTP-22 > ddTTP-21 > ddTTP-20, with the later 
two showing little to no incorporation (TAMRA ddTTP is a common dye used in 
sequencing and was included for comparison).  The leading hypothesis for this trend is 
that longer donors separate the acceptors from the nucleotides affording more room for 
the polymerase to operate.  Although the cassette conjugates showed slower 
incorporation, their favorable photophysical properties still lend to their potential 
applications in DNA labeling so long as a linker of suitable length is used. 
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Figure 1.11. Cassettes studied as DNA labels. 
 
A serendipitous discovery of side product 23 was observed upon synthesis of cassette 
20.22  The time and temperature of a Sonogashira coupling step was critical as longer 
reaction times and higher temperatures tended to favor formation of 23.  Melting 
experiments with oligonucleotides containing 23 revealed that the modified nucleobase 
is a better mimic for thymine than other nucleobases.  The use of cassettes of type 23 in 
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DNA is complicated due to their tendency to readily hydrolyze to the corresponding 
saturated ketones. 
Cassettes as possible fluorescent labels for Sanger sequencing were also investigated.23  
Common dyes available from ABI for Sanger sequencing are FAM, JOE, TAMRA, and 
ROX and emit from 520 to 620 nm compared to 12-15-primers conjugates that emit 
from 519 to 641 nm.  The cassettes were attached to DNA primer R931.  Although 
incorporation and thus chain termination appeared to have occurred as would be 
expected in Sanger sequencing, the analysis software complicated the utilization of 
cassettes 12-15 for sequencing. 
The Burgess group has investigated an intriguing use of TBET in which a 
chemiluminescent, as opposed to a fluorescent dye, is used as a donor.24  Just as in 
traditional TBET cassette systems, upon excitation the donor transfers the energy to the 
fluorescent acceptor; the difference in these systems being the initial donor excitation 
occurs by chemical reactions rather than light.  Two compounds containing a luminol 
donor, and xanthene (24) and Nile Red (25) acceptors were prepared (Figure 1.12).  
Luminol is activated in the presence of oxidants while the acceptors would otherwise not 
be affected by such conditions.  In systems 24 and 25, no luminescence was observed 
from the luminol donor upon oxidation and emission occurred only from the acceptors at 
524 and 634 nm respectively.✵  Interestingly, upon excitation of 24 and 25 by light, the 
                                                
✵ There is some ambiguity in whether compound 25 is acting as a true TBET cassette or 
an extended Nile Red with luminol functionality; the required twist for TBET in this 
system is not evident.  Nile reds are particularly sensitive to their microenvironments 
causing significant fluctuations in their photophysical properties25 making a 
determination based solely on absorbance and emission spectra difficult.  This is trivial 
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emission wavelengths shifted to the blue by 6 nm in both cassettes compared to 
chemiluminescent activation, something that cannot easily be explained but may be an 
artifact of the slight change in microenvironment caused by the addition of the oxidant.  
Potential uses of chemiluminescent cassettes include cellular oxidant sensing which 
could help the study of cell signaling pathways26, and 24 and 25 could be used in 
conjunction with horseradish peroxidase’s Enhanced ChemiLuminescence (ECL) 
method of enhancing chemiluminescent signals for biological applications. 
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Figure 1.12. Chemiluminescent systems incorporating TBET. 
                                                                                                                                           
in the case of chemiluminescence since the properties of the cassettes versus the 
extended dyes would be similar. 
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Other TBET Cassettes 
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Figure 1.13. Ziessel’s star-shaped multichromophoric system that absorbs most 
wavelengths of the visible spectrum.  Donors (blue, green, and orange) all relay energy 
to the acceptor (red). 
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TBET cassettes have also been studied for solar cell applications.  The concurrent 
harvest of energy by multiple donor dyes at many wavelengths is the premise of such 
systems.  Ziessel et al. designed cassette 26 with one truxene and two BODIPY donors 
that absorb light from 300 to 636 nm while a BODIPY acceptor expands the absorbance 
of the system to 750 nm and emits at 767 nm (Figure 1.13).18  In the context of a TBET 
cassette, 26 is interesting in so far as it has three different donors.  Irradiation at each of 
the donors produces emissions primarily from the acceptor with minimal leakage from 
the other donors.  Mechanistically, the energy absorbed by the truxene is quickly 
transferred to the BODIPYs, indicative of TBET.  The energy from the BODIPYs is then 
transferred, perhaps in a step-wise fashion, to the acceptor through slower energy 
transfer processes in good agreement with theoretical RET calculations.  It is unclear 
why inter-BODIPY energy transfer occurs through RET although the arrangements of 
the BODIPYs around the truxene (acting as a linker after it quickly passes off its energy) 
could be the reason since it is unclear if multiple energy transfers can simultaneously 
occur through a single linker. 
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Figure 1.14. BODIPY TBET cassettes with differing donor to acceptor ratios.  The 
molar absorptivities do not increase linearly with the amount of donors. 
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Further work by Akkaya investigated cassettes 27-2927 designed with donor to 
acceptor ratios greater than 1 (Figure 1.14).  The ETE remained high for all cassettes in 
the series, even as three donors to one acceptor were incorporated.  This is congruent 
with work discussed above by Lindsey (Figure 1.6) where a drop in ETE occurred only 
as eight donors to one acceptor where incorporated.  Perhaps the most remarkable part of 
the work is the non-linear increase in molar absorptivities as the number of donors was 
increased; the incorporation of two donors increased the molar absorptivity by 2.7 times 
(compare 27 and 28) demonstrating the potential of TBET cassettes as bright fluorescent 
probes. 
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Figure 1.15. TBET systems with donors attached on different parts of the cassette.  The 
ETEs where not reported by the authors but where calculated here by taking the ratio of 
the quantum yield when exciting at the donor to the one when exciting at the acceptor 
(see Chapter III for a detailed explanation) 
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Akkaya (Figure 1.15) described similar studies using a deep red emitting acceptor.28  
The ETE remained high even as three donors were used, something that is notable 
considering the pseudo-Stokes shift of these systems: the absorbance of the cassettes was 
near 528 nm with emissions at ca 668 nm.  The molar absorptivities in this series did 
increase in a near-linear fashion as opposed to cassettes 27 and 28.  An interesting aspect 
of these cassettes is that the donors all retained the same photophysical properties even 
though they were incorporated in different parts of the molecule indicating a strong 
electronic decoupling produced by the molecular twists.  This, the authors argued, was 
an indication that the mechanism of energy transfer occurred through RET although the 
aforementioned twist is also a requirement for fast TBET and in fact both processes may 
be occurring simultaneously. 
 
Optimization of TBET  
Burgess et al. tested the effect of the relative placement of donors and acceptors as 
well as the nature of the molecular twist on the energy transfer rates (these rates are 
usually proportional to ETE).29  In these systems an anthracene donor was attached in 
different arrangements to a BODIPY acceptor; no linker was present on these systems 
(Figure 1.16).  It is easy to explain the photophysical properties✙ (especially absorbance 
and emission wavelengths) of the cassettes based on the nature of the molecular twist 
                                                
✙ The photophysical properties described in Figure 1.16 do not match those in the 
referenced paper29.  There appears to be some disagreement between Table 2 and Figure 
4 in the manuscript.  Consequently, the photophysical properties reported herein are 
from the raw, original, data that is included in Appendix A. 
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between the donor and acceptor. Understanding the position of the molecular twist in 
these systems is important as the photophysical properties depend heavily on these.  
Cassettes 33, 34, and 36 for example are twisted only at the junctions of the BODIPYs 
and phenylacetylene units.  In these cases, the phenylacetylene and anthracene parts are 
electronically conjugated and the absorbance wavelengths of the anthracenes are red-
shifted compared to that of free anthracene; these whole units in essence become the 
donors.  The absorbance of anthracene in 34 is further red-shifted by the introduction of 
bromine.  It is interesting to note that systems attached at the meso position of BODIPY 
(33 and 34) appear to be more electronically decoupled from the BODIPY than those 
attached at the C-2 position (35 and 36).  This is indicated by the emission wavelengths 
of the BODIPYs where 33 and 34 match the emissions of the free acceptor while 35 and 
36 are greatly red-shifted.  This difference can be explained in terms of the steric 
interactions between the BODIPY core and the donor.  Substituents at the meso position 
encounter greater steric strain thus locking them in a near perpendicular orientation 
relative to the BODIPY core.  This orthogonal arrangement fundamentally breaks the 
electronic conjugation between the two systems.  The steric constraints at the C-2 
position appear to be less; this is corroborated by X-ray crystallography.  
Ultra-fast relaxation time measurements of the anthracene donors were measured and 
are good indications of the rates of energy transfer within the cassettes.  Lindsey 
revealed that cassettes with greater electronic conjugation between the donor and 
acceptor have generally faster energy transfer rates (vide supra).  It is therefore not 
surprising that cassettes 35 and 36 have faster relaxation rates than 33 and 34 supporting 
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the above assertion that the formers are have better electronic conjugation between the 
donors and acceptors. 
Cassettes 37 and 38 have virtually no steric constraints between the donor and 
acceptor and spectrographically they behave nearly as one entity with bathochromic 
shifts in both the absorbance of the anthracenes and the emission of the BODIPYs.  The 
anthracene and BODIPY units still do appear to retain some of their photophysical 
properties, for example in the case of 37 and 38 both BODIPY and anthracene 
absorbance peaks are present though the anthracene one is relatively weak and deformed 
(anthracenes generally have “triplet” absorbance spectra while the ones in these cassettes 
are broad singlets). 
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Figure 1.16. Structures and basic photophysical properties of cassettes to study various 
aspects of energy transfer.  All ETE are > 95 % and t is the time for the energy transfer 
process (see note in text about the wavelengths reported here). 
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A subsequent publication by Burgess et al. correlated the rates of energy transfer with 
respect to the S1 ↔ S0 transition moments of the donors and acceptors (Figure 1.17).30  
Their findings indicated that fastest energy transfer (ca 200 fs) occurred when the donor 
and acceptor transition moments were parallel to one another, representative of 
compounds 35 and 36.  The next fastest energy transfer (ca 420 fs) occurred when the 
donor and acceptor had perpendicular transition moments such as cassettes 33 and 34.  
Finally the introduction of linkers slowed the energy transfer process considerably.  
Cassettes 12-15 and 39-42 for example have energy transfer rates ranging from 2.5 to 20 
ps.  Interestingly, in some circumstances, as the length of the linker increased the rate of 
energy transfer became faster.  Cassettes 14 for example displayed an energy transfer 
rate of 6 ps while analog 35, with a shorter linker, had an energy transfer rate of 30 ps.  
Notably this contradicts observations of cassettes 18 and 19 in which shorter linker 
lengths gave more efficient energy transfers as well as Lindsey’s observations for faster 
energy transfer.  Several factors seemed to indicate that TBET and not RET was the 
primary energy transfer mechanism in these cassettes: 
(i) RET should not occur when the donor and acceptor are locked in an arrangement in 
which their transition dipoles are perpendicular to one another 
(ii) as the distance between the donor and acceptor increased the energy transfer rates 
either did not change or actually became faster 
(iii) no correlation between the transfer rates and the nature of the acceptor was found, 
a correlation would be expected in RET due to the spectral overlap requirements for 
efficient transfer of energy 
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Figure 1.17. Correlation of donor-acceptor transition moment with energy transfer rates. 
 
1.5 Goals and Aims 
The focus of this dissertation is on the development of new fluorescent molecules for 
labeling of proteins to visualize their locations and/or study their interactions with other 
biomolecules by: 
(i) developing ideal acceptor dyes for incorporation in TBET cassettes (Chapter 
II) 
(ii) synthesizing new TBET cassettes (Chapter III) 
(iii) examining the potential use of bright polymer based TBET systems and 
nanoparticles made from them (Chapter IV) 
  Another part of this dissertation deals with the development of dyes for 
PhotoDynamic Therapy (PDT) that have potential for cancer treatment; this will be 
discussed in Chapter V. 
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CHAPTER II 
MODIFICATIONS OF THE BODIPY CORE 
 
2.1 Introduction 
BODIPYs© (BOronDIPYrromethene or 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) 
are good imaging dyes for numerous reasons.31,32  BODIPYs are compact fluors and 
therefore have minimal impact on biomolecular conformations upon binding.  
Furthermore, BODIPYs are highly conjugated owing to their nitrogen-to-nitrogen push-
pull system leading the high molar absorptivities.  The boron chelate holds the dyes rigid 
while also preventing photo-isomerization processes; consequently BODIPYs possess 
high fluorescence quantum yields.  BODIPY dyes are relatively photostable and are used 
for a variety of biological imaging applications.33-38 The BODIPY core is generally 
insensitive to pH or solvent environments.  Overall BODIPYs’ brightness, 
photostabilities, and insensitivities to their environments meet criteria ii, iii, and v of 
ideal imaging dyes discussed in section 1.1.  The drawbacks of simple BODIPYs are 
their blue-green emissions and hydrophobicities, which complicates their use as 
acceptors in TBET cassettes for biological imaging applications. 
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Figure 2.1. BODIPY core and commonly encountered BODIPY dyes 
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BODIPY dyes were discovered in 1968 by Treibs et al.39 although the parent 
unsubstituted  BODIPY core A remained unsynthesized until recently.40-42  Some general 
photophysical trends are apparent from Figure 2.1; as the substitution on BODIPY 
increases, so do the absorbance and emission wavelengths.  Not surprisingly, since these 
substituents can easily rotate, the quantum yields are negatively affected.  Unfortunately, 
even the fully substituted BODIPY C fluoresces near 550 nm and is therefore of limited 
value for fluorescence imaging or as an acceptor for TBET cassettes. 
General syntheses of BODIPYs are shown in Scheme 2.1.  BODIPYs can be 
categorized into ones with meso-substituents and those without.  For meso-substituted 
BODIPYs, the synthesis usually involves the condensation of the corresponding pyrrole 
with a benzaldehyde derivative (Scheme 2.1).37  This gives a dipyrrole intermediate that 
is oxidized and subsequently treated with base in the presence of BF3•OEt2 to yield the 
BODIPY dye.  The oxidation step can be avoided by initial condensation of the 
corresponding pyrrole with acyl chlorides instead of aldehydes though these reactions 
tend to be harder to purify.43,44  
The syntheses of meso-unsubstituted BODIPYs are accomplished via condensation of 
the pyrrole with the corresponding pyrrole-2-carbaldehyde under acidic conditions, 
followed by treatment with BF3•OEt2 in the presence of base (Scheme 2.2).39  A more 
recent procedure involves the condensation of 2 equivalents of pyrrole-2-carbaldehydes 
in the presence of phosphorous oxychloride45 followed by chelation to boron.  This 
method is generally cleaner and higher yielding and is now the preferred method to 
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synthesize symmetrical meso-unsubstituted BODIPYs though it was not yet discovered 
at the start of this dissertation. 
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Scheme 2.1. Examples syntheses of a. meso-substituted BODIPYs 
NH HN
OHC
+
(i) H+ or LA
(ii) Et3N, BF3•OEt2
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70 %  
Scheme 2.2. Examples syntheses of unsubstituted BODIPYs. 
 
Prior to the start of the work described in this dissertation, few red emitting (> 600 
nm) BODIPYs were known (Figure 2.2).  Emissions of type E systems are modestly red-
shifted to 609 nm by the modification of the BODIPY with isoindoles though syntheses 
of such compounds require multiple steps and their quantum yields tend to be low.46,47   
BODIPYs of Types F-I possess aryl groups on the α-positions.  The simplest, compound 
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F48,49 has freely rotatable α-aryl groups and emits at 626 nm with a quantum efficiency 
of 0.42.  Compounds G-I possess even deeper red emissions by restricting the rotation of 
the α-aryl groups, increasing the overall conjugation of the α-aryl groups with the 
BODIPY core.38,50,51  An α-distyryl BODIPY derivative (K) has also been reported and 
emits at 642 nm with a very high quantum yield of 0.84.52  Unfortunately BODIPYs F-
I,K are inconvenient to make since the α-functionality needs to be introduced on the 
pyrroles prior to BODIPY formation; this extends and complicates the syntheses of such 
compounds.  The introduction of nitriles on the meso-position of type J BODIPYs also 
red-shifts the emissions though syntheses of these are cumbersome and not 
generalized.39,53  A general approach to modify existing BODIPY cores was therefore 
warranted to avoid the lengthy or difficult syntheses of the pyrroles for compounds of 
type E-K.  A condition developed by Akkaya et al. was known to adequately red-shift 
BODIPY dyes by modifying the BODIPY core and was the only known example at the 
time of this work (Scheme 2.3). 
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Figure 2.2. Known red-emitting BODIPYs prior to start of dissertation work. 
 
Akkaya’s modification involved Knoevenagel condensation of D with 4-
dimethylaminobenzaldehyde yielding BODIPY L that fluoresced at 672 nm (Φ 0.58) in 
THF though photophysical properties were heavily dependent on solvent due to the 
presence of aniline functionality.54  For example, in acetonitrile L fluoresced at 731 nm 
with a quantum yield of 0.13 while it emitted at 672 nm with a quantum yield of 0.58 in 
tetrahydrofuran.  Another drawback was that only mono-condensation was obtained and 
in low yields (24 %).  Therefore the goal of this chapter deals with the exploration of 
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novel ways of modifying BODIPY cores to extend their emission wavelengths into the 
red to use these dyes as acceptors for TBET cassettes in multiplexing applications. 
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Scheme 2.3. Modification of BODIPY core to obtain L. 
 
2.2 Phenylacetylene-BODIPY Derivatives 
We hypothesized that compounds of type 43, in which the conjugation of the BODIPY 
core are extended by the addition of phenylacetylene units, should have red-shifted 
emission wavelengths and the rigidity of such systems should not negatively impact 
quantum yields (Scheme 2.4).  Furthermore, derivative 43 contains no functionality that 
should increase the pH or solvent dependence versus those of simple BODIPYs. 
Synthesis began with standard Vilsmeyer Haack formylation of 2,4-dimethylpyrrole to 
yield 44 in 98 % yield.  Condensation of 44 with 2,4-dimethylpyrrole under Lewis acid 
conditions followed by treatment with triethylamine and BF3•OEt2 yielded BODIPY B in 
51 % yield.  Diiodination of B55 with iodine and iodic acid56 gave BODIPY 45 in 88 % 
yield.  Diiodide 45 was subjected to Sonogashira coupling with phenylacetylene to give 
BODIPY 43 albeit in low yields (12 %). 
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Scheme 2.4. Synthesis of BODIPY 43. 
 
We were pleased that 43 had red-shifted absorbance at 576 nm and emission at 604 nm 
compared to parent compound B which absorbs at 505 nm and emits at 516 nm.  
Furthermore 43 displayed a bigger Stokes shift which is a quality that can be useful for 
imaging purposes.  Unfortunately, 43 was nearly insoluble in every solvent tested which 
prevented us from measuring other photophysical properties.  Furthermore, 43 lacked 
functionality to attach to biomolecules.  We theorized that the addition of an aliphatic 
chain would help solubility in organic solvents and the inclusion of carboxylic acid 
functionality would allow for conjugation to biomolecules; for these reasons compound 
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46 was investigated (Scheme 2.5). Synthesis of 46 was accomplished by condensation of 
2,4-dimethylpyrrole with succinic anhydride under Lewis acid conditions followed by 
addition of triethylamine and BF3•OEt2 to yield BODIPY 47 in 18 % yield.  BODIPY 47 
was diiodinated using iodine and iodic acid though the yields tended to be modest (54 
%) due to a side reaction involving formation of the methyl ester derivative of 46.  
Finally Sonogashira coupling of 48 with phenylacetylene gave acceptor 46 in moderate 
yield (55 %). 
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Scheme 2.5. Synthesis of BODIPY 46. 
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Table 2.1. Photophysical properties of compounds 46 and 49. 
Cmpd basea λabs (nm) / ε x 10-4 
λem 
(nm) 
fwhm 
(nm) Φ
b 
B57 _ 505 / 8.0 516 22 0.80 
46 _ 560 / 2.6 587 41 0.72 
46 + 559 / 2.6 587 41 0.71 
49 _ 565 / 0.9 593 46 0.46 
49 + 563 / 1.0 592 43 0.61 
Absorption data recorded at 1 x 10-5 M.  Emission data taken at 1 x 10-6 M.  a With 
Bu4NOH at a concentration of 8 x 10-5 M.  b Rhodamine 101 (Φ = 1.0 in ethanol)58 was 
the standard for 46 - 49. FWHM is “Full-Width at Half Maximum” and is a measure of 
the sharpness of emission signals. 
 
BODIPY 46 emitted at 587 nm (Table 2.1), displayed a favorable quantum yield (Φ 
0.73), had greater solubility in organic solvents than 43, and its fluorescence properties 
were not affected by the presence of base.  Solubility of 46 in aqueous solvent however 
was poor and this led to significant fluorescence quenching due to aggregation in such 
media.  We attempted to increase water solubility of 46 through addition of carboxylic 
acids on the phenylacetylene parts while being mindful that such modifications could 
increase the pH dependence of the compound.  For this purpose compound 49 was made 
via Sonogashira coupling of 48 and 50 (Scheme 2.6)  This BODIPY was obtained in 13 
% yield reflecting the difficulty in purifying the compound through preparatory HPLC.  
Emission of 49 was slightly red-shifted compared to compound 46 (Table 2.1) and 
fluoresced near 600 nm.  Interestingly, 49 did not exhibit pH-dependent fluorescence 
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properties and this characteristic is attractive for imaging applications.  Furthermore, 49 
is soluble in alkaline aqueous conditions which further adds to its potential as not only a 
fluorescent label but as an acceptor for TBET cassettes. 
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Scheme 2.6. Synthesis of BODIPY 49. 
 
After completion of the work above, Ziessel et al. looked into similar phenylacetylene 
extended BODIPYs with the aim of extending their emissions to the red (Figure 2.3) and 
published their findings in 2008.59  Compound M fluoresced near 600 nm, similar to the 
emissions of compounds 43, 46, and 49.  BODIPY N displayed a remarkable emission 
bathochromic shift compared to emissions of other phenylacetylene BODIPYs, emitting 
at 700 nm but unfortunately possessed a quantum yield below 0.01.  Addition of acid to 
N caused hypsochromic shifts in the emission wavelength to 584 nm and also increased 
the quantum yield to 0.53.  This pH sensitivity precludes the use of such compounds for 
general imaging applications. 
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Figure 2.3. Phenylacetylene BODIPYs published by Ziessel after completion of the 
work described in this chapter. 
 
In summary, compounds of type 43, 46, and 49 fluoresce near 600 nm with good 
quantum yields.  Overall, the compounds show promise as acceptors for TBET cassettes 
and their incorporation into cassettes will be explored in Chapter III. 
 
2.3 C-H Functionalization on BODIPYs 
While compounds 43, 46, and 49 showed promise as TBET acceptors we were 
originally interested in developing acceptors that could be conveniently made from 
derivatizations of the BODIPY core.  While this was partially achieved for the 
phenylacetylene-BODIPY derivatives 43, 46, and 49, the BODIPYs first needed to be 
diiodinated before derivatization, which could be inconvenient and difficult on more 
complicated BODIPY systems. 
It has been demonstrated that palladium can activate aromatic compounds, particularly 
pyrroles60-62 and indoles63-65, towards C-H functionalization reactions (Figure 2.4a-b)  We 
hypothesized that similar types of reactions could be performed on BODIPY cores due 
to their nucleophilicities.  We were particularly interested in metal catalyzed 
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functionalizations of BODIPYs with electron withdrawing acrylates to disperse 
emissions into the red (Figure 2.4c).66 
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Figure 2.4.  C-H functionalization of a. indoles and b. pyrroles developed by Gaunt et 
al.. c. Guiding hypothesis for producing BODIPY dyes with extended conjugation in a 
single reaction. 
 
The Heck-type coupling shown in Figure 2.4c liberates HPdX(2+) species that 
disproportionate to Pd(0) and HX; consequently, reoxidants are required to make the 
reaction catalytic in palladium.  Two sets of conditions were explored to bring this 
about.  Method A in Table 2.2 features tert-butyl benzoyl peroxide as a reoxidant in a 
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mixed solvent system.  These conditions were devised by Gaunt62,65 based on Larock’s 
discovery that solvent systems containing DMSO ligate palladium zero preventing 
formation of insoluble aggregates.67-69  Method B is a minor modification by us, based on 
other conditions originating from Larock and Gaunt, but with microwave irradiation. 
Table 2.2 indicates method A gave good overall yields when the EWG group was an 
ester, and that mixtures of mono- (50) and di- (51) substitution were formed.  These 
were easily separable via flash chromatography (entries 1 and 2). Functionalization with 
acids was of particular interest to label biomolecules.  Entry 3 shows that the 
predominant product 50c arose from mono-substitution when an α,β-unsaturated acid 
was the electrophile.  A very low yield of the monosulfonated product 50d was isolated 
in entry 4.  Diminished yield in this reaction reflects difficulties encountered in the 
isolation procedure for the sulfonic acid, and perhaps some attenuation of alkene 
electrophilicity associated with the negatively charged sulfonate form. 
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Table 2.2.  Oxidative functionalization of tetramethyl-BODIPY. 
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isolated 
yield (%) entry EWG method 
50 51 
a CO2Me A 61 30 
b CO2Bu A 56 28 
c CO2H A 29 trace 
d SO3H B 2 0 
Method A: 20 mol % Pd(OAc)2, tBuOOBz, AcOH:dioxane:DMSO, 35 ºC, 5 d. Method 
B: 20 mol % Pd(OAc)2, Cu(OAc)2, DMF:DMSO, microwave (200W, cooling, 80 ºC, 30 
min) . 
 
The fact that both mono- and disubstituted products were formed in some cases gave a 
good dispersion of UV absorbance and fluorescence emissions for the series as a whole 
(Figure 2.5).   Further, the molar absorptivities of the dyes are comparable to the starting 
material.35  Their quantum yields tend to be excellent, ranging from 0.51 to 0.73 for the 
esters and 0.42 for the carboxylic acid 50c, though the quantum yield of sulfonic acid 
50d was lower (0.25).  Brightness of dyes is a function of absorbance and quantum 
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yields (see section 1.1), thus it is unsurprising that compounds 50 and 51 are colorful to 
the eye, and brilliant when irradiated (Figure 2.4c).  Spectral data for all the dyes in 
EtOH is collected in Table 2.3.  The sharpness of the fluorescence emissions, 
characterized as the width of the emission peak at half the fluorescence intensity (full 
width at half maximum; fwhm), was comparable to the parent 1,3,5,7-tetramethyl-
BODIPY (22 nm) but tended to become slightly broader with increased conjugation.  
This is somewhat unfortunate since dyes ideally need sharp emissions to be used as 
acceptors in TBET cassettes to obtain well-resolved signals for multiplexing applications 
(see sections 1.3 and 1.4). 
a 
 
 
Figure 2.5. Normalized a. absorbance; and, b. emission spectra of dyes 50a - b, 51a – b 
in EtOH (1.23 x 10-5 M, excited at the respective λmax) with the exception of 51a which 
was measured in EtOAc due to poor solubility in EtOH.  c. Photograph of the dyes 51a, 
51b, 50b, 50a, 53f, 53e, 52f, and 52e (in that order) under UV irradiation. 
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c 
 
 
Figure 2.5 Continued. 
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Table 2.3 Spectral Properties Measured in Ethanol 
 
λmax 
(nm) 
log(εmax) 
λf 
(nm) 
fwhm 
(nm)a 
Φf 
      
50a 527 4.80 ± .01 549 40 0.73 ± .01 
51a 559b 4.13 ± .01 580 45 0.51 ± .02 
50b 528 4.79 ± .01 551 39 0.73 ± .01 
51b 560 4.48 ± .01 580 37 0.52 ± .01 
50c 531 4.43 ± .02 570 58 0.42 ± .02 
50d 529 -c 560 50 0.25 ± .01 
52e 518 4.37 ± .02 525 24 0.72 ± .01 
53e 530 4.86 ± .01 539 25 0.92 ± .05 
52f 517 4.80 ± .01 527 25 0.78 ± .01 
53f 529 4.74 ± .01 540 24 0.89 ± .01 
a Full width at half-maximum height: a measure of the sharpness of the fluorescence 
peaks.  b Measured in ethyl acetate.  c Quantity isolated too small for accurate 
measurement 
 
At the time of this work, there were relatively few water soluble BODIPY dyes, and 
even fewer that had well documented synthetic procedures to make them.44,70  In the 
context of TBET cassettes, water solubility is important to avoid quenching of the dyes 
by intercalation in biomolecules and also to aid the labeling process, however since the 
use of dyes 50 and 51 in cassettes is precluded by their emission wavelengths we chose 
to shift the focus of these BODIPYs as simple biomolecule labels.  Fluorescent labels 
also need to be water soluble to avoid aggregation effects and to aid the labeling process; 
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and functionality should be present for labeling purposes.  Dye 50c is slightly water 
soluble, and has a carboxylic acid that could be activated with water solubilizing groups, 
e.g. a sulfonated N-hydroxysuccinimide.  Consequently, it has potential for covalent 
linking to biomolecules.  BODIPY 50d is water soluble, and could find other 
applications where fluorescence in aqueous media is required.  For these reasons, we 
chose to study these two dyes in aqueous buffers at different pH values (Figure 2.6).  
50c-d show no sensitivity to pH range of 6.05 – 8.04 where the emissions vary by only 3 
nm.  This is a marked contrast to fluorescein dyes for which equilibria between xanthene 
and ring-closed-lactone forms cause the emissions wavelengths and intensities to vary 
greatly over a similar pH range. 71 
a 
 
 
Figure 2.6.  Normalized absorbance and emission spectrum of 1c (a) and 1d (b) in 
various solvents (1.23 x 10-5 M in ethanol and 1.00 x 10-5 M in buffer). Buffers used 
were: pH = 2.19 citric acid; pH = 6.05 MES/LiOH; 7.10 bis-tris/H3PO4; 8.04 
HEPES/LiOH 
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Figure 2.6 Continued. 
 
Mechanistically, C-H functionalization was thought to proceed first by ligand 
exchange between the BODIPY and Pd(OAc)2 yielding a BODIPY-Pd-OAc 
intermediate (Figure 2.7).  The substituted BODIPY then undergoes Heck-type 
migratory insertion between the BODIPY and acrylate followed by β-hydride 
elimination.  To test this mechanistic hypothesis we tried the functionalization reaction 
on cyclic substrates lacking syn β-hydrides that would otherwise allow for elimination 
producing alkenes in conjugation with BODIPY. 
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Figure 2.7. Hypothesis for mechanism of C-H functionalization. 
 
Reaction 1 (Figure 2.8) shows the C-H functionalization process applied to two α,β-
unsaturated esters, Q and R.   As before, mono- and disubstituted products were isolated 
(52 and 53, respectively), but the alkene double bond was shifted out of conjugation with 
the BODIPY core. Migratory insertion of intermediates like S cannot undergo β-
elimination to form an alkene in conjugation with the BODIPY part; the only hydrogen 
available on the same face of the carbocyclic ring is the one marked Hβ below, which 
takes the alkene out of conjugation.  The products 53 are probably mixtures of 
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diastereomers, but the two chiral centers are so far apart that the NMR data is as if this 
were essentially one compound. 
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Figure 2.8. C-H functionalization of B with carbocyclic unsaturated esters that lack β-
hydride that can eliminate to give a conjugated product with the BODIPY core. 
 
In summary, palladium mediated C-H functionalization reactions provide a direct way 
to extend the conjugation of BODIPY B.  The strategy does not require that halogenated 
or metallated intermediates be isolated prior to the coupling reaction.  Mono- and 
disubstituted products can be obtained; these have brilliant fluorescence with emissions 
that span 525 – 580 nm.   Further the methodology has potential for syntheses of systems 
with handles for bioconjugation and inclusion of water-solubilizing groups.  The 
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fluorescence wavelengths and large FWHM however are not conducive towards use of 
the compounds as acceptors for TBET cassettes. 
 
2.4 Conclusions 
Functionalizing the BODIPY core provides direct methods of shaping BODIPY dyes 
for specific uses.  There have been numerous modifications to BODIPY cores to 
increase both emission wavelengths and water solubilities since the work described 
herein. 
C-H activation72-76 has potential for functionalizing BODIPYs since otherwise 
unreactive C-H bonds could potentially be functionalized and regioselectivities can be 
different than other methods.  Boronic esters are valuable intermediates since they 
undergo many transformations including Suzuki couplings77, Heck-type couplings78, 
oxidations to alcohols, and deprotections to boronic acids.79  For this purpose we 
explored the C-H activated borylation of BODIPY B (Scheme 2.7a).  Unfortunately, the 
BODIPY proved unreactive towards C-H borylation reactions, though similar borylation 
was subsequently achieved by others on less substituted BODIPYs (Scheme 2.7b).78  The 
differences in reactivity between our attempt and theirs can be ascribed to steric 
hindrances since these types of C-H borylation reactions tend to be highly sensitive to 
such interactions; this also explains β-selectivity of such borylation reactions since α-
selectivity are favored electronically.72  Unfortunately, borylated BODIPY T was 
obtained in low yield and as a mixture with mono-activated product U although the 
authors found that the borylation step could be more conveniently carried out at earlier 
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stages of BODIPY synthesis.  The authors utilized the borylated BODIPY intermediates 
for Heck-type coupling reactions to acrylates (Scheme 2.7c) to obtain products similar to 
BODIPYs 50 and 51.  Comparable reactions with dienoates where also attempted but the 
yields were low (not shown). 
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Scheme 2.7. C-H activated borylation of the BODIPY core.  
 
Although modifications described so far focused on functionalization to increase 
emission wavelengths, modifications of the BODIPY core can be performed for other 
purposes.  The BODIPY core is nucleophilic and therefore reacts with a variety of 
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electrophiles.31  Vilsmeier–Haack formylation provides a convenient way to add 
carbonyl functionality to electron rich aromatic systems.  Once the functionality is 
introduced the oxidation state of the carbonyl can be adjusted to yield alcohols by 
reduction, and esters and acids by oxidations.  For this reason we sought to formylate 
BODIPY using standard Vilsmeier–Haack conditions.  Unfortunately only mono-
formylation was obtained.  Oxidation to the acid using perchromates tended to react in 
poor yields often leading to decomposition of the BODIPY.  Although this work was 
never published the results were briefly mentioned in a review published in 2007.31 
Subsequent work by Jiao et al. expanded formylation of BODIPYs to meso-aryl 
substrates and found that these could also be mono-formylated.80  The authors further 
explored Knoevenagel condensation of the aldehydes with nucleophiles such as 
malononitrile and found the reactions to proceed in good yields (Scheme 2.8).  
Surprisingly, only modest emission bathochromic shifts were obtained upon these 
condensations; for example formylated BODIPY W emitted at 516 nm while extended 
BODIPY X emitted at 543 nm. 
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Scheme 2.8. β-selective formylation of the BODIPY core by us and others. 
 
Other than extending the emission wavelengths, perhaps the most important 
modifications of the BODIPY core are ones that increase water solubility.  Although 
water solubility can be an important factor for imaging application, there are relatively 
few known water-soluble analogs of BODIPYs.44,70,81-88  Sulfonation of the BODIPY core 
provides a convenient way of increasing water solubility without affecting photophysical 
properties.  Sulfonation is usually performed by the reaction of the BODIPY with 
chlorosulfonic acid, followed by base hydrolysis (Figure 2.9a). 86,87  Using this method 
probes like Z have been synthesized and attached to proteins (Figure 2.9b).  
Unfortunately, compounds like Z do not fluoresce very far to the red.  In practice it 
becomes harder to modify the BODIPY core to simultaneously enhance water solubility 
and emission wavelengths.  It is not hard to image dyes such as the one in Figure 2.9c 
that would be ideal as both acceptors and fluorescent probes due to their water 
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solubilities, red emissions, and possession of functionality to attach biomolecules.  
However, such dyes are difficult to make and a balance must exist between the 
complexity of dyes and the cost and time needed to make them.  Overall, in TBET 
cassettes, an opportunity exists to spread the needed modifications unto the donor and 
acceptors.  Such examples will be presented in Chapter III and in the concluding chapter.  
In this regard, even non-ideal dyes such as compounds 46 and 49 have scope as 
acceptors in TBET cassettes. 
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Figure 2.9. a. Example of sulfonation of BODIPYs to increase water solubility.  b. 
Example of probes that have been made from such sulfonations.  c. Example of an 
“ideal” acceptor that could be made from derivatizations of the BODIPY core. 
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Figure 2.9 Continued. 
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CHAPTER III 
THROUGH-BOND ENERGY TRANSFER CASSETTES WITH 
PHENYLACETYLENE-BODIPY ACCEPTORS 
 
3.1 Introduction 
TBET cassettes were discussed in detail in Chapter I so only a brief overview will be 
reviewed here.  When two dyes are connected together in a way that prevents the two 
from being co-planar with each other or with a conjugated linker (if one is used) fast 
energy transfer can occur through-bonds (Figure 3.1).  The advantage of such an 
arrangement is that large virtual Stokes’ shifts are accessible because the energy transfer 
efficiency from donor to acceptor is not governed by any known spectral overlap of the 
donor and acceptor, a requirement of RET. 
through-bond
energy transfer
hv
donor acceptor
hv'
energy transfer through 
bonds facilitates production 
of systems with large 
apparent Stokes shifts
TBET
 
 
Figure 3.1. Basic concept of TBET cassettes. See Chapter I for a detailed explanation. 
 
Although BODIPY dyes are ideal imaging fluors due to their photostabilities, high 
quantum yields, and favorable molar absorptivities, most lack functionality to attach to 
biomolecules and fluoresce in the blue-green region.  Furthermore they are usually 
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lipophilic and have a tendency to intercalate in hydrophobic portions of biomolecules.  
For these reasons derivatives of BODIPYs that: (i) fluoresce to the red, (ii) contain 
biomolecular handles, and (iii) are water soluble, were explored in Chapter II.  In this 
chapter, some of the dyes developed in Chapter II will be incorporated in TBET 
cassettes in attempts to study protein-protein interactions, and used as pH probes. 
 
Preliminary Work 
Of the dyes developed in Chapter II, 46 and 49 showed promise as acceptors for TBET 
cassettes because they emitted near 600 nm and contained a handle to attach to proteins 
and other biomolecules (Figure 3.2).  Since 46 is not water-soluble and 49 is only so 
under basic conditions we decided to convey water solubility on to the donors.  Donors 
for TBET do not need to absorb or fluoresce far to the red and therefore compound A 
was ideal for our purposes.  It has been observed by others that increasing the number of 
donor dyes in cassettes simultaneously increased the molar absorptivities, increasing 
brightness of the cassette in the process.27  For this reason we designed cassette 55, with 
two peripheral sulfonated BODIPY donors (corresponding to A) and a 
diphenylacetylene BODIPY acceptor (corresponding to 46).  The twist in such cassettes 
should be afforded by the steric interactions at the meso-position on the BODIPY 
donors.  It is also noteworthy that there is no linker in this cassette design.  
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Figure 3.2. Design of TBET cassette 55. 
 
Synthetically it is generally more difficult to work with polar, hydrophilic compounds 
than lipophilic ones.  For this reason we wished to add polar functionality in late stages 
of the synthesis.  To briefly summarize our efforts to obtain cassette 55 (Scheme 3.1), 
our first attempt involved the Sonogashira coupling between acetylene BODIPY 57 with 
diiodoBODIPY 59 to yield cassette 60.  The idea was to first hydrolyze the methyl ester 
60 and then sulfonate the free acid four times with chlorosulfonic acid.  Strangely, 60 did 
not hydrolyze under various conditions and more rigorous methods decomposed the 
starting material.  Comparable hydrolysis of diiodoBODIPY 59 did yield the acid though 
the reaction time had to be carefully monitored to avoid decomposition (not shown).  
After much effort we theorized that hydrolysis of sulfonated cassette 62 might be more 
successful, mindful that purification of intermediate 62 could be difficult.  However, 
Sonogashira coupling between the sulfonated p-iodophenylBODIPY B and 
 67 
diacetyleneBODIPY 61 was not successful.  We then attempted Sonogashira coupling of 
free acid BODIPY 48 with sulfonated donor 63 but this too failed produce the desired 
product.  We finally synthesized cassette 64 with the intent of sulfonating it to obtain 
cassette 55, unfortunately the reaction yielded complex mixtures and mass spectrometry 
failed to confirm presence of 55. 
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Scheme 3.1. Attempted syntheses of cassette 55. 
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Scheme 3.1 Continued. 
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Scheme 3.1 Continued. 
 
Although compound 55 would have been interesting for cellular imaging, its synthesis 
was becoming time and resource consuming.  For this reason we the reconsidered 
synthesis of 55 and looked into the use of lipophilic compound 64 as an alternative.  
Photophysical properties of 64 in methylene chloride are adequate for imaging, the 
donors absorb at 502 nm with a molar absorptivity of 110,000 cm-1M-1.  The emission of 
the acceptor part at 588 nm was slightly blue shifted compared to free acceptor 46.  
Cassette 64 displayed excellent energy transfer, only <5 % of the total fluorescence of 
the cassette was attributed to donor emission when the cassette was excited at the donor. 
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Figure 3.3. Absorbance and emission spectra of 64 in CH2Cl2 at 10-5 M. 
 
Encouraged by the energy transfer properties of 64 we wanted to test if these favorable 
characteristics were retained after labeling to protein.  For this purpose we chose Avidin 
for no other reason than its availability.  Labeling was accomplished by first activating 
absorbance 
emission 
donor 
acceptor 
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the acid on 64 with sulfo-NHS in the presence of DIC (Figure 3.4a)  This activated 
intermediate was then used to label lysines on Avidin.  The absorbance of the labeled 
protein in water confirmed the presence of the cassette and the spectrum is not 
significantly different than the free cassette in organic solvents (Figure 3.4b).  The 
emission of cassette on Avidin however was weak compared to the free cassette and the 
emission came from mostly the donor parts.  This suggests poor energy transfer possibly 
due to intercalation of the cassette in the protein.  Further experiments carried out in 
collaboration with Robin Hochstrasser’s lab involved the absorption of the labeled 
protein on glass (Figure 3.4c).  In these experiments the cassette showed similar 
fluorescence characteristics as the cassette on Avidin in water.  Interestingly, when 
labeled Avidin was bound to PalmitoylOleoylPhosphatidylCholine (POPC) bilayer, 
better energy transfer was observed.  This could be because the cassette intercalates less 
when the protein is introduced to a hydrophobic environment.  POPC bilayers have been 
found to be suitable models of the matrix of endoplasmic reticulum89 hinting at the 
potential of cassette 64 as a labeling agent of membranes.  However, its use to label 
proteins especially to study protein-protein interactions is limited. 
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Figure 3.4. a. Attachment of 64 to protein.  b. Absorbance and emission spectra of 64-
avadin conjugate in water.  c. Energy transfer studies of 64-avidin absorbed on glass 
and bound to POPC. Excitation and detection wavelengths used: D->D = λex 488 nm and 
λdet 510-600 nm; A->A = λex 568 and λdet 590-650 nm; D->A = λex 488 and λdet 590-650 
nm. 
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Figure 3.4 Continued. 
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Figure 3.4 Continued. 
 
Concurrent to the work outlined above, others in our lab looked into using dyes of type 
46 and 49 as acceptors for TBET cassettes.  For example cassette C is based on acceptor 
49 with the addition of a triethylene glycol linker for increased water solubility (Figure 
3.5).  Cassette C further differs from 64 in the use of xanthene donors rather than 
BODIPYs.  Interestingly, energy transfer properties of C showed remarkable sensitivity 
to pH.  Efficient energy transfer occurred in acidic pHs with emission primarily at ~600 
nm while poor transfer arose under basic conditions leading to green emission at 525 
nm.  Neutral conditions produced simultaneous emission from the donors and acceptor.  
Although pH sensitivity is not a property associated with ideal imaging dyes, the use of 
such systems as pH probes is, at the very least, intriguing. 
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Figure 3.5.  Structure and pH sensitivity of C. 
 
Fluorescent sensors are widely used for detection of protons and metals in several 
applications,90,91 especially intracellular imaging.92  Types of indicators may be divided 
into three: (i) ones that are insignificantly fluorescent in the absence of analyte, but are 
much more emissive when it is present; (ii) the inverse, where fluorescence of the probe 
is quenched by the analyte; and, (iii) sensors which have observable spectroscopic 
differences when the analyte is present compared to when it is absent.  The third type of 
sensor is “always on”; this is a significant advantage because it is clear that the probe is 
present even if the analyte is not (Figure 3.6).   
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Figure 3.6.  Fluorescent sensors may be activated (i) or quenched (ii) by analytes; ones 
that are “always on” (iii) but change wavelength of fluorescence emissions on binding. 
 
Intracellular pH (pHi) is a fundamental property that correlates with many events in 
cell biology.  To measure this, researchers tend to rely on subtle changes in sensors that 
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are “always on”;93-101 for instance, they observe emission intensities as a function of 
excitation wavelength.71,101-103  However, these sensors do not change emission 
wavelength maxima as the pH is varied; if they did, they would be far easier to use.  
That is why we were excited to realize cassette C is always fluorescent at pH ranges 
around the physiological region, but with emission maxima that varying over a very 
significant spectral region, ca 530 and 600 nm.  Probe C compared favorably with 
commercial pH sensors such as carboxySNARF-1 (Invitrogen), insofar as its pH 
response range is complementary, and its quantum yields are higher.  Further, probe C 
exhibits a greater wavelength difference (~80 nm) between the two ratiometric emission 
peaks than carboxySNARF-1.  It also has acid functionality to conjugate to proteins 
while carboxySNARF-1 does not.  
Endosomes within cells are markedly more acidic (pH 5.0 – 5.5) than the cytosol (ca 
pH 7.4).104  We have observed that when the non-covalently bound carrier peptide “Pep-
1”105 imports dye labeled proteins into COS-7 cells the protein-dye conjugates tend to be 
encapsulated in endosomes.106  Consequently, it was anticipated that when C-BSA was 
imported into cells using Pep-1, it would localize in endosomes and, in that acidic 
environment the probe would emit around 600 nm.  When C-BSA was imported into 
COS-7 cells using Pep-1, irradiation at 488 nm resulted predominantly in red 
fluorescence localized in punctate vesicular structures (Figure 3.7a). 
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A discovery from our laboratories shows that Pep-1 mediated import into COS-7 cells 
tends to deposit the dye-labeled protein cargoes into the cytosol when the experiment is 
performed at 4 °C.106  Thus, C-BSA under these conditions would be expected to 
fluoresce with diminished red-to-green ratios.  The fluorescence intensity for C-BSA is 
distributed within the cytosol, hence the images in Figure 3.7b appear to be deceptively 
weak relative to situations (e.g. Figure 3.7a) where the probe is concentrated in 
punctates.   
Quantitative data for pH measurements in cells were obtained via a calibration 
experiment.  A curve generated with the calibration experiment (Figure 3.7c) was used 
to determine pH values for the endosomes and the cytosol for the experiments shown in 
Figure 3.6a and b.  The pH values, obtained from the red/green ratio, were 5.4 and 7.4 
and were in good agreement with those expected for such intracellular regions, matching 
very closely to values obtained from commercially available sensors (not shown).   
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Figure 3.7.  Pep-1 mediated cellular uptake of C-BSA into COS-7 cells after 1h 
incubation at a. 37 °C and b. 4 °C.  The cells were irradiated at 488 nm and fluorescence 
from donor (503-553 nm) and acceptor (575-625 nm) was detected respectively.  c. ex-
vivo calibration curve with pH values corresponding to those observed within endosomes 
(red/green = 5.03; import at 37 °C) and the cytosol (red/green = 2.03; import at 4 °C). 
a 
b 
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Fluorescent Proton Sensors Based On Energy Transfer* 
Research described in this chapter was undertaken to explore how the photophysical 
properties of energy transfer cassettes correlate with their structures, and specifically try 
to explain the difference in energy transfer between compounds 64 and C.107  As already 
mentioned, it is generally easier to work with lipophilic compounds than polar, 
hydrophilic ones.  We therefore opted to work with tert-butyl protected compound 65 
(Figure 3.8) rather than free acid C. 
Nagano has published on the photoinduced electron transfer (PeT) between meso-
phenyl groups and BODIPY cores.108  These PeT processes can negatively impact the 
fluorescence quantum yields of BODIPYs and we therefore set out to prepare cassette 
66, a modification of 65 wherein the meso-phenyl functionality is absent.  For 
comparison, cassettes 67 and 64 were also targeted; these maintain the basic design, two 
donors perpendicularly aligned to the same central BODIPY31,32,109,110-acceptor.  
However, they are fundamentally different insofar as the donors are also BODIPY-
based, and there was no obvious reason to suspect transfer of energy from the donors in 
these molecules to the acceptors should be pH dependant.  These were envisaged as 
reference compounds for comparison of the extent of energy transfer in these systems. 
                                                
* The work described forth in this chapter is the result of an equal collaboration with Dr. Junyan 
Han.  In general, Dr. Han was responsible for compounds 65 and 67 and no further distinction 
between his efforts and mine will be provided. 
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Figure 3.8. Cassettes targeted in this study. 
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In outline, the research described here investigates: (i) syntheses of the cassettes; (ii) 
effects of changing of the meso-substituent on the central BODIPY {acceptor} fragment 
represented by the difference between cassettes 65 and 66 and between 67 and 64; (iii) 
changes of donor fragment from xanthene to BODIPY represented by the structural 
differences between 65 or 66, and 67 or 64.  Comparison of the cassettes is made on the 
basis of photophysical and electrochemical data measured at different pH levels. The 
latter measurements are related to orbital levels in the donor and acceptor fragments.  
 
3.2 Results and Discussion 
Syntheses of the Cassettes 64 - 67. 
Two key diiodinated BODIPY intermediates were prepared to make the cassettes 
featured in this chapter.  The first, compound 69 (Scheme 1a), was designed to have a 
triethylene glycol linker that would somewhat separate the dye from the protein as well 
as increase solubility in polar solvents.  Conditions for the diiodination reactions shown 
in Scheme 1 were based on work from Nagano et al.56  The second, compound 48 
(Scheme 1b), was formed via a route that is analogous to one used for a homolog formed 
from glutaric anhydride.111  Synthons 69 and 48 lead to cassettes with different meso 
substituents: aryl and alkyl functionalities. 
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Scheme 3.2.  Syntheses of pivotal diiodinated synthons: a BODIPY 69; and, b BODIPY 
48. 
 
Sonogashira reactions59,112 were used to assemble the cassettes from the acceptor 
components 69 and 48, and the fluorescein-based and BODIPY-based donor components 
E21,24 and F13 (Scheme 3.3).  The diacetate intermediate 70 is of some importance 
because this compound has been shown to be cell permeable, and hydrolyzes in the 
cytosol to give green fluorescence.113  The fluorescein-based cassettes 65 and 66 are 
soluble in lower alcohol solvents giving pink solutions. 
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Scheme 3.3.  Syntheses of cassettes: a. 65; and, b. 67. 
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Scheme 3.3 Continued. 
 
Cassette 66 (Scheme 3.4) was difficult to purify.  Flash chromatography did not give 
pure material, but the compound was isolated via preparative reverse phase HPLC in 4 
% yield.  Both cassettes 67 and 64 are soluble in lipophilic solvents like CH2Cl2, and 
give strongly colored pink or red solutions. 
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Scheme 3.4. Syntheses of cassettes: a. 66; and, b. 64. 
 
The methyl ester of cassette 64, compound 60, was crystallized for single crystal X-ray 
diffraction studies (Figure 3.9).  They show the BODIPY donor fragments resting 
perpendicular to the acceptor part.  In part, it is this molecular twist that differentiates 
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cassettes from planar dyes consisting of a single conjugated chromophore.   
Interestingly, the molecule appears to “sag” around the central BODIPY fragment, 
because the alkyne parts are not exactly in the same plane; an ideal linear arrangement 
would give a 180° angle, but the observed angle was 168.2 degrees.  This parameter may 
have some relevance because if the angle were 180° and rigid then the transition dipoles 
of the BODIPY acceptor and the two donor fragments (which are aligned with their long 
axes)30 would be exactly perpendicular in any conformation about the alkyne.  In that 
orientation there can be no dipole-dipole coupling hence fluorescence resonance energy 
transfer (RET) could not occur.  The fact that the molecule is not perfectly linear means 
that RET cannot be completely excluded because rotation about the alkyne bond could 
place the BODIPY donors in conformations in which weak dipole-dipole coupling could 
occur.  However, the “sag-angle” is small, and conformations that allow dipole-dipole 
coupling also take the phenyl group out of conjugation with the rest of the acceptor; 
consequently, energy transfer via this mechanism1 is unfavorable. 
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Figure 3.9.  Single crystal X-ray structure of 60. 
An important set of new acceptor fragments 46, 49, 108, and 109 and known BODIPY 
G39 and xanthene H114 reference compounds were also generated for this study.  
Photophysical and electrochemical properties in cassettes tend to be accurately 
represented by the individual donor and acceptor fragments.12  Consequently, 
electrochemical studies were performed on these constituents, thus avoiding the need for 
destructive experiments (electrochemistry) on the valuable cassette samples.  Syntheses 
of the new materials are outlined in APPENDIX D. 
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Photophysical Properties 
Salient photophysical properties of the cassettes are shown in Table 3.1.  The acceptor 
fragment is formed by the 2,6-(alkyne-aryl) substituents because these impose a 
dramatic red-shift on the absorbance and fluorescence properties of the BODIPY core.59  
The fluorescein and BODIPY donor parts exhibit characteristically large molar 
absorptivities, and absorb/fluoresce at wavelengths that are characteristic of the free dye 
fragments (see Table 3.2 below). 
Through bond energy transfer cassettes are usually designed to absorb light at the 
donor excitation wavelength, relay it to the acceptor part, then emit fluorescence from 
there.  The term “energy transfer efficiency” (ETE %) quantifies this, it is defined as 
follows: 
 
quantum yield of the acceptor fragment in the cassette
excited at the donor
ETE % = x 100
quantum yield of the acceptor fragment in the cassette
excited at the acceptor  
 
 
ETE % is a measure of the quantum yield of the cassette when irradiated at the donor.  
It reflects the extent of energy transfer including the negative effects of non-radiative 
loss in the transfer process.  The product of the molar absorptivity of the donor in the 
cassette and the ETE give a measure of the brightness of the acceptor in the system.  
Values of the ETE % for the cassettes 64 – 67 are shown in Table 3.1.  Several 
important observations are clear.  First, the fluorescein-based cassettes 65 and 66 have 
moderate ETE values in the absence of base, but not when Bu4NOH is added.   Second, 
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the BODIPY-based cassettes 67 and 64 have excellent ETE values, and these are not 
influenced by base.    
 
Table 3.1.  Photophysical properties of 64 - 67 in 1:1 ethanol:CH2Cl2. 
absorptionb fluorescencec 
cmpd basea 
λmax donor (nm) / 
ε x 10-4 
λmax acceptor (nm) / 
ε x 10-4  
λmax donor 
(nm) 
λmax acceptor 
(nm) 
Φacceptor 
excited at 
acceptord 
Φacceptor 
excited at 
donore,j 
ETE 
(%)f Φdonorg 
          65 - 505 / 5.6 575 / 3.5 521 600 0.30i 0.15 51 0.05 
65 + 505 / 11 578 / 3.0 529 - 0.01i - < 5 0.09 
66 - 506 / 3.7 560 / 1.9 528 579 0.24j 0.09 38 0.07 
66 + 505 / 13 561 / 2.8 529 - 0.01j - < 5 0.08 
67 - 502 / 14 566 / 6.6 513 606 0.62i 0.58 93 -h 
67 + 502 / 14 566 / 6.6 516 604 0.66i 0.60 92 -h 
64 - 502 / 11 561 / 4.7 521 588 0.84j 0.79 94 -h 
64 + 502 / 11 560 / 5.2 515 588 0.93j 0.85 91 -h 
a with nBu4NOH at a concentration of 8 x 10-5 M.  b At 1 x 10-5 M.  c At 1 x 10-6 M.  d 
Quantum yield of acceptor when excited at the acceptor.  e Quantum yield of acceptor 
while excited at the donor.  f Energy transfer efficiency calculated with the quantum 
yield of the acceptor with excitation at donor divided by that with excitation at the 
acceptor.  g Fluorescein (Φ = 0.92 in 0.1 M NaOH)115 was used as a standard.  h Donors 
in these cassettes show no significant fluorescence emission.  i Rhodamine 101 (Φ = 1.00 
in EtOH)58 was used as a standard.  j Rhodamine B (Φ = 0.97 in EtOH)115 was used as a 
standard. 
 
Effects of base on the cassettes are probably best visualized from their absorbance and 
fluorescence spectra (Figures 3.10).  Addition of nBu4NOH to cassettes 65 and 66 
increases the absorption corresponding to the fluorescein component relative to that from 
the BODIPY acceptor part.   This is logical because addition of base forces the 
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fluorescein donor into its ring-opened phenolate carboxylate form.  Absorbance spectra 
of cassettes 67 and 64 are almost completely insensitive to base, as would be predicted 
since the electronic spectra of BODIPY dyes are not significantly affected by pH. 
In the absence of base, excitation of the fluorescein donor of cassettes 65 and 66 leads 
to significant fluorescence from the BODIPY acceptor.  However, no significant 
fluorescence is observed from the BODIPY part when base is added to the same 
solutions (Figure 3.10a and b).  Conversely, addition of base has no significant effect on 
the extent of energy transfer for the cassettes 67 and 64 that have BODIPY donors.  Thus 
in 1:1 ethanol/CH2Cl2 the fluorescein donor parts of cassettes 65 and 66 are, at least 
partially, protonated, and energy transfer to the BODIPY acceptor occurs.  Energy 
transfer is quenched when the fluorescein donors are completely deprotonated.  
Cassettes 67 and 64 have BODIPY, not fluorescein, donor parts, but they are otherwise 
identical to 65 and 66. 
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a 
 
 
 
Figure 3.10.  a. Absorbance spectra of 64 – 67 (10-5 M conc. in 1:1 ethanol/CH2Cl2) with 
and without nBu4NOH (concentration of 1 x 10-4 M).  b. Fluorescence spectra of 
cassettes 64 - 67 (1 x 10-6 M in 1:1 ethanol/CH2Cl2), spectra recorded without added base 
are shown in blue, and with nBu4NOH (concentration of 1 x 10-4 M) are shown in red. 
65 
65 + base 
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Figure 3.10 Continued. 
66 + base 
66 
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Figure 3.10 Continued. 
 
67 
67 + base 
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Figure 3.10 Continued. 
64 
64 + base 
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b 
cassette 65 (fluorescein donor)  
 
 
cassette 66  (fluorescein donor) 
 
Figure 3.10 Continued. 
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cassette 67  (BODIPY donor) 
 
 
cassette 64  (BODIPY donor) 
 
Figure 3.10 Continued. 
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Table 3.2 shows photophysical properties for the reference compounds 46, 49, 108, 
109, G, and H.  None of the building blocks that were assembled to give cassettes 64 – 
67 have fluorescence characteristics that are significantly changed by added base.  The 
largest change in quantum yield is seen for the dicarboxylate 109 and xanthene G: for 
these compounds a 25 % increase in the presence of base.  There are no appreciable 
shifts in λabs, λem, or even the peak width values when these fragments are compared 
without and with base. 
None of the reference compounds can undergo changes like that shown in equilibrium 
1, but this has been comprehensively studied for fluorescein in aqueous media.71  These 
data show that the quantum yield of fluorescein is highest in its dianion state.   However, 
Table 3.1 shows that the quantum yield of the donor part in the fluorescein-based 
cassettes 65 and 66 are less than 0.1, with or without base.  Without base there is 
significant energy transfer to the acceptor, so some quantum yield reduction is 
anticipated.  With base, however, less of the energy transferred between the donor and 
acceptor is emitted as acceptor fluorescence.  Further, the xanthene quantum yields in 
the cassettes are much less than for fluorescein in any of the accessible protonation 
states, or for the xanthene G.  Thus, integration of the xanthene donors in cassettes 65 
and 66 reduces their quantum yields relative to the parent fragments. 
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Table 3.2.  Photophysical properties of reference compounds in 1:1 ethanol/CH2Cl2 
cmpd baseb λabs (nm) / 
ε x 10-4 
λem 
(nm) 
fwhm 
(nm) Φ
a 
       46 _ 560 / 2.6 587 41 0.72 
46 + 559 / 2.6 587 41 0.71 
49 _ 565 / 0.9 593 46 0.46 
49 + 563 / 1.0 592 43 0.61 
108 _ 574 / 3.2 606 44 0.52 
108 + 574 / 3.2 605 53 0.54 
109 _ 573 / 2.3 612 53 0.42 
109 + 578 / 2.5 613 52 0.44 
G _ 506 / 8.7 511 16 0.98 
G + 506 / 8.7 511 17 0.90 
H _ 508 / 7.4 517 26 0.76 
H + 508 / 11 517 25 0.95 
Absorption data recorded at 1 x 10-5 M.  Emission data taken at 1 x 10-6 M. a 
Rhodamine 101 (Φ = 1.0 in ethanol)58 was the standard for 46, 49, 108, and 109 and 
fluorescein (Φ = 0.92 in 0.1 M NaOH)115 for G and H.  b with Bu4NOH at a 
concentration of 8 x 10-5 M.  
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Electrochemical Studies 
Oxidation and reduction potentials were measured for the reference fragments G, H, 
108, 109, and for cassette 67 relative to the ferrocene/ferrocinium couple. The 
electrochemical measurements provide an approximation of the band gap magnitude.  
The HOMO and LUMO energies were estimated based on the onset of REDOX events 
as described by Reynolds et al.116  BODIPY 108 shows a reversible reduction wave, 
while for 109 and G the wave is quasi-reversible for the first reduction events.  For H 
and HNa the first reduction wave is irreversible.  The oxidation events for all compounds 
are irreversible.  In a method similar to the one used by Reynolds et al.116 the 
ferrocene/ferrocenium couple in Volts is estimated to an orbital level of 5.15 eV and 
5.16 eV relative to vacuum in DMF and CH2Cl2, respectively.117,118  Thus energy levels of 
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HOMO and LUMOs can be pegged relative to this reference point.  The same data was 
acquired for compounds 46 and 49 (see Appendix D). 
Figure 3.11a plots HOMO and LUMO energy levels for the reference BODIPY E and 
the acceptor mimic 108 that represent cassette 67 (BODIPY donor and acceptor).  The 
LUMO levels of the donor and acceptor parts are close in energy with the latter 0.35 eV 
lower.  This corresponds to the system for which high ETE was observed (93 %), and for 
which no pH dependence was observed or expected.  Figure 3.11b and c shows data 
corresponding to the pH dependant cassette 65.  Under conditions favoring protonation 
of the phenolic-O atoms the two LUMO levels are also close in energy (0.1 eV), and 
again, significant ETE was observed.  However, for the same cassette but under 
conditions wherein the phenol groups would be completely deprotonated, poor energy 
transfer corresponds with a large energy gap between the donor and acceptor LUMO 
levels. 
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Table 3.3.  Electrochemical data for reference compounds G, H, 108, 109, and cassette 
67. 
cmpd Eonset,ox (V) HOMO (eV) Eonset,red (V) 
LUMO 
(eV) Eg (eV) 
      
Ga +0.68 5.84 -1.32 3.84 2.00 
Hb +0.33 5.48 -1.03 4.12 1.36 
HNab, d +0.04 5.19 -1.67 3.48 1.71 
108a +0.99 6.15 -0.91 4.48 1.87 
109b +0.49 5.64 -0.93 4.22 1.42 
109c +0.49 5.64 -0.92 4.23 1.41 
67a +0.99 6.15 
-0.92 
-1.18 
4.24 
3.98 
1.91 
2.17 
Cyclic voltammograms were recorded using a glassy carbon working electrode (A = 
0.071 cm2) referenced to Fc/Fc+ and a Pt counter electrode at a scan rate of 200 mV/s.  
All potentials are reported vs. Fc/Fc+ and all HOMO and LUMO energies are derived 
from electrochemical results based on Fc/Fc+ = 5.15 eV (DMF) and 5.16 eV (CH2Cl2) vs. 
vacuum.  All solvents were flushed with Ar(g) before use.  a In CH2Cl2.  b In DMF.  c In 
DMF and 0.1 M pyridine.  d Xanthene was first reacted with NaOH to obtain the sodium 
salt.   
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corresponds to cassette 65 protonated on xanthene
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ETE < 5 %
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3.48 eV
5.19 eV
5.64 eV
4.23 eV
109H-Na
 
 
 
Figure 3.11. a HOMO and LUMO levels of the reference compounds representing 
cassettes: a, 67; b, 65 (under neutral conditions); and, 65 (basic conditions). 
 
3.3 Conclusions 
Rapid and efficient energy transfer may be possible when a fluorescent donor is joined 
to an acceptor in such a way that the two fragments would be electronically conjugated if 
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they became planar, but are sterically prevented from doing so.14,119-121  The fact that they 
cannot easily achieve planarity means that the absorption spectra of the cassette 
resembles the sum of the donor and acceptor parts.  However, the donor part will not 
fluoresce when it is excited in an efficient energy transfer cassette; instead the energy 
will be rapidly transferred to the acceptor that will then fluoresce (Figure 8).23,29,30,122-130 
Previous studies from these laboratories provided evidence that energy transfer 
mechanisms besides RET can be dominant in cassettes like the ones described in this 
paper.  Specifically, energy transfer rates between anthracene (donor) and BODIPY 
(acceptor) fragments were much faster than would be expected from a RET 
mechanism.23,29,30  Further, some of those cassettes have the donor and acceptor parts 
oriented in ways that should largely exclude the possibility of RET, yet fast transfer rates 
were observed.  Others in this field had documented similar effects for energy transfer 
cassettes.10,12,131,132   
In this work, we do not profess to know the mechanisms by which energy is 
transferred between the donor and the acceptor.  It seems highly probable that all 
possible mechanisms compete; these include dipole-dipole coupling (RET), electron 
transfer, and processes in which relaxation of energy from the donor excited state leads 
to excitation of the acceptor via through-bond mechanisms that rely on orbital overlap.   
Moreover, the proportions of each energy transfer mechanism operative will be 
influenced by the protonation state of the donor, at least for the xanthene dyes.  
Comparisons with the all-BODIPY donor-acceptor systems 108 and 109 reveal that the 
relative orbital energy levels between the donor and acceptor fragments in these 
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cassettes are comparable to those in the pH-sensitive systems 65 and 66 in protonation 
states where efficient energy transfer is observed.  Moreover, the meso-aromatic 
substituent of 65 and 67 has no significant effect on the photophysical properties of these 
cassettes; this can be inferred from the data collected for 66 and 64 which have only 
aliphatic groups in that position. 
Communication between the donor and the acceptor in these systems, by whatever 
mechanisms, does appear to be impacted by the relative energies of the frontier orbitals 
involved.  Electrochemical studies as described here are therefore valuable in elucidating 
what these orbital energy levels are. 
The work described here may represent the beginning of a new paradigm in which 
electronically coupled dye pairs can be used to sense analytes in biomedical applications. 
There is considerable scope for molecular modifications in this series because the donor, 
acceptor, and linker fragments133 could all be modified to give sensors. 
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CHAPTER IV 
BRILLIANT BODIPY-FLUORENE COPOLYMERS WITH DISPERSED 
ABSORPTION AND EMISSION MAXIMA 
 
4.1 Introduction 
It is important to have bright fluors that are easily discernible from endogenous 
fluorophores when imaging cells.  Likewise, in vivo imaging necessitates probes whose 
fluorescence intensities are suitable for detection through tissue.  As discussed in 
Chapter I, brightness of a fluorophore is the product of its quantum yield and molar 
absorptivity.  For this reason probes that have high quantum yields and strong 
absorptivities tend to have advantages over other probes for imaging applications.  
Although quantum yields and molar absorptivities can generally be optimized by 
structural modifications of a dye’s core, these modifications can be synthetically 
challenging and often unpredictable requiring trial and error; for these reasons a 
systematic way of increasing either the quantum yield or molar absorptivity of fluors 
would be of great value. 
Our lab134 and others27,28 have observed that molar absorptivity of TBET cassettes (see 
chapter I) increases with the inclusion of two or more donors to acceptors (Figure 4.1a).  
In these cases two or more donor parts absorb light more efficiently than a single one 
and relay the energy to the acceptor part that emits the energy.  Theoretically, the 
photophysical properties of the acceptor are independent from those of the donors so the 
quantum yield of the acceptor should not be negatively affected by an increase in the 
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number of donors.  It has been shown however that energy transfer efficiency can 
diminish in cases where extreme ratios (8:1) of donors to acceptor are used.8  We 
theorized that polymerization of donors with random incorporation of acceptors 
throughout the polymer would be conducive to bright TBET systems because of the 
large harvest of energy afforded by the donors, fast TBET to the acceptors, and 
favorable fluorescence quantum yields from those acceptors (Figure 4.1b).135 
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Figure 4.1.  a. Increase in molar absorptivities resulting from increases in the number of 
donors (compare 27 to 28).  Addition of too many donors can decrease ETE as in 
compound 7.  b. Model of polymer harvesting energy to acceptor.  
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Figure 4.1 Continued. 
The choice of acceptor in these types of polymers should be ones that possess high 
quantum yields and can easily be tunable to different fluorescent wavelengths.  BODIPY 
dyes31,32,110 meet these criteria and were therefore chosen for these studies.  A recent 
trend in the research of BODIPY dyes has been to polymerize them to concentrate 
multiple fluor units in single molecules,136-139 hence to form bright particles for materials 
or for imaging biological systems.  Polymers of this kind tend to have desirable 
properties for those applications because they concentrate several fluorescent groups in 
one molecule.  Brightness-per-fluor in homopolymeric-dye systems is not necessarily 
greater than the free dye, and scope for manipulation of spectroscopic properties is 
limited; consequently it is logical to research similar polymers from two or more 
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components such as the case discussed in Figure 4.1b.  This strategy allows donor 
fragments that absorb light of a desirable wavelength to collect and transfer energy to 
fluors that then fluoresce.  In this paradigm, donor:acceptor ratios may be adjusted to 
optimize the brightness-per-fluor (note brightness-per-fluor = absorption cross-section of 
the donor parts x quantum yield of the fluor in the polymer). 
To the best of our knowledge this has not been attempted; all the BODIPY-containing 
polymers reported to date are homopolymeric or BODIPY-bridge-BODIPY-bridge...  
(i.e. ABAB) composites (Figure 4.2).136-146  There are none of the type (donor)m-
BODIPY-(donor)n-BODIPY-... in which the acceptor fluors is “doped” into the donor-
polymer backbone.  This is significant because donor-rich polymers could have 
extremely high UV absorption cross sections, and accommodate fast, efficient, energy 
transfer to the BODIPY fluors, affording bright probes with excellent separations of 
absorption and emission wavelengths. 
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Figure 4.2. Examples of BODIPY homo- and co-polymers done by others. 
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This chapter describes donor-rich polymers 70 designed to maximize energy transfer 
to BODIPY or related acceptor fragments (Figure 4.3).  Fluorene donor parts were 
chosen because of their photostabilities, large molar absorptivities, high two-photon 
cross-sections, and ease of syntheses.147-149  Violet-blue fluorescence emissions from 
polyfluorenes are not ideal for cellular or in vivo imaging, but we hypothesized that 
appropriately designed BODIPY-doped polyfluorene polymers could be excited at the 
donor parts, and would emit brightly at much longer wavelengths characteristic of the 
acceptor parts.  Another design attribute of these systems is that variations of the 
acceptors would enable tuning of fluorescence outputs.  Data described here shows that 
in fact such polymers could be made and optimized for emission via the acceptor.  
Further, representative systems were cast into particles of around 50 nm that were shown 
to permeate into Clone 9 rat liver cells where they could be imaged. 
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Figure 4.3. Design of BODIPY-doped polyfluorenes and structure of BODIPY 
acceptors. 
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4.2 Results and Discussion 
Synthesis 
Acceptors 71 were chosen to have dispersed emissions of about 30-40 nm ranging 
from 520 to 700 nm.  Two iodines present on BODIPYs provide the means for 
polymerization via Suzuki reaction.  Incorporation of methoxy group on the meso-
phenyl of 71a-d restricts rotation of the phenyl group thereby avoiding large decreases in 
quantum yields.  BODIPYs 71a-d were synthesized by acid catalyzed condensation of 
corresponding pyrroles 72a-d with 3,5-diiodo-2-methoxybenzaldehyde 74 followed by 
oxidation with chloranil to yield dipyrromethenes 75a-d.  Chelation of BF2 was achieved 
by subsequent addition of triethylamine and BF3•OEt2 to obtain BODIPYs 72a-d in 25–
75% yields (Scheme 4.1).  AzaBODIPY 72e was synthesized according to literature 
procedures.150  
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Scheme 4.1. Syntheses of BODIPY acceptors 71a-d. 
 
Synthesis of the polymers was achieved by Suzuki polymerization of fluorenes B and 
C with the appropriate acceptors using Pd(PPh3)4 and K2CO3 in DMF at 80 ºC (Scheme 
4.2).  The polymers were purified by precipitation from the medium used for the Suzuki 
couplings (toluene) by addition to methanol.  Low molecular weight impurities were 
subsequently removed via multiple acetone washes, each over an extended period. 
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Scheme 4.2.  Syntheses of the polymers 70a-e. 
 
Photophysical Properties 
Acceptors have emissions that are dispersed at intervals of about 30 to 40 nm, from 
520 to 700 nm (Table 4.1).  BODIPY 71b has an extremely high molar absorptivity and 
an exceptional quantum yield, and 71c shows an unusually large Stokes’ shift (i.e. 1565 
cm-1).  Acceptor-precursors 71a-d have ortho-methoxy-substituents on their meso-aryl 
groups to minimize radiation-less decay via rotation. 
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Table 4.1. Spectroscopic properties of fluorene and acceptors in CH2Cl2 
 λabs max 
(nm) 
ε x 10-4 
(cm-1•M-1) 
λem max 
(nm) 
Φ 
 
fwhma 
(nm) 
Stokes 
Shift 
(cm-1) 
fluorene 266 14.7 308 0.28 b 26 5126 
71a 510 8.0 521 0.36c 26 414 
71b 556 12.0 573 1.0d 32 534 
71c 556 5.6 609 0.48d 46 1565 
71d 667 15.0 685 0.46e 37 394 
71e 678 6.0 710 0.05 e 47 665 
       
a Fluorescence full width at half maximum peak height b Naphthalene in cyclohexane as 
standard (Φ = 0.92)151 c Fluorescein in 0.1M NaOH as standard (Φ = 0.92)115 d 
Rhodamine B in EtOH as standard (φ = 0.65)152 e Zinc phthalocyanine in pyridine as 
standard (Φ = 0.30)153 
 
We hypothesized that energy transfer would increase with greater amounts of acceptor 
and therefore a measurement of the minimum amount of acceptor necessary for good 
energy transfer was necessary.  This was done by varying the amount of acceptor in the 
polymerization while at the same time adjusting the amount of C to keep a constant 1:1 
ratio of diiodinated to boronic acid monomers.  Acceptor 71a was chosen for this study 
and was copolymerized in 0.05 - 0.67 equivalents (Table 4.2).  NMR studies show that 
BODIPY was incorporated in 6 – 21 mol % in the polymer. 
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Table 4.2. Physical properties of polymer with varying amounts of acceptor 71a 
eq. acceptor in 
polymerization  
mol % acceptor in polymera Mn (kDa)b 
0.05 6.1 5.5 
0.14 6.9 6.1 
0.27 12.6 7.6 
0.40 14.4 8.5 
0.54 18.7 9.6 
0.67 21.1 9.8 
aDetermined by proton NMR.  bMn determined by GPC in THF. 
 
Table 4.3 lists the photophysical properties of the polymers in dichloromethane.  The 
absorbance wavelength of the polymers goes down with increasing amounts of acceptor; 
this is indicative of random placement of the acceptor throughout the polymer, breaking 
the polyfluorene repeats.  No significant changes in either the absorbance or emission 
wavelengths were observed for the acceptor when increasing its concentration in the 
polymer.  As predicted, significant increases in ETE % and ET % were obtained with 
higher amounts of acceptor.  This increase was offset by a simultaneous decrease in 
quantum yield of the polymer as the amount of acceptor increased.  Taking both factors 
into account, an amount of 19 mol % acceptor was found to give the brightest polymers 
(Figure 4.4). 
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Table 4.3. Photophysical properties of polymer with varying amounts of acceptor 71a 
mol % 
acceptora 
λabs 
fluorene 
(nm) 
ETE %b ET %c Φacceptor 
(%)d 
Φpolymer 
(%)e 
ε x 10-5 brightness 
x 10-4 
6.1 366 25±5 28±2 26±6 6.31±0.03 2.7±0.2 1.7±0.1 
6.9 362 38±1 51±3 25±1 9.5±0.6 2.8±0.2 2.7±0.4 
12.6 363 55±7 73±5 28±3 15.2±0.6 2.9±0.8 4±1 
14.4 352 61±1 86±2 20±1 12±1 3.5±0.3 4.2±0.7 
18.7 342 70.8±0.5 92±2 15.6±0.2 11.0±0.2 4.3±0.7 4.7±0.9 
21.1 336 73.8±0.5 95±1 12.2±0.2 9.09±0.07 4±1 4±1 
a Determined by proton NMR.  b Energy transfer efficiency, a measure of how 
efficiently energy absorbed by the fluorenes is transferred to BODIPY (see Table 2).  c 
Percent of energy transferred between fluorene and BODIPY.  d Fluorescein in 0.1M 
NaOH as standard (Φ = 0.92). 115   e Quantum yield of polymer calculated as the product 
of ETE and the quantum yield of the acceptor. 
 
 
Figure 4.4. Optimization of amount of acceptor in polyfluorene. 
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Overall the observations described above motivated us to make a series of polymers 
that contained ca 0.19 equivalents of the acceptor monomers; this was achieved using 
0.54 equivalents of the BODIPY acceptor.  A 48 h polymerization run was used; shorter 
times gave less brilliant polymers (Figure 4.5).  Table 4.4 gives the essential parameters 
of polymers 70a – e formed via the conditions mentioned above.   
 
 
Figure 4.5. Relative brightness of polymer as a function of reaction time 
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Table 4.4. Physical properties of polymer with different acceptors 
polymer Mna Mwa PDIa mol % 
acceptorb 
1a 8.8 11.3 1.29 18.7 
1b 7.3 9.2 1.27 26.7 
1c 9.9 14.7 1.49 22.2 
1d 6.1 8.2 1.34 25.0 
1e 5.8 7.0 1.21 40.0 
aMn determined by GPC in THF.  bDetermined by proton NMR. 
 
Emissions from the polymers occur mainly from the acceptors with ET % ranging 
from 86-98 % (Table 4.5).  The emission maxima of polymers 70a-d emit at 
wavelengths slightly lower to that of the free acceptors 71a-d.  For example, polymer 
70d has an emission maximum at 685 nm while acceptor 71d has a maximum at 677 nm.  
Polymer 70e shows a considerable increase (43 nm) in its emission wavelength 
compared to acceptor 71e.  This could be because the phenyl groups on azaBODIPYs in 
70e can adopt conformations that are more planar with the heterocyclic core than the 
ortho-substituted meso-aryl groups of 70a - d.  In other words, polymerization with 
fluorene extends the conjugation of the azaBODIPY. 
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Table 4.5. Photophysical properties of polyfluorenes incorporated with acceptors in 
CH2Cl2 
polymer mol % 
acceptora 
λabs 
fluorene 
(nm) 
λabs 
bodipy 
(nm) 
λem 
(nm)b 
ETE %c ET %d Φ acceptor Φ polymerh molar 
absorptivity 
x 10-5 (cm-
1•M-1) 
70a 19 343 505 517 70.8±0.5 90.5±0.6 0.147±0.002e 0.104±0.002 5.1±0.9 
70b 27 343 549 566 60±2 97.2±0.3 0.24±0.01f 0.14±0.05 5.74±0.07 
70c 22 344 547 602 48±8 95.9±0.5 0.13±0.02f 0.06±0.02 5.18±0.03 
70d 25 347 657 677 37±3 98±1 0.25±0.07g 0.09±0.03 4.3±0.3 
70e 40 336 703 753 49.4±0.3 86±2 0.002g 0.001 4.58±0.07 
a Estimated by NMR.  b Emission maximum when excited at 358 nm (fluorenes) c 
Energy transfer efficiency (ETE) was calculated by dividing the quantum yield of 
acceptor when excited at fluorene donor by the quantum yield of acceptor when excited 
at acceptor.  d Percent of the total fluorescence being emitted by the acceptor.  e 
Fluorescein in 0.1M NaOH as standard (Φ = 0.92).115  f Rhodamine B in EtOH as 
standard (Φ = 0.65)152  g Zinc phthalocyanine in pyridine as standard (Φ = 0.30)153  h 
Quantum yield of polymer calculated as the product of ETE and the quantum yield of the 
acceptor. 
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a 
 
 
 
Figure 4.6. a. Absorbance (10-5 M) and emission (10-6 M) spectra of 70 in CH2Cl2.  b. 
Combined normalized fluorescence of 70 in CH2Cl2 at 10-6 M excited at 358 nm.  c. 
Photograph of polyfluorene and 70 in CH2Cl2 under UV lamp irradiation. 
70a 
70b 
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Figure 4.6 Continued. 
70c 
70d 
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b 
 
Figure 4.6 Continued. 
 
70e 
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c 
 
 
Figure 4.6 Continued. 
 
Cell Imaging via Nanoparticles Fabricated from Polymers 
McNeill et al. have reported efficient generation of organic nanoparticles from 
polyfluorene and similar systems.154-164 We investigated whether comparable 
nanoparticles could be constructed from doped polymer 70.  In the event, slight 
modifications were found to be more suitable for these polymers; slower addition rate of 
a more dilute THF solution of the polymer to water gave particles of 48.4 ± 13.3 nm by 
dynamic light scattering in the case of 70b (Figure 4.7).  TEM investigations of particles 
made from 70a-d led to aggregation before the analysis though smaller particles 
averaging 20 to 60 nm could be seen (see Appendix E). 
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Figure 4.7. DLS and analysis of particles made from 70b averaging 48.4 ± 13.3 nm. 
Uptake of the organic nanoparticles from 70 was studied on normal rat liver cells 
(Clone 9).  After 40 h incubation at 37 °C in Ham’s + 5% fetal bovine serum (FBS) 
culture medium, the nanoparticles were observed as bright dots inside the cells (Figure 
4.8); they did not specifically target organelles. Polymers incubated under same 
conditions did not enter the cells. 
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Figure 4.8. Confocal imaging of Clone 9 rat liver cells with polymeric nanoparticles 
70a-d.  
 
4.3 Conclusions 
The work reported here features cassettes with donor and acceptor fluors joined via 
linkers that would allow conjugation if the molecules became planar.9,13,14,28-30,165  
However, the twist between these fragments “insulates” the donor and acceptor parts so 
that the overall  emission characteristics of the composites mirror those of the free 
acceptor.  This makes it possible to design of materials with predictable fluorescence 
70a 70b 
70c 70d 
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emission wavelengths.  This property coupled with the fact that there are several donors 
per acceptor part, offers potential for fluorescent probe design, OLEDs and lasing 
materials. 
Further work is needed to address two important issues: (i) lack of water-solubility of 
the polymers and; (ii) quenching of the acceptors.  Luckily the first issue appears trivial 
since water-soluble analogs of polyfluorene are known.  For example, ammoniums166,167, 
carboxylic acids168, sulfonic acids169, phosphonic acids170, amino acids171, crown ethers172, 
and sugars173 have all been used to increase water solubility of polyfluorenes.  It should 
be noted however that complications could arise in the synthesis of such polymers due to 
the hydrophilicities and hydrophobicities of the donors and acceptor respectively.  It may 
be necessary, for instance, to mask the water-solubilizing groups until after isolation of 
the polymers or incorporate water solubility on the BODIPY acceptors as well, making 
both parts hydrophilic. 
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Figure 4.9.  Examples of water-soluble polyfluorenes. 
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The issue of self-quenching of the acceptors can be addressed by decreasing the 
amount of acceptor used.  It is known that incorporation of electron withdrawing 
aromatics can have drastic effects on the emissive properties of polyfluorenes, mainly 
shifting the λmax emiss to the red (Figure 4.10a).138,158-164 These types of electron 
withdrawing groups could be doped in polyfluorenes and act as electronic “bridges” that 
modulate the flow of energy in such polymers leading to increases in ETE; increases that 
could potentially offset the lowered ETE consequential from the decrease in acceptor.  
An example of how such a system could be designed for in vivo imaging is shown in 
Figure 4.10b.  Compound 76 would possess water solubility needed for in vivo imaging, 
have bright emissions into the red due to the energy bridges facilitating energy transfer 
from donors to acceptors, and also possess targeting ligands to bind cancer cells. 
a 
OR
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!abs 343 nm
!em 421 nm
" 0.07  R = O O O O  
Figure 4.10.  a. Electron withdrawing rings can affect the photophysical properties of 
fluorene.  b. Example of how we can use electron-withdrawing rings to increase energy 
transfer efficiency in BODIPY doped polyfluorenes for in vivo imaging. 
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Figure 4.10 Continued. 
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CHAPTER V 
DYES FOR PHOTODYNAMIC THERAPY 
 
5.1 Introduction 
Cancer is an ever-present threat that accounts for 1 out of every 4 deaths and was the 
second leading cause of death in the United States in 2010.174  Indeed, it is no surprise 
that much research is currently aimed at discovering cures.  One relatively new approach 
to combat cancer is through the use of PhotoDynamic Therapy (PDT).  PDT agents are 
dyes that are non-cytotoxic unless, ideally, they are activated by light.  Phototoxicity is 
caused by the generation of Reactive Oxygen Species (ROS) inside of cells.175,176  In 
practice, the PDT agent is either injected or applied topically to the cancer patient.  Once 
the agent has localized in the tumor, it is selectively irradiated with powerful lasers, 
killing the irradiated cells in the process. 
The advantage of such an approach over other types of treatments is that only the 
cancer is irradiated and theoretically only these cells should be killed, as opposed to 
chemotherapeutic drugs that often target normal cells.  In spite of this, only a few PDT 
agents have been approved; these are for treatment of skin, gynecological, gastro-
intestinal, and some head and neck cancers.177  Photofrin® was the first and its structure is 
derived from hematoporphyrin (HpD) (Figure 5.1).  Unfortunately, Photofrin is isolated 
as an oligomeric mixture so batch reproducibility is problematic and, in fact, the most 
active component of Photofrin is ambiguous.178  Furthermore, Photofrin lacks selectivity 
for cancer cells and can stay in the body for up to two months after treatment.176 Foscan® 
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is a synthetic analog of Photofrin though its structure is based of the chlorin rather than 
porphyrin.  Furthermore, unlike Photofrin, Foscan is a single component and batch 
reproducibility is not problematic. 
Unfortunately, Photofrin and Foscan are not selective to tumor cells;  once the agents 
are introduced in the blood stream they localized throughout the body.  This is 
problematic because activation due to exposure to sunlight can occur.  A clever approach 
towards selectivity was achieved in the development of Levulan® in which a prodrug, 5-
aminolevulinic aid (ALA), is applied topically over the tumor.  The body absorbs ALA 
and produces an active PDT agent. Importantly, the agent is mostly localized near the 
point of application of the prodrug as opposed to rapid dispersal throughout the host.  
The process tends to be only effective for cancers near the skin surface because ALA has 
to reach the tumor. 
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Figure 5.1. Commonly clinical PDT agents encountered. 
 
Besides the tetrapyrrolic agents, naturally occurring dyes have also been investigated 
as PDT agents.  Nile Blue, Nile Red, and the chalcogenopyrylium class of 
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photosensitizers have all shown promise but have undesirable dark cytotoxicities.  A 
relatively new class of PDT agents is those derived from the BODIPY chromophore.  
BODIPYs are discussed in detail in Chapter II and they possess several attributes 
attractive for PDT including: (i) high molar absorptivities, (ii) high fluorescence 
quantum yields, (iii) relatively low sensitivity to environment, and (iv) resistance to 
photobleaching.  Despite these encouraging properties, the uses of BODIPYs for PDT 
remain scarce.  Nagano et al. investigated a simple diiodinated BODIPY as a PDT agent 
and found it to be efficient at producing singlet oxygen presumably due to the heavy 
atom effect induced by the iodines (Figure 5.2).56  Similarly, Akkaya et al. studied 
dibrominated BODIPYs with extended conjugation at the α-positions.179  These were 
also effective agents and have the added advantage of absorbing above 650 nm, 
alleviating problems of tissue penetration by incident light.  Our aim for this work was 
two-fold, (i) further investigate the scope of simple BODIPYs as PDT agents; and (ii) 
use the information from the first aim to design a new class of PDT agents that absorb in 
the near-IR region. 
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Figure 5.2. Previously studied BODIPYs for PDT. 
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5.2 In Vitro and In Vivo Photocytotoxicity of BODIPY Derivatives for PDT 
The work described in this section✪ is aimed at understanding how structural 
variations affect the PDT properties of BODIPY.180  For this purpose we studied many of 
the dyes produced in Chapter II and compound 77 (Figure 5.3) that was synthesized by 
diiodination of B using iodine and iodic acid in methanol. 
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Figure 5.3. Potential PDT agents studied here. 
                                                
✪ The biological data presented in section 5.2 is mainly from a collaboration with the 
Boon research group in Malaysia. 
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Figure 5.3 Continued. 
 
Structural Variations and Photophysical Properties 
Two structural variations around the BODIPY core of compound A were investigated 
in this study (Figure 5.4).  The first (compounds B, C, 77, 48, 45) investigated the 
effectiveness of various iodinated derivatives in order to maximize the “heavy atom 
effect”.  To fine-tune the activity of iodinated BODIPY based structures, additional 
functionalizations such as meso-substitution with alkyl or aryl groups as well as 
sulfonation to improve hydrophilicity were tested.  Compound 48 contains a carboxylic 
acid handle and could be easily attached to other molecules later if required.  For the 
second variation (compounds 50-54), the effect of extended conjugation at the 4-pyrrolic 
position was examined.  Extended conjugation at the 4-pyrrolic positions increases the 
absorption wavelength of the compounds to the red, permitting the use of longer 
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excitation wavelength that penetrates deeper into biological tissues for effective 
treatment. 
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Figure 5.4. Structural variation of BODIPYs studied here. 
 
Table 5.1 summarizes the photophysical data of the compounds studied for PDT.  The 
absorption and emission wavelengths of the series of BODIPYs range from 500 to 600 
nm.  As expected for dyes 50-53, extending the conjugation with an acrylate shifts the 
λabs max to the red by 20-30 nm while attaching two acrylates red-shifts the λabs max by 50-
60 nm, compared to compound A.  The λabs max values for iodinated compounds 77, 48, 
and 45 are also red-shifted compared to compound A but not for compounds B and C, 
which are aryl-iodinated at the meso-position.  In addition, all compounds have high 
extinction coefficients and high quantum efficiencies of fluorescence except for a few 
structures. Among the exceptions, compounds 77, 48, and 45 have much lower 
fluorescence quantum efficiency and a correspondingly higher singlet oxygen generation 
rate (Table 5.2) compared to the other BODIPYs studied here, probably as a result of the 
enhanced intersystem crossing efficiency from the lowest singlet excited state to the 
triplet state contributed by the internal heavy-atom effect. 
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Table 5.1. Photophysical properties of BODIPY derivatives 
Compound λabs max (nm) ε (x 10
-6) 
λem max 
(nm) 
Φ Ref  a solvent 
A 505 8.3 516 0.80 1 EtOH 
B 504 8.2 510 0.64 1 CHCl3 
77 537 8.9 552 0.05 2 CH2Cl2 
C 498 10 509 0.34 1 H2O 
48 525 9.3 540 0.03 2 EtOH 
45 539 9.1 555 0.04 3 CH2Cl2 
54 494 8.1 504 0.95 1 EtOH 
50c 531 2.7 570 0.42 2 EtOH 
50d 529 -b 560 0.25 2 EtOH 
50a 527 6.3 549 0.73 2 EtOH 
51a 559 1.3 580 0.51 3 EtOH 
50b 528 6.2 551 0.73 2 EtOH 
51b 560 3.0 580 0.52 3 EtOH 
52f 517 6.3 527 0.78 2 EtOH 
53e 530 7.2 539 0.92 2 EtOH 
a Reference dyes used for quantum yield determination (solvent, Φ): 1. fluorescein (0.1 
M NaOH, 0.92), 2. rhodamine 6G (EtOH, 0.94), 3. rhodamine B (EtOH, 0.97); b value 
not determined. 
 
As in the case of the λabs max values above, compounds B and C which contain a para-
iodoaryl group at the meso position did not demonstrate the same loss in fluorescence 
yields or the same increase in singlet oxygen generation rate as compounds 77, 48, and 
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45 probably because in the former group, first, the iodine atom is not directly attached to 
the BODIPY core and, second, the iodoaryl plane is twisted relative to the BODIPY 
plane49, overall causing the aryl iodine atom to only, at most, elicit an intramolecular 
external heavy-atom effect.181  
 
In Vitro Photocytotoxic and Comparative Singlet-Oxygen 
The in vitro photocytotoxic activity of all the compounds against a promyelocytic 
leukemia cell line (HL-60), an oral squamous carcinoma cell line (HSC-2), and a 
nasopharyngeal carcinoma cell line (HK1) following irradiation with 4.1 J/cm2 of a 
broad spectrum light was determined by the Boon group using a modified 
methylthiazolyldiphenyltetrazolium bromide (MTT) assay.  Parallel assays without light 
irradiation were also carried out to determine cytotoxicity in the dark.  Results were 
expressed as IC50, the concentration of compound (in μM) that inhibits proliferation rate 
by 50 % compared to control untreated cells.  The parent compound, denoted as A, was 
also prepared and tested for comparison (Table 5.2).  From the assay, all compounds had 
negligible or undeterminable un-irradiated cytotoxicities up to 100 μM.  Upon 
irradiation with 4.1 J/cm2 of light, compounds A-C, 45, 48, 77, 50a-b, and 51-53 
demonstrated photosensitized cytotoxicities with IC50 values in the submicromolar to 
tens of micromolar range.  Compounds 48 and 45, which have two iodine atoms directly 
attached to the BODIPY core, showed the highest activity among the analogues, with 
IC50 values that are up to 100 times lower than that of compound A (0.045 μM vs. 4.4 
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μM in HL-60). In contrast, compounds 54 and 50c-d displayed poor activity with 
undeterminable IC50 up to 100 μM. 
The influence of the iodine atom on the photocytotoxic activity of the compounds was 
evident from studying compounds A-C, 45, 48, and 77.  Meso-substitution with a para-
iodoaryl group in compound B does not alter the photocytotoxicity significantly 
compared to compound A, while further substitution with iodine atoms on the two 
pyrrolic 4-carbon to yield either compound 77 from B or compound 45 from A improved 
the activity by 10- and 100-fold, respectively, in all three cell lines, alluding to the 
importance of iodine atom substitution on the pyrrolic carbons rather than on the meso-
aryl position.  Compound 48, which has an additional carboxylic acid tether at the meso 
position, has similar to marginally better activity than compound 45 in all three cell 
lines. An attempt to improve the water solubility of compound B by substituting with 
sodium sulfonate to yield compound C resulted in 10 times loss in activity.  
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Table 5.2. Comparative singlet oxygen generation and in vitro photo cytotoxicity 
induced by BODIPY. a Comparative singlet oxygen generation of photosensitizers in 
relative to methylene blue.  b IC50, the concentration of compound, which inhibits the 
proliferation rate by 50% as compared with control untreated cells.  Values represent the 
mean ± SD of three determinations assessed 24 h using standard MTT assay.  Cells were 
incubated with compound for 2 h prior to irradiation with 9.6 J/cm2. 
Activity IC50 (µM)b 
HL60 HSC2 HK1 
Cmpd 
Singlet 
oxygen 
generation 
relative 
ratea 
0 J/cm2 
(dark) 
9.6 J/cm2 
0 J/cm2 
(dark) 
9.6 J/cm2 
0 J/cm2 
(dark) 
9.6 J/cm2 
A 0.48 >100 4.4±0.4 >100 8.7±2.0 76.8±10.6 6.2±1.2 
B 0.15 >100 2.7±1.2 >100 5.1±0.8 >100 5.7±0.1 
77 13.9 10 0.42±0.06 10 0.5±0.1 95.5±7.9 0.69±0.08 
C 0.07 >100 54.3±8.3 >100 59.4±6.2 >100 59.0±7.1 
48 24.6 >100 0.045±0.004 >100 0.10±0.06 55.8±0.8 0.57±0.1 
45 23.9 3.34±0.37 < 0.01 54.5±6.0 0.083±0.014 75.4 0.052±0.01 
54 0.07 >100 >100 >100 >100 >100 >100 
50c 0.01 >100 >100 >100 >100 >100 >100 
50d 0.00 >100 >100 >100 >100 >100 >100 
50a 0.57 >100 4.8±0.7 >100 5.4±0.6 >100 5.3±0.6 
51a 0.41 >100 5.2±0.6 >100 11.1±7.4 >100 8.5±0.5 
50b 0.73 >100 0.49±0.07 >100 0.6±0.1 99.6±0.6 1.1±0.6 
51b 0.17 >100 57.7±6.6 >100 37.7±15.7 >100 >100 
52f 0.24 >100 4.9±0.6 >100 4.1±0.2 >100 5.0±0.6 
53e 0.29 >100 3.8±0.7 - - >100 4.8±0.9 
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For the effect of extended conjugation at 4-pyrrolic positions on photocytotoxic 
activity of BODIPYs, compounds 50-53 were studied.  Extending the 4-pyrrolic carbon 
with a single aldehyde 54 or the hydrophilic allylic carboxylic acid 50c and allylic 
sulfonic acid 50d resulted in loss of activity of greater than 100 μM IC50 values.  Single 
extensions at the 4-pyrrolic position with acrylate esters affected the activity differently 
depending on the length of the alkyl ester group, where the methyl compound 50a 
showed no change in activity while nbutyl compound 50b demonstrated 10-fold 
improvement in activity compared to compound A.  For compounds with double 
extension with the same groups at the 4-pyrrolic positions, the methyl compound 51a 
displayed comparable activity to compound A, but interestingly, the nbutyl compound 
51b showed 10-fold loss in activity compared to A or 100-fold loss compared to the 
singly extended counterpart 50b.  The explanation for the reversal in structure-activity 
relationship of the nbutyl acrylate esters compared with the methyl acrylate esters from 
the single to the double-extension (compounds 50a and 50b compared with compounds 
51a and 51b) is not obvious and could just be due to the poorer solubility of the doubly 
extended nbutyl derivative 51b.  Compounds 52f and 53e, which were failed attempts to 
prepare the analogous ring-constrained conjugated structures, were also tested and 
showed similar activities compared to compound A, further suggesting the minor role 
that 4-pyrrolic extended conjugation or the lack of it plays in modulating the 
photocytotoxicity of the BODIPY structures. 
Subsequently, the relative rate of singlet oxygen generation was measured for all the 
compounds by monitoring the reaction of known singlet oxygen acceptor 1,3-
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diphenylisobenzofuran (DPBF) with photosensitizers generated singlet oxygen.182  This 
was achieved by following the loss of DPBF absorbance at 410 nm at an initial 
concentration of 50 μM over a period of 1 h. A light source filtered at 510 nm 
wavelength was used to minimize the photobleaching of DPBF.  As a result, this would 
have caused an underestimation of singlet oxygen generation rate of the compounds with 
λabs max lower than 510 nm, as the light transmission through the filter begins to drop 
below 510 nm. Each of the compounds was tested at an equivalent concentration of 
reference sensitizer methylene blue. The results from this study ranged from 0.01- to 
over 24-fold of singlet oxygen generation rate compared to that of methylene blue. 
Importantly, the rate of reactive oxygen generation measured generally correlated with 
the potency of these compounds and may be a main factor affecting the 
photocytotoxicity of these BODIPYs. 
 
Photosensitizer Cellular Localization 
 To ascertain the intracellular localization of the BODIPYs, compound 48, owing to its 
good potency data, was chosen and examined by spinning disk confocal microscopy 
using dual staining techniques (Figure 5.5).  Co-staining images and topographic profiles 
of HSC-2 cell line loaded with compound 48 and a mitochondria-specific dye rhodamine 
123 (Rh123) revealed an almost identical overlap, suggesting that compound 48 
localized particularly well in mitochondria (Figure 5.5B,C).  In comparison, compound 
48 displayed only partial colocalization with endoplasmic reticulum and lysosomes, 
according to the confocal images and topographic profiles of compound 48 with ER-
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Tracker (Figure 5.5D,E) and with LysoTracker (Figure 5.5F,G), respectively.  Staining 
of the cytoplasmic or nuclear membrane by compound 48 was not detected, indicating 
that it does not react nonspecifically with biological membranes.  Furthermore, the 
nucleus remained free of compound 48 (dark nuclear area), signifying that this class of 
compounds would not be expected to directly damage DNA. 
 
Figure 5.5. Relative rates of singlet oxygen generation for agents 45, 48, and 77 (A) and 
intracellular localization of compound 48 in HSC-2 cells. Spinning disk confocal images 
(B, D, F) and fluorescence topographic profiles (C, E, G) of HSC-2 cells double-stained 
with 100 nM compound 48 and respective organelle probes. (B, C) Mitochondria were 
labeled with 100 nM Rh123 and excited at 494 nm. (D, E) Endoplasmic reticulum were 
labeled with 100 nM ER-Tracker and excited at 365 nm. (F, G) Lysosomes were labeled 
with 500nM of LysoTracker and excited at 365 nm. Compound 48 was excited at 575 
nm. Line indicates the longitudinal transcellular axis analyzed to generate the 
topography fluorescence profiles. Objective magnification is 63. 
N
B
F2
N
45
II
N
B
F2
N
CO2H
II
48
N
B
F2
N
I
I I
77
A 
 144 
0
20
40
60
80
100
120
140
Length
F
lu
o
re
s
c
e
n
c
e
 I
n
te
n
s
it
y
0
10
20
30
40
50
60
70
80
90
Rhodamine 123
Compound 5
 
48
 
0
50
100
150
200
250
300
Length
F
lu
o
re
s
c
e
n
c
e
 I
n
te
n
s
it
y
0
20
40
60
80
100
120
ER-Tracker
Compound 5
 
48
 
0
20
40
60
80
100
120
140
160
180
200
Length
F
lu
o
re
s
c
e
n
c
e
 I
n
te
n
s
it
y
0
20
40
60
80
100
120
Lyso Tracker
Compound 5
 
48
 
Figure 5.5 Continued. 
 
Mitochondria perform vital cellular functions and are involved in multiple signaling 
cascades in regulation of metabolism, cell cycle control development, and cell death.183  
In PDT, mitochondria are an important target.  During mitochondria-photosensitization 
in PDT, cytochrome c is released from mitochondria to directly effect rapid cell death 
through downstream effector pathways of apoptosis, bypassing other upstream apoptotic 
signaling pathways that require synthesis of new proteins.  This mechanism of action is 
B 
D 
F 
C 
E 
G 
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particularly useful in the treatment of cancer types that are chemoresistant because of 
mutations in upstream proapoptotic signaling pathways.184 
 
Cell Cycle Arrest and Apoptosis  
To study the mechanism of action of compound 48 that contributed to its 
photocytoxicity, the effect of compound 48 on cell cycle and apoptosis of HSC-2 cells 
was investigated by the Boon group using flow cytometric method.  The cell cycle 
profile of HSC-2 cells treated with compound 48 was analyzed in a time course 
experiment.  At 0.25 μM, compound 48 was found to induce G2/M arrest in HSC-2 cells 
as early as 2 h following light irradiation (Figure 5.6a).  HSC-2 cells in G2/M phase 
gradually increased from 26.1% in the control group to 39.8 %, 48.4 %, 55.5 %, 
respectively, at 2, 4, and 6 h after light irradiation.  Concomitant with the increased 
proportion of G2/M phase cells, HSC-2 cells in the G1 phase were reduced from 57.7 % 
to 46.3 %, 33.8 %, and 26.4 % while the proportion of HSC-2 cells in S phase remained 
fairly constant.  At 8 and 12 h, the proportion of cells arresting in the G2/M phase was 
reduced to 48.8 % and 26.0 %, respectively, after light irradiation.  Following the 
reduction of the proportion of cells arresting in G2/M phase, an increase of sub-G1 cells 
population from 8 to 12 h (from 4.4 % to 10.6 %) was observed.  The proportion of cells 
treated with compound 48 without irradiation remains unchanged compared to control.   
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a 
 
Figure 5.6. a. Effects on HSC-2 cell cycle phase at various intervals post irradiation 
analyzed using flow cytometry after treatment with 0.25 μM compound 48 and irradiated 
with a light dose of 4.1 J/cm2. DC represents unirradiated dark control.  b. 
Representative histograms of the event of annexin V-fluorescein isothiocyanate (FITC) 
binding to phosphatidylserine as an indicator of apoptosis in HSC-2 cells treated with 
0.5 μM compound 48 and irradiated with a light dose of 4.1 J/cm2.  M1 represents viable 
cell population, M2 represents apoptotic cell population, and DC represents unirradiated 
dark control. 
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Figure 5.6 Continued. 
 
In the present study, the maximal level of G2/M cell cycle arrest was observed at 6 h 
after PDT.  Thereafter, the recovery of the cell cycle profile to one with a reduced G2/M 
peak may be due to the redistribution of cells to sub-G1, indicating the onset of 
apoptosis of arrested cells. A similar G2/M arrest was also observed in hypericin-based 
PDT, a naturally occurring photosensitizer currently undergoing research.185,186  
Photosensitization of Hela cervical cancer cells with hypericin resulted in 
phosphorylation of mitochondria Bcl-2 that correlated with G2/M cell cycle arrest, 
followed by the onset of apoptosis.186 
In addition to cell cycle analysis, the onset of apoptosis was also quantified in flow 
cytometry experiments by measuring the externalization of membrane 
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phosphatidylserine through annexin V-FITC staining, an event that is considered 
characteristic of cells undergoing apoptosis (Figure 5.6b). Flow cytometric analysis of 
HSC-2 cells treated with 0.5 μM compound 48 showed the onset of apoptosis by 12 h 
following irradiation with 20.7% of the cells stained positive for annexin V compared to 
less than 10% at 0 or 4 h time points. The proportion of cells undergoing apoptosis 
continued to increase rapidly to 47.4% by 16 h, and at 24 h the apoptotic cell proportion 
was at 89.9%.  
 
PDT-Induced Vascular Occlusion  
One of the ways PDT causes damage during cancer treatment is by shutdown of blood 
vessels feeding the tumor.187  Hence, the ability of compound 48 to exert in vivo 
vasculature disruption was investigated using the in ovo CAM model. In the present 
study by the Boon group, the ability of compound 48 to induce occlusion of blood 
vessels in the CAM by PDT was performed at 3.5-7.0 nmol/embryo with a light dose of 
20-40 J/cm2. The degree of vascular occlusion was scored 24 h after treatment according 
to Table 5.3.  The score for photosensitized-mediated PDT-induced vascular occlusion is 
shown in Figure 5.7, and the angiograms representing the vascular occlusion score are 
shown in Figure 5.8. As expected, the degree of vascular occlusion increased with drug 
and light dose. 
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Table 5.3. The damage score of PDT-induced vasculature network occlusion. 
Occlusion score Findings 
0 No occlusion 
1 Partial closure of capillaries of diameter < 10 µm 
2 
Closure of capillary system, partial closure of 
blood vessel of diameter < 30 µm and size 
reduction of larger blood vessels 
3 Closure of vessels of diameter < 30 µm and partial closure of larger blood vessels 
4 Total closure of vessels of diameter < 70 µm and  partial closure of larger vessels 
5 Total occlusion of vessels in the irradiated area 
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Figure 5.7.  Effects of drug concentration and light dose on vascular occlusion efficacy 
of compound 48 in the CAM model.  Error bars represent standard error mean from at 
least 10 embryos. 
 
The average CAM vasculature damage score when irradiated at 20 J/cm2 on embryos 
treated with 3.5 and 7.0 nmol/embryo of compound 48 was approximately 2 and 3, 
respectively.  When the light dose increased to 40 J/cm2, the damage score increased 
accordingly to 3.5 and 5.  Meanwhile, the control eggs that received 20 μL of vehicle 
(cremophor EL 2.5%, EtOH 2.5% in saline) and exposed to a similar light dose showed 
no detectable vascular alteration in the treated area. This indicated that the vascular 
occlusion observed in embryos treated with compound 48 was neither caused by the 
vehicle components nor was it thermally induced.  Finally, treatment with compound 48 
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alone without irradiation did not induce any vascular occlusion, as non-irradiated areas 
remained perfused after 24 h.   
 Irradiated Area FITC fluorescence 24 h after PDT 
Vehicle (20 µl) 
Occlusion score 0 
 
 
Compound 48 
3.5 nmol/embryo 
20 J/cm2 
Occlusion score 2 
 
 
Compound 48 
3.5 nmol/embryo 
40 J/cm2 
Occlusion score 3.5 
 
 
Figure 5.8. Representative angiographies of blood vessels supplying the CAM at 
beginning and 24 h after PDT, illustrating the vascular occlusion efficacy induced by 
compound 5 at 3.5-7 nmol/embryo.  Irradiation was performed at 510-560 nm of 
excitation with 20-40 J/cm2 light dose.  Cremophor EL (2.5%) and EtOH (2.5%) in 
saline were used as a control vehicle.  Objective magnification is 4. 
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Figure 5.8 Continued. 
 
As the main respiratory organ of the chick embryo, CAM is a well-vascularized 
membrane that is suitable as a model for PDT. It is easily accessible, inexpensive, and 
relatively easy to handle for photosensitizer administration, light irradiation, 
fluorescence analysis of administered photosensitizer, and microscopy examination of 
PDT-induced vascular damage.188,189  CAM is a viable model that has been successfully 
used to evaluate the photodynamic-induced vascular occlusion efficacy of some 
photosensitizers that are in clinical trials as well as those that are already clinically 
approved such as palladium bacteriopheophorbide, porfimer sodium, lutetium 
texaphyrin, 5-aminolevulinic acid, and verteporfin.190,191  For example, a PDT experiment 
in the CAM model using verteporfin at a dose that is similar to the recommended clinical 
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dosage for the treatment of age related macular degeneration has been shown to cause 
complete occlusion of the large neovessels, an observation that correlates well with 
clinical setting.188  In addition, in a BALB/c mouse model where PDT treatment by 
verteporfin resulted in suppression of tumor growth, antivascular effects were also 
observed, whereby a decrease in the blood volume at the tumor site was noted.192,193  The 
results from the study demonstrated that compound 48 was able to induce complete 
closure of larger vessels, which is considered favorable in PDT treatment of cancer. 
  
PDT Agent 48 for Enhanced Permeability and Localization (EPR) Effect 
It has been demonstrated that lager molecules tend to localize inside of tumor cells 
more readily than in normal ones.194  This phenomenon is known as the EPR effect and 
is a result of cancer cells’ promiscuity towards nutritional supplies to meet the demands 
of rapid growth of the tumor.  In PDT, agents that localize preferably in tumor cells over 
normal ones are desirable since the agents can stay inside the host for several hours to 
even days after initial therapy.  In these cases, exposure to sunlight can produce 
undesirable “side effects” if the PDT agents are localized without specificity. 
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Polyglutamic acid (PGA) has been shown to be an effective promoter of EPR 
effect.195,196  We envisioned an approach in which BODIPY 48 is attached to PGA, 
enhancing its localization inside tumor cells, may promote its use as a PDT agent.  
BODIPY derivative 78 was targeted as a key precursor that would covalently bind to 
PGA via amide bond formation (Scheme 5.1). Synthesis of 78 was accomplished first by 
condensation of 2,4-dimethylpyrrole with 4-chlorobutanoyl chloride yielding alkyl 
chloride functionalized BODIPY 79 in 32 % yield.  Azide functionality was introduced 
by reacting alkyl chloride 79 with sodium azide yielding 80 in 99 % yield.  Azide 
intermediate 80 was diiodinated with iodine and iodic acid to yield diiodinated BODIPY 
81 in 75 % yield.  The azide functionality of 81 was reduced via Staudinger reduction 
and the crude product was reacted with PGA-H in the presence of 0.1 eq. of DCC✱ and 
catalytic amount of DMAP to yield the PGA-78 conjugate.  The conjugate was first 
precipitated from the reaction medium (DMF) by addition of chloroform, filtered, and 
subjected to sodium bicarbonate to convert the unlabeled carboxylic acids on the 
conjugate to the carboxylate form.  Conjugate PGA-78 was further purified by dialysis 
in water and was isolated as pink fibers after lyophilization.  The carboxylate form of 
PGA-78 displays good solubility in water, a desirable property for in vivo work.  
                                                
✱ Equivalents here are calculated as moles of DCC to moles of carboxylic acids in PGA-
H.  This number is important since similar polymers that were made with 0.2 eq. of DCC 
proved to be insoluble in water presumably do the hydrophobicities of these conjugates. 
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Scheme 5.1.  Synthesis of PGA-78 conjugate. 
 
Basic photophysical properties of the conjugate were measured in pH 7.4 PBS buffer 
(Figure 5.9).  The conjugate possesses a λabs max at 533 nm corresponding to the BODIPY 
and at 285 nm ascribable to an overlap of absorption from BODIPY and carboxylic 
functionality of the polymer.  Interestingly, no fluorescence is observed when the 
conjugate is excited at the λabs max of the BODIPY suggesting good internal conversion to 
the triplet state and/or quenching of the fluorescence due to the polar environment.  The 
loading of BODIPY on PGA was calculated as 2.5 mol of BODIPY to mol of polymer 
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through the use of absorption spectroscopy.  This number reflects the difficulty in the 
coupling reaction and indeed different loadings were obtained for different batches.  
Unfortunately, at the time this dissertation is written, testing of PGA-78 as an in vivo 
PDT agent remains in progress. 
 
 
Figure 5.9.  Absorbance spectrum of PGA-78 conjugate in pH 7.4 PBS buffer. 
 
In conclusion, we have demonstrated the in vitro photocytotoxic activity of BODIPY 
derivatives against cell lines from leukemia and two types of solid tumor.  Structure-
activity relationship study indicated the importance of having iodine atoms directly 
substituted on the BODIPY pyrrolic carbon-4 position rather than at the meso-aryl 
position, in accordance with the high singlet oxygen generation rate of these compounds.  
Extended conjugation at the 4-pyrrolic positions shifts the λmax abs to the red but did not 
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confer extra potency except for the compound with a single nbutyl acrylate ester 183.  
Hydrophilic analogues substituted with groups such as carboxylic acid, sulfonic acid, or 
sodium sulfonate generally drastically diminished the activity to the comparable 
compounds without these groups.  An exception here was the doubly iodinated 
compound 48 with an aliphatic carboxylic acid which showed up to 100-fold lower IC50 
value in HL-60 compared to the parent compound A, perhaps because of the structural 
difference where the carboxylic acid group is not directly conjugated with the BODIPY 
core.  Fluorescence microscopy studies showed that compound 48 localized exclusively 
within the mitochondria.  This, together with data from cell cycle analysis and onset of 
apoptosis studies, suggests that compound 48 probably induced cell death through 
mitochondria-dependent apoptosis rather than through damage to nucleic materials.  In 
addition, an emulsion of compound 48 was able to occlude the vasculature network in 
the CAM in vivo model, further showing its potential as an effective PDT agent. 
Although photosensitizers with > 600 nm excitation wavelengths allow deeper access 
into biological tissues for effective treatment of abnormal tissues of bigger volume, the 
shorter absorption wavelength of the BODIPY-based photosensitizers studied here, such 
as compound 48, may be preferred in the treatment of superficial tissues.  In a clinical 
PDT of cancer in the esophagus and bronchi with porfimer sodium II, treatment regime 
with light corresponding to the 514 nm excitation wavelength exhibited similar 
effectiveness as that with 630 nm in terms of tumor eradication but, significantly, with 
less damage of the deep tissue which could cause perforation in the esophagus.197  
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Overall, our results suggest that BODIPY structures, especially compound 48, have 
potential to be explored as a clinically useful agent for PDT of cancer. 
 
5.3 Design and Synthesis of Near-IR PDT Agents 
Though we were encouraged by the favorable activities of PDT agents such as 48, 
their absorbance wavelengths precludes their use for deep skin cancer treatments due to 
poor tissue penetration of wavelengths below 600 nm.2  This led us to search for near-IR 
dyes that could potentially be used as PDT agents.  PyrroloPyrrole Cyanines (PPCy) are 
a relatively new class of near-IR fluorophores developed by the Zumbusch lab. 198-202  
These dyes are remarkable not only for their absorbance wavelengths that extend far 
beyond 700 nm, but also for their high molar absorptivities and fluorescence quantum 
yields.  Though high fluorescence quantum yield is desirable in imaging applications, it 
is indicative of efficient conversion of energy as fluorescence and not other pathways 
that could lead to ROS production. 
We have seen in the study of BODIPY dyes (Section 5.2) that introduction of heavy 
atoms such as iodines on BODIPY’s core is an efficient method to promote ROS 
production.  We hypothesized that a similar method could be used to promote ROS 
pathways in PPCy dyes.  To this end we targeted compounds of type 82 as potential PDT 
agents.  Our hopes were that compounds of type 82 would have ROS production 
efficiencies similar to 46, absorb at wavelengths greater than 800 nm for deep tissue 
penetration, and do so with high molar absorptivities. 
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Scheme 5.2. Synthesis of PPCy 82. 
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The key reaction for synthesis of 82 is the condensation between DPP dye 90 and 
quinoxaline 88 (Scheme 5.2).  Unfortunately, to our knowledge, there is no detailed 
procedure in the literature for the synthesis of 88.  Our route began with tin mediated 
reduction of 4-iodo-2-nitroaniline 83 under acidic conditions to yield 4-iodobenzene 
diamine 84 in 95 % yield.  Diamine 84 was condensed with ethyl 2-oxoacetate in 
methanol resulting in cyclization to form a regioisomeric mixture of iodoquinoxalinones 
85 (86 %) that could not be conveniently separated due to poor solubility of the mixture 
in all solvents attempted.  Quinoxalinone mixture 85 was chlorinated by reacting with 
neat phosphorus oxychloride at reflux to yield the dihalogenated quinoxaline mixture 86 
in 96 % yield.  tButyl 2-cyanoacetate was deprotonated with sodium hydride and reacted 
with mixture 86 to yield the isomeric mixture of quinoxalinylidene 87 in 72 % yield.  
Mixture 87 was subjected to trifluoroacetic acid first resulting in the tbutyl cleavage of 
the ester and subsequent decarboxylation to yield a 1:1 mixture of isomers 88 in 40 % 
yield, which are conveniently separable via flash chromatography.  The structures of 
isomer 88a and 88b were assigned based on X-ray crystallography. 
DPP (1,4-Diketo-3,6-diarylpyrrolo{3,4-c}pyrroles)203 intermediate 90 was synthesized 
by alkylation of 4-hydroxybenzonitrile to give octyloxybenzonitrile 89 in quantitative 
yield.  Benzonitrile 89 was subjected to a one-pot, double condensation-cyclization to 
yield DPP dye 90 in 14 % yield.  Unfortunately, syntheses of, perhaps, more interesting 
DPPs such as the ones in Figure 5.10 failed at the DPP formation stage.  Reaction of 92 
with diethyl succinate yielded complex mixtures that were not easily separable.  The 
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same reaction with 93 failed to yield any products, presumably due to deprotenation on 
α-carbon of the tbutyl ester. 
PPCy formation occurred by two sequential substitutions on DPP 90 with either 
isomer of 88 in the presence of phosphorous oxychloride.  Crude intermediate 91 was 
obtained upon removal of the reaction solvent and treated with BF3•OEt2 in the presence 
of Hunig’s base to yield either isomer of 82 in 3 % yield (2 steps).  Interestingly, 
although neither isomer is extremely soluble in organic solvents, 82b was so insoluble 
that routine 1H NMR analysis was complicated though its presence was confirmed by 
mass spectrometry.  This lack of solubility makes its use as a PDT agent difficult and is 
not considered for that purpose hereafter.  1H NMR of 82a was obtainable under normal 
conditions and normal phase HPLC was used to confirm purity. 
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Figure 5.10. Failed syntheses of polar DPP dyes as PPCy precursors. 
 
Absorbance and emission spectra for both compounds were recorded in CH2Cl2 
(Figure 5.11).  We were excited to see that compound 82a absorbs strongly above 800 
nm with a molar absorptivity of 156,000 cm-1M-1 at maximum.  Fluorescence of 82a 
occurs at 823 nm though the quantum yield could not be confidently measured with our 
instrumentation or any instrumentation easily accessible due to the high wavelength of 
fluorescence.  Compound 82b has a maximum absorbance at 801 nm and the molar 
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absorptivity could not be accurately measured due to the aforementioned solubility 
problems of this compound.  Dye 82b exhibits an emission maximum at 820 nm. 
 
 
 
 
Figure 5.11. Absorbance and fluorescence spectra of 82 in CH2Cl2. 
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5.4 Conclusions 
In this work we studied simple BODIPYs and found that ones with iodines directly 
attached to the BODIPY core tend to have good activities for PDT.  We then derivatized 
a relatively new type of near-IR fluorophores with iodines to make them suitable PDT 
agents.  Studies are currently underway on PPCy 82a to assay its ROS production and 
the depth of tissue activation.  If these studies show 82a to be favorable for PDT, in vivo 
assays will then be conducted. 
Modifications of 82a could be attempted to make it more suitable for PDT if 
preliminary in vitro and in vivo testing of 82a show promise.  Compounds similar to 94 
(Figure 5.12) with ethylene glycol linkers and sulfonic acids should considerably 
increase the hydrophilicities of such compounds and the carboxylic acids could be used 
to attach targeting agents and/or macromolecules that promote EPR effect.  Although 
similar compounds have already been attempted (Figure 5.10), an approach could be 
taken to add the problematic polar functionality at the PPCy stage, thus circumventing 
tricky DPP formations. 
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Figure 5.12.  Potential next generation of PDT agents. 
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Figure 5.12 Continued. 
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CHAPTER VI 
   CONCLUSIONS 
 
Overall this dissertation examined numerous ways in which dyes could be modified to 
make them more suitable for a variety of biological applications such as imaging, 
detection of protein-protein interactions, and as PDT agents.  In this chapter closing 
remarks for the work discussed in this dissertation are given. 
Concurrent to the work done in Chapter III on TBET cassettes, others in the Burgess 
group explored different approaches to design systems suitable for detection of protein-
protein interactions.  Water-soluble TBET cassettes 95–99 were reported by Burgess and 
coworkers and204-206 have favorable photophysical properties even in aqueous solutions 
(Figure 6.1a).  Cassettes 95-97 share a common BODIPY donor and differ in BODIPY 
acceptors, each of which emit above 595 nm.  BODIPY 95 possesses a handle to label 
biomolecules on the acceptor part while 96 and 97 have handles on the linker portion of 
the cassette.  Cassette 96 has additional water solubility provided by the ethylene glycol 
linker.  Overall, these cassettes show promise for biomolecular labeling and multiplex 
detection of protein-protein interactions as discussed in Chapter I.   
Cassettes 96 and 97 were utilized to monitor three-component interactions, (via RET 
and TBET) as illustrated in Figure 6.1b.  This model mimics typical experiments to 
detect protein-protein interactions using such cassettes.  A RET donor (Atto425 attached 
to BSA-biotin) was mixed with 96-streptavidin and 97-avidin conjugates, and the 
interactions between (strept)avidin and biotin were monitored by observing emissions 
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from 96 and 97 upon excitation at 458 nm.205  These cassettes allow increased dispersion 
of fluorescence emissions from a single excitation source. 
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Figure 6.1.  a. Water soluble TBET cassettes developed by the Burgess group.  b. 
Depiction of how cassettes 96 and 97 can be used in multiplex experiments to detect 
protein-protein interactions. 
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Figure 6.1 Continued. 
 
Cassettes 98 and 99206 both possess Nile Red acceptors but differ in numerous ways.  
The Nile Red acceptor in 98 emits at 632 nm and contains two carboxylic acids that 
could conveniently label proteins and other biomolecules.  The donor of 98 is a 
disulfonated BODIPY that absorbs at 501 nm.  The Nile Red acceptor of cassette 99 is 
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slightly extended in conjugation owing to the phenylacetylene portion and 
consequentially emits at a higher wavelength (648 nm) than cassette 98.  The donor 
portion of cassette 99 is a pH sensitive xanthene that absorbs at 498 nm.  Overall 
cassettes 98 and 99 have good energy transfer efficiencies of 81 % and 77 % 
respectively, and are promising as biological fluorescent labels. 
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Figure 6.2.  Examples of hydrophobic cassettes encapsulated in nanoparticles, in this 
case calcium phosphate, to make them suitable for work in aqueous media. 
 
Although we were pleased that water-soluble cassettes could successfully label 
biomolecules and retain their favorable photophysical properties in aqueous 
environments, a general way of conferring water-solubility unto hydrophobic cassettes 
was still lacking.  For this purpose, the Burgess group attempted to encapsulate cassettes 
like 100 within calcium phosphate207 and silica to form nanoparticles (Figure 6.2).  
Theoretically, the shell of such particles should prevent the hydrophobic cassettes from 
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encountering the polar solvent environment when the particles are suspended in water.  
Indeed, when cassette 100 was encapsulated inside of calcium phosphate its 
photophysical properties compared well as a suspension in aqueous buffer with those of 
the free cassette in organic solvent (ethanol).  This implies efficient encapsulation of the 
hydrophobic cassette and suggests a general method of solubilizing other hydrophobic 
TBET cassettes.  Interestingly, when calcium phosphate nanoparticles of 100 were 
imported inside of clone 9 rat liver cells, the cargo inside the nanoparticles seemed to 
dictate localization of the particles within the cell.  An unfortunate drawback of such an 
approach however is the difficulty in attaching the nanoparticles to biomolecules without 
disrupting their functionalities. 
Others have had findings similar those described in this dissertation.  For example, Lin 
et al. have reported a ratiometric pH sensitive TBET cassette (101) consisting of a 
coumarin donor and rhodamine acceptor (Figure 6.3).208  The donor of the cassette 
absorbs near 400 nm with an emission maximum is at 465 nm.  The rhodamine acceptor 
emits at 587 nm. Like cassettes 65 and 66, probe 101 can measure the pH of its 
environment by calculating the ratio of emission intensities at 465 and 587 nm.  Under 
acidic conditions, efficient energy transfer from donor to acceptor was observed while 
the opposite was true in basic conditions. 
 
 173 
N
B
F2
N
O
O
O
OtBu
O
HO
O
O
OH
O
HO2C
CO2H
65
donor acceptor
2
O
 
 
N
B
F2
N
O
HO
O
O
OH
O
HO2C
CO2H
CO2H
66  
 
O
O
OH
O
N N
Cl
101 pH 3.0
!em donor 465 nm
!em acceptor 587 nm
I587/I465 47
101 pH 8.6
!em donor 465 nm
!em acceptor 587 nm
I587/I465 0.2  
 
Figure 6.3.  Ratiometric pH probes based on TBET. 
 
Jaschke et al. recently reported an elegant use of TBET cassettes to monitor 
intracellular biocatalytic Diels-Alder reactions.209  Water-soluble versions of cassette 33 
were used for this purpose by sulfonating the BODIPY acceptor.  Upon undergoing 
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Diels-Alder reactions on the anthracene donor, the photophysical properties of cassette 
102 change dramatically.  In fact, it is possible to differentiate free cassette with those 
bound to DAse (an enzyme that catalyzes Diels-Alder reactions), the Diels-Alder 
product bound to DAse, and the free products of type 103 in intracellular settings.  Most 
importantly, in each of these states the probes remain fluorescent and the probes 
locations can be ascertained. 
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Figure 6.4.  Water-soluble TBET cassette used to monitor intercellular Diels-Alder 
reactions. 
 
Other examples of TBET cassettes are xanthene-BODIPY cassettes 104 and 105 
reported by Akkaya et al..210  These cassettes share commonality with cassettes 65 and 
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66 although the authors reported no pH sensitivity and 104 and 105 are hydrophobic and 
lack functionality to attach to biomolecules.  The proximity of the two BODIPY units of 
105 resulted in significant excimer emission.  Unfortunately, the authors did not study 
these compounds in the context of TBET cassettes and therefore details such as the 
absorbance wavelength of xanthene and the ETE % are not mentioned.  Interestingly, 
contrary to cassettes synthesized in Chapter III, probes 104 and 105 are composed of two 
acceptors to one donor.  A comparative study of the brightness of such systems to ones 
with multiple donors to acceptor would be interesting. 
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Figure 6.5.  Other examples of TBET cassettes developed by the Akkaya group.  
 
The polymer work described in Chapter IV leads to many possibilities.  The Achilles’ 
heel of systems of type 70 is the concurrent quenching of acceptors as the amount of 
acceptors increases in the polymers, placing a limit on attainable brightness.  One 
possible remedy concerning “energy bridges” was already discussed in the conclusion of 
Chapter IV.  An alternative to using polymers could be the use of well-defined oligomers 
as opposed to polymeric systems.  It was proved in Chapter IV that energy transfer 
remained efficient with 4:1 donor to acceptor ratios.  Compounds such as 106 could be 
constructed to maximize molar absorptivity of the oligomers thus increasing overall 
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brightness, while avoiding the counteracting intramolecular quenching of the acceptor 
(Figure 6.6). 
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Figure 6.6.  Proposed highly brilliant probe for imaging and multiplexing applications. 
 
It is harder to make conclusions on the PDT work of Chapter V since testing is, at the 
time of this dissertation, still ongoing.  It is obvious that if PPCy dyes of type 82 are 
efficient at producing ROS without significant dark cytotoxicities then water-soluble 
versions would be of immediate interest.  A possible way of conferring water-solubility 
in such dyes was discussed in the conclusion of Chapter V.  The PDT activity of 48 
however has been established and current work deals with making it suitable for in vivo 
therapy.  A method of promoting the EPR effect, by attaching 48 to polyglutamic acid, 
 177 
was attempted in Chapter V and the results are still pending.  Another method could be 
to attach 48 to water-soluble polyfluorenes (Figure 6.7).  The advantage of polyfluorene 
versus other polymers such as polyglutamic acid is the large amounts of light that can be 
collected by polyfluorene using two-photon excitation.  The energy would then 
conceivably be funneled via RET to the PDT agent.  Of course testing would be 
necessary to assure that ROS produced do not significantly degrade the polymer before 
damaging tumor cells, and also quantification of the promotion of the EPR effect by 
polyfluorenes is, to the best of our knowledge, unknown. 
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Figure 6.7.  Proposed polyfluorene as both a promoter of the EPR effect and an efficient 
two-photon harvester of energy that can readily transfer energy via RET to PDT active 
agents such as 48. 
 
The use of through-bond energy transfer cassettes for biological applications appears 
to be spreading throughout the research community though overall still remains small.  
Factors antagonizing the growth in this area of research are undoubtedly the ambiguity 
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of the militating factors controlling the energy transfer and the complexity and cost of 
synthesizing these rather complex molecules.  These obstacles however are not 
insurmountable with proper research.  It remains to be seen what impact TBET systems 
have in long-term biological research. 
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APPENDIX A 
SUPPLEMENTARY DATA FOR REFERENCE 29 
 
This data is supplementary to the data found in reference 29.  In short, Table 2 and 
Figure 4 do not match.  Luckily the raw data was still available within the group and is 
presented here for clarity. 
 
 193 
 
 
 
 194 
 
 
 
 195 
APPENDIX B 
GENERAL EXPERIMENTAL PROCEDURES 
 
All reactions were carried out under an inert nitrogen or argon atmosphere unless 
specified otherwise.  All reaction solvents were either dried on activated alumina or 
distilled prior to use.  All reagents were used as received without further purification. 
NMR spectra were recorded on a VXP-300 MHz and Inova-500 MHz spectrometers 
(1H at 300 MHz or 500 MHz and 13C at 75 or 126 MHz) at room temperature unless 
otherwise mentioned.  Chemical shifts of 1H NMR spectra were recorded and reported 
in ppm from the solvent resonance (CDCl3 7.26 ppm, CD3OD 3.31 ppm). Data are 
reportedas follows: chemical shift, multiplicity (s = singlet, bs = broad singlet, d = 
doublet, t = triplet, q = quartet, dd = doublet of doublets, dt = doublet of triplets, br = 
broad, m = multiplet), coupling constants, and number of protons. Proton decoupled 13C 
NMR spectra were also recorded in ppm from solvent resonance (CDCl3 77.16, CD3OD 
49.0 ppm). Analytical thin layer chromatography (TLC) was performed on EM Reagents 
0.25 mm silica-gel 60-F plates, and visualized with UV light.  Flash chromatography 
was performed using silica gel (230–600 mesh).  MS were measured under ESI, MALDI 
or APCI conditions. All solvents and reagents were used as received unless noted 
otherwise.   
 
Determination of Quantum Yields and Molar absorptivities 
UV/Vis absorbance spectra were recorded on a Cary 100 Bio spectrophotometer.  
Steady-state fluorescence spectroscopic studies were performed on a Cary Eclipse 
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fluorometer.  The slit width was 5 nm for both excitation and emission.  Fluorescence 
spectra were corrected.  The relative quantum yields of the samples were obtained by 
comparing the area under the corrected emission spectrum of the test sample with that of 
a solution of standard.  The quantum efficiencies of fluorescence were obtained from 
three measurements with the following equation: 
Φx = Φst (Ix/Ist) (Ast/Ax) (ηx2/ηst2)   
Where Φ st is the reported quantum yield of the standard, I is the area under the 
emission spectra, A is the absorbance at the excitation wavelength and η  is the refractive 
index of the solvent used, measured on a pocket refractometer from ATAGO.  X 
subscript denotes unknown, and st denotes standard. 
Energy transfer percentage (ET %) were measured a ratio of the integral of 
fluorescence area corresponding to the acceptor to the total integral of fluorescence area.  
The energy transfer efficiencies (ETE %) were measured as a relative ratio of the 
integral of fluorescence area corresponding to the acceptor when exciting the donor to 
the integral of fluorescence area when exciting the acceptor directly.  The molar 
absorptivities at both excitation wavelengths were used as correction factors. 
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APPENDIX C 
EXPERIMENTAL DATA FOR CHAPTER II 
 
 
Phenylacetylene-BODIPY Derivatives 
 
H
N
(i) succinic anhydride
BF3•Et2O, toluene, 80 
oC, 5 h
(ii) BF3•Et2O, Et3N
20 oC, 16 h
N
B
F2
N
CO2H
47  18 %  
47; A solution of 2,4-dimethylpyrrole (1.0 mL, 10 mmol), succinic anhydride (400 
mg, 4.0 mmol), and BF3•Et2O (0.50 mL, 4.0 mmol) in 30 mL toluene was heated to 80 ºC 
under N2 for 5 h.  The mixture was cooled to 25 ºC and BF3•Et2O (5.0 mL, 40 mmol) and 
Et3N (10 mL, 80 mmol) were then added.  After stirring for 16 h at 20 ºC under N2 the 
reaction was quenched with 60 mL of 0.1 M HCl aqueous solution.  Extraction was 
performed and the organic fractions were combined and dried over magnesium sulfate. 
The organic solvent was removed under reduced pressure and the product was purified 
via flash silica column with 85 % ethyl acetate:hexane to afford the desired product as an 
orange solid (203 mg, 18 %).  1H NMR (300 MHz, CDCl3) δ (ppm) 6.07 (s, 2H), 3.29-
3.35 (m, 2H), 2.62-2.68(m, 2H), 2.52 (s, 6H), 2.44 (s, 6H), 13C NMR (75 MHz, CDCl3), 
δ (ppm), 176.6 154.8, 142.8, 140.3, 131.2, 122.0, 35.1, 23.4, 16.4, 14.5. MS (ESI) calcd 
for C16H18BF2N2O2 {M-H}- 319.15, found 319.15. TLC (50 % EtOAc:Hexane) Rf = 0.50. 
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1H NMR of 47 (CDCl3) 
 
N
B
F2
N
CO2H
 199 
13C NMR of 47 (CDCl3) 
 
N
B
F2
N
CO2H
 200 
N
B
F2
N
CO2H
47
N
B
F2
N
CO2H
II
I2, HIO3
MeOH, 25 ºC, 30 min
48  54 %  
 
48; Tetramethyl-BODIPY acid 47 (600 mg, 1.87 mmol) was suspended in 200 mL of 
MeOH.  I2 (1.24 g, 4.87 mmol) was added followed by iodic acid (660 mg, 3.75 mmol) 
in ~3 mL water was added over 5 min.  The mixture was stirred for 30 min at 25 ºC.  
The MeOH was then removed under reduced pressure and the crude product was 
purified via flash silica column with 50 % ethyl acetate:hexane to afford the desired 
product as a red solid (574 mg, 54 %). 1H NMR (300 MHz, CDCl3) δ (ppm) 3.28-3.32 
(m, 2H), 2.45-2.52 (m, 2H), 2.50 (s, 6H), 2.43 (s, 6H), 13C NMR (75 MHz, CDCl3), 
δ (ppm), 175.1 156.3, 142.5, 142.3, 131.1, 87.0, 34.9, 24.2, 19.3, 16.5. ESI HRMS calcd 
for C16H16BF2I2N2O2{M-H}- 570.9362, found 570.9340. TLC (50 % EtOAc:Hexane) Rf = 
0.55. 
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1H NMR of 48 (CDCl3) 
 
 202 
13C NMR of 48 (CDCl3) 
 
N
B
F2
N
CO2H
II
 203 
N
B
F2
N
CO2H
II
48
phenylacetylene
cat. PdCl2(PPh3)2, cat. CuI
Et3N, THF, 50 ºC, 16 h
N
B
F2
N
O OH
46 55 %  
 
46; A mixture of 48 (34 mg, 0.11 mmol), phenylacetylene (47 µL, 0.43mmol), Et3N 
(0.15 mL, 1.1 mmol), PdCl2(PPh3)2 (8 mg, 0.01 mmol), and CuI (4 mg, 0.02 mmol) were 
dissolved in 2 mL THF under N2.  The solution was degassed three times via the freeze-
thaw method and then heated to 50 ºC for 16 h under N2.  The solvent was removed 
under reduced pressure and the crude product was purified via flash silica column 
eluting with 20% methanol:CH2Cl2 to give the desired product as a red solid (17 mg, 55 
%).  1H NMR (500 MHz, CDCl3), δ 7.44-7.46 (m, 4H), 7.27-7.31 (m, 6H), 3.32-3.36 (m, 
2H), 2.62 (s, 6H), 2.56 (s, 6H), 2.53-2.57 (m, 2H), 13C NMR (125 MHz, 3:1 
CDCl3:CD3OD), δ 174.0, 157.5, 144.9, 141.4, 131.4, 131.2, 128.4, 128.3, 123.2, 116.7, 
96.7, 81.4, 24.2, 15.1, 15.1, 13.6. MALDI MS calcd for C32H27BF2N2O2 (M-H)- 519.21, 
found 519.21.  TLC (50 % EtOAc:Hexane) Rf = 0.20. 
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1H NMR of 46 (1:2 CDCl3/CD3OD)  
 
N
B
F2
N
O OH
 205 
13C NMR of 46 (1:2 CDCl3/CD3OD) 
 
N
B
F2
N
O OH
 206 
N
B
F2
N
CO2H
II
48
m-ethynylbenzoic acid
cat. PdCl2(PPh3)2, cat. CuI
Et3N, THF, 40 ºC, 7 h N
B
F2
N
O OH
49 13 %
CO2H
HO2C
 
 
49; A mixture of 48 (30 mg, 0.05 mmol), m-ethynylbenzoic acid (23 mg, 0.16 mmol), 
Et3N (0.30 mL, 2.1 mmol), PdCl2(PPh3)2 (5 mg, 0.01 mmol), and CuI (2 mg, 0.01 mmol) 
were dissolved in 1 mL DMF under N2.  The solution was degassed three times via the 
freeze-thaw method and then heated to 40 ºC for 7 h under N2.  The solvent was removed 
under reduced pressure and the crude product was extracted from ether (20 mL) using 10 
% MeOH in 0.1 M NaHCO3 aqueous solution (3 x 20 mL).  The aqueous layers are 
combined and brought to pH ~ 3 using 1 M HCl to yield purple precipitate.  The 
precipitate is filtered and further purified via C-18 preparative HPLC eluting with a 75 – 
95 % MeOH and 0.1 % TFA/water linear gradient over 25 min gave the desired product 
with a retention time of 11 min as a purple solid (4 mg, 13 %).  1H NMR (500 MHz, 
CD3OD), δ 8.11 (s, 2H), 8.00 (d, J = 7.5 Hz, 2H), 7.72 (d, J = 7.5 Hz, 2H), 7.50 (t, J = 
7.5 Hz, 2H), 3.65 (bs, 2H), 2.66 (s, 14H). 13C NMR could not be obtained due to poor 
solubility in organic solvents.  ESI MS calcd for C34H27BF2N2O6 (M-H)- 607.19, found 
607.19.  TLC (5 % MeOH:CH2Cl2) Rf = 0.10.  
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1H NMR of 49 (CD3OD)  
 
N
B
F2
N
O OH
CO2H
HO2C
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C-H Functionalization on BODIPYs 
 
Method A 
Solid Pd(OAc)2 (0.2 equiv) was added to a solution of 4,4-difluoro-1,3,5,7-
tetramethyl-4-bora-3a,4a-diaza-s-indacene (0.2 mmol, 50 mg), alkyl acrylate (5.0 
equiv.), and tert-butylperbenzoate (2.0 equiv.) in 3:9:1 (AcOH:Dioxane:DMSO) (1.5 
mL).  After stirring for 5 d at 35 °C, the reaction mixture was diluted with water (15 mL) 
and diethyl ether (15 mL).  The resulting solution was filtered through short pad of 
celite.  The filtrate was washed with saturated solution of sodium bicarbonate (3 X 10 
mL), organic layers were dried over anhydrous MgSO4, filtered and concentrated under 
vacuum. 
 
Method B 
Solid Pd(OAc)2 (0.2 equiv.) was added to a solution of 4,4-difluoro-1,3,5,7-
tetramethyl-4-bora-3a,4a-diaza-s-indacene (0.4 mmol, 100 mg), vinylsulfonic acid 
sodium salt (3 equiv.) and Cu(OAc)2 (4.0 equiv.) in 10:1 (DMF:DMSO) (8.2 mL).  The 
reaction mixture was irradiated with microwave radiation (200 W) at 80 ºC for 30 min 
with constant N2 cooling flow.  The resulting suspension was concentrated under 
vacuum. 
 
Method C 
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Solid Pd(OAc)2 (0.2 equiv.) was added to a solution of 4,4-difluoro-1,3,5,7-
tetramethyl-4-bora-3a,4a-diaza-s-indacene (0.4 mmol, 100 mg), methyl-1-cyclohexene-
1-carboxylate (4.0 equiv.) and Cu(OAc)2 (3.6 equiv.) in 10:1 (DMF:DMSO) (1.0 mL).  
After stirring for 5 days at  70 °C, the reaction mixture was diluted with water (15 mL) 
and extracted into diethyl ether (2 x 15 mL).  The resulting solution was dried with 
MgSO4 and filtered through short pad of celite and concentrated under vacuum.  
 210 
N
B
F2
N
CO2Me
N
B
F2
N
CO2MeMeO2C
50a 51a  
 
Method A was followed. Crude mixture was subjected to flash column 
chromatography that provided 50a (75% hexanes in ethyl acetate) in 61% (37 mg) and 
51a (60% hexanes in ethyl acetate) in 30% (20 mg) yields as orange solids: 50a; Rf = 
0.30 (60% hexanes/EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.66 (d, 1H, J = 16 Hz), 7.07 
(s, 1H), 6.14 (d, 1H, J = 16 Hz), 6.14 (s, 1H), 3.80 (s, 3H), 2.65 (s, 3H), 2.56 (s, 3H), 
2.37 (s, 3H), 2.28 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 168.2, 160.2, 154.9, 143.8, 
138.1, 136.2, 135.6, 132.1, 123.9, 120.8 (2C), 116.5, 51.8, 15.2 (2C), 13.7, 11.6; MS 
(ESI) calcd for C17H19BF2N2O2 332.15 found 333.15 (M+H+). 
 211 
 
 
 
 
 212 
51a; Rf = 0.20 (60% hexanes/EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.64 (d, 2H, J = 
10 Hz), 7.25 (s, 1H), 6.18 (d, 2H, J = 10 Hz), 3.80 (s, 6H), 2.68 (s, 6H), 2.40 (s, 6H); 13C 
NMR (125 MHz, CDCl3) δ 167.9, 159.0, 140.4, 135.4, 133.8, 125.2, 121.6, 118.0, 52.0, 
14.1, 11.7; MS (APCI) calcd for C21H23BF2N2O4 416.17 found 417.20 (M+H+). 
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N
B
F2
N
CO2
nBu
N
B
F2
N
CO2
nBunBuCO2
50b 51b  
 
Method A was followed. Reaction was carried out at 0.4 mmol scale.  Crude mixture 
was subjected to flash column chromatography that provided 50b (90% hexanes in ethyl 
acetate) in 61% (72 mg) and 51b (75% hexanes in ethyl acetate) in 30% (56 mg) yields 
as orange solids: 50b; Rf = 0.40 (60% hexanes/EtOAc); 1H NMR (300 MHz, CDCl3) δ 
7.66 (d, 1H, J = 16 Hz), 7.14 (s, 1H), 6.13 (d, 1H, J = 16 Hz), 6.14 (s, 1H), 4.20 (t, 2H, J 
= 7 Hz), 2.65 (s, 3H), 2.56 (s, 3H), 2.37 (s, 3H), 2.28 (s, 3H), 1.63-1.71 (m, 2H), 1.39-
1.48 (m, 2H), 0.97 (t, 3H, J = 7 Hz); 13C NMR (75 MHz, CDCl3) δ 167.7, 160.2, 155.8, 
143.5, 138.0, 135.7, 135.0, 132.1, 123.6, 120.6, 120.5, 116.7, 64.5, 30.8, 29.7, 19.2, 
14.9, 13.9, 13.7, 11.4; MS (ESI) calcd for C20H25BF2N2O2 374.20 found 381.21 (M+Li+). 
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 216 
51b; Rf = 0.35 (75% hexanes/EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.64 (d, 2H, J = 16 
Hz), 7.26 (s, 1H), 6.18 (d, 2H, J = 16 Hz), 4.24 (t, 4H, J = 6.6 Hz), 2.69 (s, 6H), 2.40 (s, 
6H), 1.63-1.78 (m, 4H), 1.39-1.48 (m, 4H), 0.97 (t, 6H, J = 7.5 Hz); 13C NMR (125 
MHz, CDCl3) δ 167.4, 158.7, 140.1, 134.9, 133.5, 125.0, 121.3, 118.2, 64.50, 30.8, 19.2, 
13.9, 13.8, 11.4; MS (APCI) calcd for C15H17BF2N2O3S 354.1 found 501.10 (M-H+). 
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Method A was followed. Reaction was carried out at 0.2 mmol scale.  Crude mixture 
was subjected to flash column chromatography that provided 50c (50% hexanes in ethyl 
acetate) in 29% (19 mg) as an orange solid: 50c; Rf = 0.30 (50% hexanes/EtOAc); 1H 
NMR (300 MHz, CD3OD) δ 7.47 (d, 1H, J = 16.2 Hz), 7.27 (s, 1H), 6.20 (d, 1H, J = 
16.2 Hz), 6.13 (s, 1H), 2.60 (s, 3H), 2.50 (s, 3H), 2.37 (s, 3H), 2.28 (s, 3H); 13C NMR 
(75 MHz, CD3OD) δ 172.7, 168.9,  158.5, 155.2, 143.0, 137.9, 134.3, 132.3, 124.1, 
122.0, 120.6, 120.0, 13.7, 12.1, 10.2 (2C); MS (ESI) calcd for C16H17BF2N2O2 318.13 
found 317.14 (M+-H). 
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Method B was followed. Crude mixture was subjected to flash column 
chromatography that provided 50d (4% methanol in dichloromethane) in 2% (4 mg) an 
orange solid; 1H NMR (300 MHz, CD3OD3) δ 7.52 (s, 1H), 7.23 (d, 1H, J = 18 Hz), 6.66 
(d, 1H, J = 18 Hz), 6.21 (s, 1H), 2.57 (s, 3H), 2.55 (s, 3H), 2.40 (s, 3H), 2.32 (s, 3H); MS 
(ESI) calcd for C15H17BF2N2O3S 354.10 found 353.11 (M-H+). 13C could not be obtained 
due to small isolated quantity.  
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Method A was followed. Reaction was carried out at 0.4 mmol scale. Crude mixture 
was subjected to flash column chromatography that provided 52e (75% hexanes in ethyl 
acetate) in 7.3% (11 mg) and 53e (75% hexanes in ethyl acetate) in 63% (126 mg) yields 
as orange solids: 52e; Rf = 0.30 (75% hexanes/EtOAc); 1H NMR (300 MHz, CDCl3) δ 
6.99 (s, 1H), 6.88 (s, 1H), 6.00 (s, 1H), 4.18-4.21 (m, 1H), 3.63 (s, 3H), 2.45-2.78 (m,  
9H), 2.23 (s, 3H), 2.16 (s, 3H), 1.86-195 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 165.2, 
156.5, 155.6, 144.2, 140.3, 137.6, 133.1, 132.0, 127.9, 119.5, 118.6, (2C), 51.6, 40.6, 
32.8, 30.7, 29.9, 14.7, 11.4, 9.8; MS (APCI) calcd for C20H23BF2N2O4 372.18 found 
373.04 (M+H+).  
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 224 
53e; Rf = 0.20 (75% hexanes/EtOAc); 1H NMR (300 MHz, CDCl3) δ 6.93 (s, 1H), 6.86 
(dd, 2H, J = 2.4, 4.5Hz), 4.12-4.18 (m, 2H), 3.60 (s, 6H), 2.42-2.80 (m, 12H), 2.13 (s, 
6H), 1.82-1.98 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 165.3, 155.2, 144.1, 137.8, 
137.2, 132.8, 131.5, 119.0, 51.6, 40.6, 32.8, 30.8, 13.2, 9.8; MS (APCI) calcd for 
C27H31BF2N2O4 496.23 found 497.98 (M+H+). 
 225 
 
 
 
 226 
N
B
F2
N N
B
F2
N
CO2Me CO2MeMeO2C
52f 53f  
 
Method C was followed. Crude mixture was subjected to flash column 
chromatography that provided 52f (75% hexanes in ethyl acetate) in 35 % (54 mg) and 
53f (75% hexanes in ethyl acetate) in 21% (45 mg) yields as orange solids: 52f; Rf = 0.30 
(75% hexanes/EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.06-7.08 (m, 1H), 6.97 (s, 1H), 
6.00 (s, 1H), 3.75-3.83 (m, 1H), 3.60 (s, 3H), 2.51 (s, 6H), 2.29-2.30 (m, 2H),  2.21 (s, 
3H), 2.15 (s, 3H), 1.82-1.91 (m, 2H), 1.60-1.79 (m, 2H); 13C NMR (125 MHz, CDCl3) 
δ 167.8, 156.6, 155.5, 140.4, 140.2, 137.8, 133.2, 133.0, 132.5, 132.2, 119.4, 118.5, 
51.7, 32.1, 29.8, 25.9, 20.5, 14.7, 13.2, 11.4, 10.0; MS (APCI) calcd for C21H25BF2N2O4 
386.20 found 387.01 (M+H+).  
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53f; Rf = 0.25 (75% hexanes/EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.03-7.07 (m, 
2H), 6.91 (s, 1H), 3.74-3.78 (m, 2H), 3.58 (s, 6H), 2.49 (s, 6H), 2.28-2.29 (m, 4H), 2.12 
(s, 6H), 1.55-1.92 (m, 8H); 13C NMR (125 MHz, CDCl3) δ 167.9, 140.5, 140.2, 133.0, 
132.5, 132.2, 119.5, 118.6, 51.8, 36.9, 32.2, 26.0, 20.6, 14.7, 11.5; MS (ESI) calcd for 
C29H35BF2N2O4 524.27 found 531.27 (M+Li+). 
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APPENDIX D 
EXPERIMENTAL DATA FOR CHAPTER III 
Scheme for Synthesis of Cassette 60 
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Synthesis and Characterization 
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O
1 eq. C
cat. PdCl2(PPh3)2
cat. CuI
Et3N, THF
55 oC, 5 h
D  
68; Iodophenyl BODIPY (D) (142 mg, 0.316 mmol), propargyltriethyleneglycylester 
C (100 mg, 0.331 mmol), PdCl2(PPh3)2 (24 mg, 0.032 mmol), CuI (12 mg, 0.064 mmol), 
Et3N (0.44 ml, 3.16 mmol) and 5 ml THF were added into a 50 mL round bottom flask.  
The solvent was degassed three times via the freeze-thaw method to remove oxygen, and 
then the reaction was heated to 55 oC for 5 h under nitrogen.  The reaction solvent was 
removed under reduced pressure.  The crude product was purified by flash column 
chromatography eluting with 30 % hexane/ethyl acetate to give the desired product as an 
orange solid (151 mg, 77 %).  1H NMR (300 MHz, CDCl3), δ7.53 (d, J = 8.1, 2H), 7.20 
(d, J = 8.1 Hz, 2H), 5.95 (s, 2H), 4.42 (s, 2H), 3.98 (s, 2H), 3.72-3.78 (m, 2H), 3.63-3.69 
(m, 10H), 2.51 (s, 6H), 1.45 (s, 9H), 1.36 (s, 6 H) 13C NMR (125 MHz, CDCl3), δ169.5, 
155.6, 142.8, 140.6, 135.0, 132.3, 131.0, 128.0, 123.4, 121.2, 86.5, 85.4, 81.4, 70.6, 
70.5, 70.4, 70.3, 69.2, 68.9,59.0, 27.9, 14.4. MS (ESI) calcd for C34H43BF2N2O6 (M+H)+, 
624.32, found 624.13. TLC (1:1 EtOAc/Hexane), Rf = 0.42. 
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1H NMR of compound 68 (CDCl3, 300 MHz) 
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13C NMR of compound 68 (CDCl3, 125 MHz) 
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69; A mixture of 68 (104 mg, 0.165 mmol), I2 (100 mg, 0.412 mmol), HIO3 (58 mg, 
0.33 mol) and 10 mL EtOH  in a 50 mL flask were warmed up to 60 oC for 20 min, and 
then it was cooled to 25 ºC.  The reaction was quenched by addition of Na2SO3 (2 mL 
1M).  Water (20 mL) was added to the reaction mixture, and the product was extracted 
from water with CH2Cl2 (25 mL x 3).  The combined organics were concentrated under 
reduced pressure, and the resulting crude product was purified by flash chromatography 
eluting with hexane and ethyl acetate (1:1) to give 69 (145 mg, 99%) as a red solid.  1H 
NMR (300 MHz, CDCl3), δ 7.60 (d, J = 8.4 Hz, 2H), 7.21 (d, J = 8.4 Hz, 2H), 4.47 (s, 
2H), 4.02 (s, 2H), 3.78-3.81 (m, 2H), 3.70-3.75 (m, 10H), 2.64 (s, 6H), 1.47 (s, 9H), 1.40 
(s, 6 H).  13C NMR (125 MHz, CDCl3), δ 169.9, 157.3, 145.4, 140.6, 135.0, 133.0, 131.3, 
128.2, 124.4, 87.3, 86.1, 85.5, 81.8, 71.0, 70.9, 70.9, 70.8, 70.7, 69.7, 69.3, 59.4, 28.4, 
17.4, 14.4.  MS (MALDI) calcd for C34H41BF2N2NaO6+ (M+Na)+, 899.10, found 898.91.  
TLC (1:1 EtOAc/Hexane), Rf = 0.45. 
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1H NMR of compound 69 (CDCl3, 300 MHz) 
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13C NMR of compound 69 (CDCl3, 125 MHz) 
 
 238 
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70; A mixture of 69 (65 mg, 0.074 mmol), diacetylfluorescein alkyne E 21 (82 mg, 
0.186mmol), Et3N (0.11 mL, 0.74 mmol), Pd(PPh3)4 (8 mg, 0.007 mmol), CuI (3 mg, 
0.014 mmol) were dissolved in THF (2 mL).  After the solution was degassed three 
times via the freeze-thawed method, the mixture was heated up to 45 oC for 16 h.  The 
reaction solvent was removed under reduced pressure and the crude product was purified 
by flash column eluting with 50% hexane:ethyl acetate to give the desired product as a 
light yellow solid (80 mg, 72%).  1H NMR (500 MHz, CDCl3), δ 8.08 (m, 2H), 7.73 (dd, 
J =8.0, 1.5 Hz, 2H), 7.65(d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.5 Hz, 2H), 7.15 (d, J = 8.2 
Hz, 2H), 7.10 (d, J = 2.0 Hz, 4H), 6.83 (bs, 4H), 6.83 (d, J = 2.0 Hz, 4H), 4.48 (s, 2H), 
4.02 (s, 2H), 3.80-3.82 (m, 2H), 3.70-3.75 (m, 10H), 2.75 (s, 6H), 2.32 (s, 12H), 1.58 (s, 
6H), 1.47(s, 9H).  13C NMR (125 MHz, CDCl3), δ 169.6, 168.8, 168.2, 159.1, 152.1, 
 239 
151.8, 151.5, 144.6, 142.1, 137.9, 134.1, 132.8, 131.1, 128.9, 127.9, 127.7, 126.6, 125.8, 
124.3, 124.2, 117.8, 116.0, 115.6, 110.5, 94.7, 87.2, 85.3, 84.1, 81.8, 81.5, 70.7, 70.6 (2 
C), 70.5, 69.5, 69.0, 59.2, 28.1, 21.1, 13.8, 13.7 MALDI MS calcd for 
C86H71BF2N2NaO20+ (M+Na)+ 1523.46, found 1523.26.  TLC (1:1 EtOAc/Hexane), Rf = 
0.20. 
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1H NMR of compound 70 (CDCl3, 500 MHz) 
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13C NMR of compound 70 (CDCl3, 125 MHz) 
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65; To 70 (12 mg, 0.01 mmol) in 5 mL 2:1 methanol/THF in was added Na2CO3 (3.5 
mg, 0.03 mmol).  The mixture was stirred for 3 h at 25 ºC under N2.  The reaction was 
quenched by adding aqueous HCl (0.1M, 10 mL) and the product was extracted out of 
the solution with 75% CH2Cl2:iPrOH (5 mL x 3).  The organic layers were washed with 
brine solution (10 mL) and dried with magnesium sulfate. The desired product was 
isolated as a purple solid (10 mg, 99 %).  1H NMR (500 MHz, 75% CD3OD:CDCl3), δ 
8.00 (s, 2H), 7.74 (dd, J = 8.0 Hz, 1.5 Hz, 2H), 7.65 (d, J = 7.5Hz, 2H), 7.33 (d, J = 8.5 
Hz, 2H), 7.15 (d, J = 8.0 Hz, 2H), 6.67 (d, J = 2.5 Hz 4H), 6.59 (d, J = 8.0 Hz, 4H), 6.51 
(dd, J = 9.0 Hz, 2.5 Hz, 4H), 4.47 (s, 2H), 4.00 (s, 2H), 3.79-3.81 (m, 2H), 3.71-3.73 (m, 
 243 
2H), 3.66-3.69 (m, 8H), 2.71 (s, 6H), 1.58 (s, 6H), 1.44 (s, 9H), 13C NMR (125 MHz, 
75% CD3OD:CDCl3), δ 170.9, 170.1, 169.8, 159.5, 153.5, 145.2, 142.9, 138.3, 134.8, 
133.4, 131.7, 131.2, 129.6, 128.7, 128.5, 128.0, 126.1, 125.9, 124.9, 116.3, 110.3, 108.2, 
103.3, 95.6, 87.4, 86.0, 84.1, 82.7, 71.0, 70.9 (2 C), 70.8 (2 C), 69.7, 69.3, 59.5, 30.2, 
28.3, 14.0. MS (MALDI) calcd for C78H63BF2N2O16+ (M+H)+ 1333.42, found 1333.44.  
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1H NMR of 65 (1:2 CDCl3/CD3OD) 
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13C NMR of 65 (1:2 CDCl3/CD3OD) 
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67; A mixture of 69 (80 mg, 0.09 mmol), F29 (69 mg, 0.20 mmol), Et3N (0.13 mL, 
0.91 mmol), PdCl2(PPh3)2 (6 mg, 0.01 mmol), CuI (4 mg, 0.01 mmol) were dissolved in 
3.0 mL THF.  The solution was degassed three times via the freeze-thaw method and the 
mixture was heated to 50 ºC for 16 h under N2.  The reaction solvent was removed under 
reduced pressure and the crude product was purified via flash silica column eluting with 
67% hexane:ethyl acetate to give the desired product as a purple solid (89 mg, 74 %).  
1H NMR (500 MHz, CDCl3), δ 7.64 (d, J = 8.0 Hz, 2H), 7.59 (d, J =8.0 Hz, 4H), 7.29 (d, 
J = 8.5 Hz, 2H), 7.27 (d, J = 8.0 Hz, 4H), 5.99 (s, 4H), 4.48 (s, 2H), 4.02 (s, 2H), 3.80-
3.82 (m, 2H), 3.70-3.75 (m, 10H), 2.76 (s, 6H), 2.55 (s, 12H), 1.58 (s, 6H), 1.47(s, 9H), 
1.43 (s, 12H), 13C NMR (125 MHz, CDCl3), δ 169.6, 158.9, 155.7, 144.1, 143.0, 141.7, 
140.7, 134.8, 134.3, 132.8, 131.9, 131.2, 128.2 (2 C), 128.0, 124.1 (2 C), 121.3, 116.0, 
96.0, 87.1, 85.3, 82.9, 81.6, 70.7, 70.6 (3 C), 70.5, 69.5, 69.0, 59.2, 28.1, 14.6 (2 C), 
 247 
14.6, 13.7. MALDI HRMS calcd for C76H77B3F6N6O6+ (M•+) 1316.6113, found 
1316.6172. 
 248 
1H NMR of 67 (CDCl3) 
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13C NMR of 67 (CDCl3) 
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66; A mixture of 48 (30 mg, 0.05 mmol), E21 (55 mg, 0.13 mmol), Et3N (0.30 mL, 2.1 
mmol), PdCl2(PPh3)2 (5 mg, 0.01 mmol), and CuI (2 mg, 0.01 mmol) were dissolved in 
1.0 mL DMF under N2.  The solution was degassed three times via the freeze-thaw 
method and then stirred at 40 ºC for 4 h and then at 25 ºC for 12 h under N2.  The solvent 
was removed under reduced pressure and the crude product partially purified via flash 
silica column eluting with 7 % methanol:CH2Cl2 to give the acetate protected form of 66 
as a purple solid (15 mg). 
The product from above (15 mg) was treated with sodium carbonate (6 mg, .05 mmol) 
in 5.0 mL of methanol.  The mixture was stirred at 25 ºC for 3 h.  The solvent was 
removed under reduced pressure and extraction was performed using CH2Cl2 and 0.1 M 
HCl aqueous solution.  The aqueous layer was washed with CH2Cl2 (2 x 5 mL) and the 
organic fractions were combined and dried over magnesium sulfate.  The solvent was 
then removed under reduced pressure and purified via C-18 preparative HPLC eluting 
with a 50 – 95 % MeOH and 0.1 % TFA/water linear gradient over 25 min to give the 
 251 
desired product with a retention time of 18 min as a purple solid (2 mg, 4 %).  1H NMR 
(500 MHz, CD3OD), δ 8.08 (s, 2H), 7.87 (d, J = 8.0 Hz, 2H), 7.23 (d, J = 8.0 Hz, 2H), 
6.70 (s, 4H), 6.67 (d, J = 8.5 Hz, 4H), 6.58 (d,  J = 7.5 Hz, 4H), 3.45 (m, 2H), 3.12 (m, 
2H), 2.70 (s, 6H), 2.68 (s, 6H) MALDI HRMS calcd for C60H37BF2N2O12 (M-2H/2)-2 
513.6243, found 513.6244 TLC (5 % MeOH :CH2Cl2) Rf = 0.20.  
 252 
 
1H NMR of 66 (CD3OD) 
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64; A mixture of 48 (30 mg, 0.05 mmol), F29 (47 mg, 0.14 mmol), Et3N (0.29 mL, 2.1 
mmol), Pd(PPh3)4 (8 mg, 0.01 mmol), and CuI (2 mg, 0.01 mmol) were dissolved in 1.5 
mL DMF under N2.  The solution was degassed three times via the freeze-thaw method 
and then stirred for 3 d at 25 ºC under N2.  The solvent was removed under reduced 
pressure and the crude product was purified via flash silica column eluting with 3 % 
methanol:CH2Cl2 followed by recrystalization from methanol to give the desired product 
as a purple solid (28 mg, 53%).  1H NMR (300 MHz, CDCl3), δ 7.65  (d, J = 8.5 Hz, 
4H), 7.30 (d, J = 8.0 Hz, 4H), 6.00 (s, 4H), 3.78 (bs, 1H), 3.46 (m, 2H), 2.73 (s, 6H), 
2.70 (m, 2H), 2.66 (s, 6H), 2.56 (s, 12H), 1.45 (s, 12H), 13C NMR (125 MHz, CDCl3), δ 
158.2, 155.9, 143.1, 141.5, 140.9, 135.1 (2 C), 132.1, 131.3, 128.4, 124.2, 121.5, 116.6, 
96.4, 83.1, 29.8, 15.5 (2 C), 14.8 (2 C), 13.9. MALDI HRMS calcd for C58H53B3F6N6O2 
(M•-) 1012.4434, found 1012.4472.  TLC (1:1 EtOAc:Hexane) Rf = 0.30.  
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1H NMR of 64 (CDCl3) 
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13C NMR of 64 (CDCl3) 
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108; A mixture of 69 (66 mg, 0.08 mmol), phenylacetylene (42 µL, 0.38 mmol), Et3N 
(0.10 mL, 0.75 mmol), PdCl2(PPh3)2 (6 mg, 0.01 mmol), and CuI (3 mg, 0.01 mmol) 
were dissolved in 5.0 mL THF.   The solution was degassed three times via the freeze-
thaw method and then heated to 45 oC for 16 h under N2.  The reaction solvent was 
removed under reduced pressure and the crude product was purified via flash silica 
column eluting with 50% hexane:ethyl acetate to give the desired product as a purple 
solid (52 mg, 79%).  1H NMR (500 MHz, CDCl3), δ 7.62 (d, J = 8.0 Hz, 2H), 7.45-7.47 
(m, 4H), 7.31-7.34 (m, 6H), 7.27 (d, J = 8.5 Hz, 2H), 4.47 (s, 2H), 4.02 (s, 2H), 3.80-
3.81 (m, 2H), 3.69-3.75 (m, 10H), 2.72 (s, 6H), 1.54 (s, 6H), 1.47(s, 9H), 13C NMR (125 
MHz, CDCl3), δ 169.6, 158.7, 143.7, 141.4, 134.5, 132.7, 131.3, 130.9, 128.3, 128.1, 
128.0, 124.0, 123.2, 116.3, 96.6, 86.9, 85.4, 81.5, 81.4, 70.7, 70.6 (2 C), 70.5, 69.4, 69.0, 
 257 
59.1, 28.1, 13.7, 13.6. MALDI MS calcd for C50H51BF2N2NaO6+ (M+Na)+ 847.37, found 
847.12. 
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1H NMR of 108 (CDCl3) 
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13C NMR of 108 (CDCl3) 
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109; A mixture of 69 (58 mg, 0.066 mmol), m-ethynylbenzoic acid (30 mg, 0.20 
mmol), Et3N (0.10 mL, 0.75 mmol), PdCl2(PPh3)2 (5 mg, 0.003 mmol), and CuI (3 mg, 
0.01 mmol) were dissolved in 5.0 mL THF.  The solution was degassed three times via 
the freeze-thaw method and heated to 45 oC for 16 h under N2.  The reaction solvent was 
removed under reduced pressure and the crude product was purified by flash silica 
column eluting with 80% CH2Cl2:MeOH to give the desired product as a purple solid (35 
mg, 58%).  1H NMR (500 MHz, CD3OD), δ 8.12 (s, 2H), 8.01 (d, J = 8.0 Hz, 2H), 7.75-
7.78 (m, 4H), 7.53-7.58 (m, 6H), 4.49 (s, 2H), 4.00 (s, 2H), 3.76-3.77 (m, 2H), 3.66-3.69 
(m, 4H), 3.61-3.64 (m, 6H), 2.71 (s, 6H), 1.60 (s, 6H), 1.44 (s, 9H), 13C NMR (125 MHz, 
CD3OD), δ 166.9, 159.2, 144.9, 141.4, 136.0, 135.0, 133.5, 132.8, 132.0, 131.8, 130.2, 
129.7, 129.3, 125.1, 124.4, 116.5, 108.8, 96.6, 88.5, 85.6, 82.8, 81.2, 71.2, 71.1, 70.0, 
69.3, 59.2, 32.6, 30.5, 28.2, 23.3, 14.3, 13.8. MALDI HRMS calcd for 
C52H51BF2N2KO10+ (M+K)+ 951.3245, found 951.3284. 
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1H NMR of 109 (CD3OD) 
 
 262 
13C NMR of 109 (CD3OD) 
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N
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II
 
 
S-1; Tetramethyl-BODIPY ester S-A211 (150 mg, 1.1 mmol) was suspended in 15 mL 
of EtOH.  I2 (290 mg, 1.1 mmol) was added and iodic acid (170 mg, 0.95 mmol) in ~0.7 
mL water was added over 20 min.  The mixture was stirred for 20 min at 60 ºC and then 
at 25 ºC for 30 min.  Formed precipitate was filtered to afford the desired product as a 
red solid (230 mg, 86 %) in adequate purity. 1H NMR (300 MHz, CDCl3) δ (ppm) 3.75 
(s, 3H), 3.38 (t, J = 9Hz, 2H), 2.62 (s, 6H), 2.50 (m, 8H). Compound solubility to poor 
for carbon NMR.  MALDI HRMS calcd for C16H18BF2I2N2O2{M-H}- 584.9519, found 
584.9532. TLC (4:1 Hexane:EtOAc) Rf = 0.45. 
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1H NMR of S-1 (CDCl3) 
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60; A mixture of S-1 (20 mg, 0.03 mmol), F (24 mg, 0.07 mmol), Et3N (0.19 mL, 1.4 
mmol), PdCl2(PPh3)2 (4 mg, 0.01 mmol), and CuI (2 mg, 0.01 mmol) were dissolved in 
1.0 mL DMF under N2.  The solution was degassed three times via the freeze-thaw 
method and then stirred for 3 d at 25 ºC under N2.  The solvent was removed under 
reduced pressure and the crude product was purified via flash silica column eluting with 
3:1 Hexane:EtOAc followed by recrystalization from CH2Cl2/hexanes to give the desired 
product as a purple solid (10 mg, 28%).  1H NMR (300 MHz, CDCl3), δ 7.64  (d, J = 8.4 
Hz, 4H), 7.30 (d, J = 8.1 Hz, 4H), 6.00 (s, 4H), 3.78 (s, 3H), 3.43 (b, 2H), 2.73 (s, 6H), 
2.65 (s, 8H), 2.56 (s, 12H), 1.45 (s, 12H), 13C NMR (125 MHz, CDCl3), δ 172.0, 158.2, 
156.0, 144.6, 143.1, 141.6, 140.9, 135.1, 132.2, 131.4, 128.5, 124.2, 121.5, 96.3, 83.1, 
52.4, 35.2, 15.5, 14.8 (2 C), 13.9. X-Ray obtained for this compound (see text) MALDI 
HRMS calcd for C59H55B3F6N6O2 (M•+) 1026.4591, found 1026.4607.  TLC (4:1 
EtOAc:Hexane) Rf = 0.20.  
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1H NMR of 60 (CDCl3) 
 
 267 
13C NMR of 60 (CDCl3) 
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Complete Electrochemical Data 
 Cyclic Voltammetry (CV) Differential Pulse Voltammetry (DPV)e 
cmpd Eonset,ox (V) 
HOMO 
(eV) 
Eonset,red 
(V) 
LUMO 
(eV) 
Eg 
(eV) 
Eonset,ox 
(V) 
HOMO 
(eV) 
Eonset,red 
(V) 
LUMO 
(eV) 
Eg 
(eV) 
           
Ga +0.68 5.84 -1.32 3.84 2.00 +0.70 5.86 -1.19 3.97 1.89 
Hb +0.33 5.48 -1.03 4.12 1.36 +0.07 5.79 -0.92 4.23 1.56 
HNab, d +0.04 5.19 -1.67 3.48 1.71 -0.25 4.85 -1.49 3.61 1.24 
46a +0.87 6.03 -0.88 4.28 1.75 - - - - - 
49b +0.40 5.55 -1.00 4.16 1.39 +0.55 5.70 -0.83 4.32 1.38 
108a +0.99 6.15 -0.91 4.28 1.87 +0.98 6.14 -0.75 4.41 1.73 
109b +0.49 5.64 -0.93 4.22 1.42 +0.47 5.62 -0.85 4.30 1.32 
109c +0.49 5.64 -0.92 4.23 1.41 - - - - - 
 
Electrochemical data for G, H, 46, 49, 108, and 109. All experiments were recorded 
using a glassy carbon working electrode (A = 0.071 cm2) referenced to Fc/Fc+ and a Pt 
counter electrode at a scan rate of 200 mV/s.  All potentials are reported vs. Fc/Fc+ and 
all HOMO and LUMO energies are derived form electrochemical results based on 
Fc/Fc+ = 5.1 eV vs vacuum.  All solvents were dearated using Ar(g).  a. CH2Cl2 solution 
b. DMF solution.  c. DMF solution (0.1 M pyridine).  d. xanthene was first reacted with 
NaOH to obtain the sodium salt.  e. Compounds 46 and 109 (base) decomposed during 
DPV scan.  
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Figure 2. Spectra of compounds G, H, 46, 49, 108, and 109 in 1:1 ethanol/CH2Cl2 1x10-
6 M: a absorbance; b absorbance with 8x10-5 M Bu4NOH; c emission; d emission with 
8x10-5 M Bu4NOH. 
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Electrochemistry Spectra 
Electrochemistry of 67 
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Electrochemistry of 46 
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Electrochemistry of 49 
 
DPV - reduction 
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DPV - oxidation 
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Electrochemistry of 108 
 
 
DPV - reduction 
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DPV - oxidation 
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Electrochemistry of 109 
 
 
DPV - reduction 
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DPV - oxidation 
 
109 with pyridine 
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Electrochemistry of G 
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DPV - Reduction 
 
 
DPV - oxidation 
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Electrochemistry of H 
 
 
 
DPV - reduction 
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DPV - oxidation 
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Electrochemistry of H-Na 
 
 
 
DPV - reduction 
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DPV - oxidation 
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APPENDIX E 
EXPERIMENTAL DATA FOR CHAPTER IV 
 
Synthesis and Characterization 
 
OH
CHO
(i) NaOH, I2
KI, H2O
reflux, 17 h
(ii) Na2CO3
MeI, DMF
80 ºC, 17 h
O
CHO
I I
 
 
3,5-diiodo-2-methoxybenzaldehyde; Salicylaldehyde (10.0 g, 81.9 mmol) was 
dissolved in 83 mL of 1 M NaOH.  Na2CO3 (23.3 g, 220 mmol) was then added followed 
by 100 mL of Lugol’s solution.*  The reaction was heated to reflux for 17 h and then 
cooled to room temperature.  The precipitate was filtered, washed with an ice/water 
mixture and then dissolved in near boiling water.  The undissolved parts were removed 
by filtration and the filtrate was cooled in an ice bath.  Sodium 2-formyl-4,6-
diiodophenolate  was isolated after filtration as green crystals (12.0 g, 37 %). 
Sodium 2-formyl-4,6-diiodophenolate (5.00 g, 12.6 mmol) was added to 50 mL of 
DMF.  Na2CO3 (4.02 g, 37.9 mmol) was added along with MeI (3.93 mL, 63.2 mmol).  
The suspension was stirred at 80 ºC for 24 h.  The reaction was then cooled to room 
temperature and 25 mL of 0.2 M Na2CO3 was added.  The product was extracted with 50 
mL EtOAc (x 2) and the combined organic layers were washed with 25 mL 0.2 M 
Na2CO3 (x 2) and 25 mL of brine.  The organic layer was dried over MgSO4 and filtered.  
The filtrate was evaporated under reduced pressure to yield 3,5-diiodo-2-
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methoxybenzaldehyde as a white powder (3.9 g, 80 %) 1H NMR (300 MHz, CDCl3), 
δ 10.18 (s, 1H), 8.31 (d, J = 2.4 Hz, 1 H), 8.07 (d, J = 2.4 Hz, 1H), 3.92 (s, 3H). 13C 
NMR (75 MHz, CDCl3), δ 188.0, 162.6, 152.7, 138.0, 131.4, 94.6, 89.5, 64.2. 
 
*Lugol’s solution was prepared by addition of I2 (43.3 g, 170.6 mmol) to KI (66.7 g, 
401.6 mmol) in ~100 mL H2O. 
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O
CHO
I I
 289 
 
 290 
Representative procedure for preparation of all BODIPYs 
 
NH N
II
O
CHO
II
(i) TFA, CH2Cl2
25 ºC, 2 h
(ii) chloranil
CH2Cl2, 25 ºC 
30 min
N
H
O
+
 
 
N N
II
B
F2
TEA, BF3
.OEt2
MePh, 80 ºC
30 min
O
 
 
71a; A solution of 2,4-dimethylpyrrole (0.88 mL, 8.51 mmol), 3,5-diiodo-2-
methoxybenzaldehyde (1.5 g, 3.87 mmol), and 5 drops of TFA (catalytic amt.) in 40 mL 
CH2Cl2 were stirred at 25 ºC for 2 h.  p-chloranil (1.00 g, 4.25 mmol) was added and the 
reaction was stirred at 25 ºC for 30 min.  The crude solution was transferred directly 
unto a basic aluminum column eluting with CH2Cl2.  Collected fractions containing the 
dipyrromethene intermediate were combined and evaporated under reduced pressure.  
The dipyrromethene was dissolved in 80 mL of toluene and triethylamine (1.60 mL, 11.6 
mmol) was added.  The mixture was stirred at 25 ºC for 15 min and BF3•OEt2 (2.40 mL, 
19.3 mmol) was added.  The reaction was stirred at 80 ºC for 30 min and then cooled to 
room temperature.  The reaction was quenched with 40 mL of H2O and stirred for 3 h.  
The mixture was extracted with 40 mL EtOAc (x 2).  The combined organic layers were 
washed with 40 mL H2O (x 2)  and 40 mL of brine.  The organic layer was dried over 
MgSO4 and then filtered.  The filtrate was evaporated under reduced pressure and the 
 291 
residue was purified via flash silica column eluting with 2:1 to 1:1 hexanes/CH2Cl2 to 
yield 576 mg (25 %) of 71a as an orange powder. 1H NMR (300 MHz, CDCl3), δ 8.22 
(d, J = 2.0 Hz, 1 H), 7.51 (d, J = 2.0 Hz, 1H), 6.01 (s, 2H), 3.67 (s, 3H), 2.55 (s, 6H), 
1.54 (s, 6H). 13C NMR (126 MHz, CDCl3), δ 156.5, 156.4, 148.3, 142.4, 139.0, 134.9, 
131.1, 130.9, 121.8, 94.2, 88.2, 60.9, 14.8, 14.3. HRMS (MALDI) calc for 
C20H18BF2I2N2O• 605.9648, found 605.9631. 
 292 
 
 
N N
II
B
F2
O
 293 
 
NH N
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CHO
II
(i) TFA, CH2Cl2
25 ºC, 2 h
(ii) chloranil
CH2Cl2, 25 ºC
30 min
N
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+
 
 
N N
II
B
F2
TEA, BF3
.OEt2
MePh, 80 ºC
30 min
O
 
 
71b; Representative procedure was followed.  The residue obtained after extraction 
was purified via flash silica column eluting with 5:2 hexanes/CH2Cl2 to yield 1.5 g (66 
%) of 71b as a red powder. 1H NMR (500 MHz, CDCl3), δ 8.19 (d, J = 2.0 Hz, 1 H), 
 294 
7.55 (d, J = 2.0 Hz, 1H), 6.31 (s, 2H), 3.61 (s, 3H), 3.07 (t, J = 6.0 Hz, 4H), 2.49 (t, J = 
6.0 Hz, 4H),  1.85 (m, 4H), 1.73 (m, 4H). 13C NMR (126 MHz, CDCl3), δ 158.7, 157.7, 
148.0, 140.7, 133.9, 133.7, 130.0, 129.9, 125.8, 93.8, 87.3, 62.0, 24.9, 23.3, 22.9, 22.4. 
HRMS (MALDI) calc for C24H23BF2I2N2O• 657.9961, found 657.9974. 
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II
(i) TFA, CH2Cl2
25 ºC, 2 h
(ii) chloranil
CH2Cl2, 25 ºC
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N N
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.OEt2
MePh, 80 ºC
30 min
O
OO
 
 
71c; Representative procedure was followed.  2-(2-methoxyphenyl)-1H-pyrrole was 
synthesized according to literature procedure.212 The residue obtained after extraction 
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was purified via flash silica column eluting with 1:1 to 1:2 hexanes/CH2Cl2 to yield 2.6 g 
(75 %) of 71c as a red powder. 1H NMR (500 MHz, CDCl3), δ 8.27 (d, J = 2.0 Hz, 1 H), 
7.78 (dd, J = 7.5, 1.5 Hz, 2H), 7.73 (d, J = 2.0 Hz, 1H), 7.35 (dt, J =  8.5, 7.5, 0.5 Hz, 
2H), 7.01 (dt, J = 7.5, 7.5, 0.5 Hz, 2H), 6.92 (d, J = 8.5 Hz, 2H),  6.77 (d, J = 4.5 Hz, 
2H), 6.62 (d, J = 4.5 Hz, 2H), 3.79 (s, 6H), 3.73 (s, 3H). 13C NMR (126 MHz, CDCl3), 
δ 157.8, 157.6, 156.3, 148.3, 140.8, 136.0, 135.3, 131.9 (t, J = 4.5 Hz), 130.9, 129.8, 
128.8, 122.9, 121.7, 120.3, 110.9, 93.8, 87.3, 66.3, 55.7 HRMS (MALDI) calc for 
C30H23BF2I2N2O3• 761.9859, found 761.9849. 
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71d; Representative procedure was followed. 7-methoxy-4,5-dihydro-1H-
benzo{g}indole was synthesized according to literature procedure.213 The residue 
obtained after extraction was purified via flash silica column eluting with 3:1 to 2:1 
hexanes/CH2Cl2 to yield 71d (35 %) as a green powder. 1H NMR (500 MHz, CDCl3), 
δ 8.76 (d, J = 9.0 Hz, 2 H), 8.22 (d, J = 2.5 Hz, 1H), 7.64 (d, J = 2.0 Hz, 1H), 6.99 (dd, J 
=  9.0, 3.0 Hz, 2H), 6.80 (d, J = 2.5 Hz, 2H), 6.40 (s, 2H),  3.88 (s, 6H), 3.67 (s, 3H), 
2.88 (t, J = 7.0 Hz, 4H), 2.67 (t, J = 7.0 Hz, 4H). 13C NMR (126 MHz, CDCl3), δ 160.9, 
157.9, 152.4, 147.9, 143.1, 141.1, 135.6, 132.6, 130.9, 130.3 {m, (triplet overlapping 
with another peak, 2C}, 123.9, 121.5, 114.4, 112.6, 93.8, 87.4, 62.0, 55.4, 31.0, 22.5 
HRMS (MALDI) calc for C34H27BF2I2N2O3• 814.0172, found 814.0185. 
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I I
1-bromooctane
KOtBu
25 ºC, 17 h
I I
C8H17H17C8
B  
B; 2,7-diiodo-9H-fluorene[Raymond, 2008 #15498] (10 g, 24 mmol) and 1-
bromooctane (10 mL, 57 mmol) were suspended in THF (60 mL).  Mixture was cooled 
to 0 ºC and KOtBu (8.1 g, 72 mmol) was added. The reaction was warmed to 25 ºC and 
stirred for 17 h. The reaction was then quenched with 4 N HCl until a color change from 
purple to tan was obtained at 0 ºC.  The product was then extracted with ether.  The 
combined ether fractions were washed with 0.2 N HCl, dried over MgSO4 and filtered. 
The solvent from the filtrate was removed under reduced pressure. The crude mixture 
was purified by flash silica chromatography eluting with 100:0 to 99:1 hexanes/CH2Cl2. 
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The product was obtained as a colorless powder (11 g, 73 %). 1H NMR (300 MHz, 
CDCl3), δ 7.70 (s, 2 H), 7.66 (d, J = 7.8 Hz, 2H), 7.40 (d, J = 7.8 Hz, 2H), 1.94 (t, J =  
8.1, 4H), 1.30-1.08 (m, 24H), 0.86 (t, J = 7.1 Hz, 6H.  13C NMR (75 MHz, CDCl3), 
δ 152.5, 139.7, 136.1, 132.0, 121.5, 93.4, 55.6, 40.2, 31.8, 29.9, 29.3, 29.2, 23.7, 22.7, 
14.3. 
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Representative procedure for preparation of polymers 
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K2CO3, 4:1 PhMe/H2O
48 h, 80 ºC
C
1 eq
B
0.46 eq  
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70a; 2,7-diiodo-9,9-dioctyl-9H-fluorene (B) (31 mg, 0.048 mmol), 9,9-dioctyl-9H-
fluorene-2,7-diboronic acid (C) (50 mg, 0.10 mmol), 71a (34 mg, 0.056 mmol), and 
K2CO3 (55 mg, 0.40 mmol) were placed in a schlenk tube.  The tube was evacuated and 
refilled with N2(g) three times and Pd(PPh3)4 (5 mg, 0.004 mmol) was added.  The tube 
was then charged with 4:1 toluene/H2O (10 mL and further degassed three times using 
the freeze/thaw method.  Reaction was heated to 80 ºC and stirred under N2(g).  After 60 h 
2 drops of iodobenzene were added and the reaction was stirred for an additional 1 h at 
80 ºC.  The mixture is then precipitated by addition to ~150 mL of vortexing MeOH, 
filtered, and thoroughly washed with MeOH.  The precipitate was transferred to a vial 
equipped with a stir bar and was stirred in 5mL of acetone at 25 ºC under Ar(g).  After 24 
h, the acetone was decanted off and the solid was stirred into an additional 5 mL of 
acetone.  This was repeated for a total of 3 times (72 h).  70a was obtained as a red 
powder (15 mg). Note: all polymers were made in parallel using a heating block to 
simultaneously heat all six mixtures with different acceptors. 1H NMR (500 MHz, 
CDCl3), δ 7.83 (bs),  7.66 – 7.35 (b), 6.07 (bs, 2H), 3.35 (bs), 2.61 (bs),  2.05 (bs, 26H), 
1.77 (bs), 1.08 (bs), 0.78 (bs). 
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70b; Representative polymer synthesis was followed.  70b was obtained as an orange 
powder (26 mg, 0.10 mmol scale). 1H NMR (500 MHz, CDCl3), δ 7.83 (bs), 7.67 (bs), 
7.58 (bs), 7.48 (bs), 7.35 (bs), 6.54 (bs, 2H), 3.36 (bs), 3.12 (bs), 2.54 (bs), 2.04 (bs, 
11H), 1.87 (bs), 1.76 (bs), 1.08 (bs), 0.77 (bs). 
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70c; Representative polymer synthesis was followed.  70c was obtained as an orange 
powder (5 mg, 0.046 mmol scale). 1H NMR (500 MHz, CDCl3), δ 7.81 (bs), 7.66 (bs), 
7.47 (bs), 7.35 (bs), 6.99 (b), 6.93 (bs), 6.64 (bs), 3.80 (bs, 6H), 3.44 (bs), 2.10 (bs, 
15H), 1.09 (bs), 0.78 (bs). 
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70d; Representative polymer synthesis was followed.  70d was obtained as a green 
powder (23 mg, 0.10 mmol scale). 1H NMR (500 MHz, CDCl3), δ 8.79 (bs), 7.82 (b), 
7.67 (bs), 7.00 (bs), 6.82 (bs), 6.63 (bb), 3.89 (bs, 6H), 3.41 (bs), 2.91 (bs), 2.71 (bs), 
2.06 (bs, 12H), 1.08 (bs), 0.77 (bs). 
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1e. Representative polymer synthesis was followed.  1e was synthesized according to 
literature procedure.150 The polymer was obtained as a blue powder (26 mg, 0.10 mmol 
scale). 1H NMR (500 MHz, CDCl3), δ 8.22 (bs), 8.10 (bs), 7.82 (bs), 7.66 (bs), 7.03 (bs), 
3.92 (bs, 6H), 2.07 (bs, 6H), 1.09 (bs), 0.78 (bs). 
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Syntheses of Nanoparticles 
Polymers were dissolved in THF at 4 ppm and and 2 mL were added to 8 mL of H2O 
under probe sonication over 7 min via syringe pump.  The mixture was passed through a 
0.2 mm filter and rotovaped for 5 min at 30 ºC. 
 
Optimization of brightness as a function of mol % acceptor  
Optimization of brightness as a function of mol % acceptor was done by varying the 
amount of acceptor in the polymerization while at the same time adjusting the amount of 
diiodofluorene to keep a constant 1:1 ratio of diiodinated to boronic acid monomers.  
Acceptor 71a was chosen for this study and was copolymerized in 0.05 - 0.67 
equivalents.  NMR studies show that BODIPY was incorporated in 6 – 19 mol % in the 
polymer.   
 
Optimization of reaction time on brightness 
The optimization of brightness of polymers 70 as a function of reaction time was 
studied by quenching the polymerizations at different times.  Analysis of crude polymers 
was performed in order to avoid removal of smaller polymers from shorter reaction 
times.  The maximum absorbance of the polymers in the crude mixture was determined 
by their excitation spectra.  The relative brightness of each polymer was then determined 
by exciting solutions of equal concentration at the λmax of the polymers and integrating 
the resulting fluorescence from the acceptors.  
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DLS and TEM Analysis of Particles 
Dynamic light scattering (DLS) measurements were conducted using Delsa Nano C 
from Beckman Coulter, Inc. (Fullerton, CA) equipped with a laser diode operating at 
658 nm.  Size measurements were made water (n = 1.3329, η = 0.890 cP at 25 ± 1 °C; n 
= 1.3293).  Scattered light was detected at 15° angle and analyzed using a log correlator 
over 70 accumulations for a 0.5 mL of sample in a glass size cell (0.9 mL capacity).  The 
photomultiplier aperture and the attenuator were automatically adjusted to obtain a 
photon counting rate of ca. 10 kcps.  The calculation of the particle size distribution and 
distribution averages was performed using CONTIN particle size distribution analysis 
routines.  The peak average of histograms from number distributions out of 70 
accumulations was reported as the average diameter of the particles.  
 
TEM showed mostly large aggregates (see 70c) for all polymers. Smaller, individual 
particles ranging from 20 to 60 nm were harder to find (70a, 70d).  Dynamic light 
scattering was done to make sure aggregation was not present on solution.  DLS showed 
average particle size of 48.4 ± 13.3 nm. 
 
 
 
TEM 
70a 
TEM 
70c 
TEM 
70d 
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DLS and TEM analysis of particles. 
DLS 70b 
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In vitro Cellular Imaging Studies 
 (a) Cell culture 
Clone 9 normal rat liver cells (American Type Culture Collection) were cultured as 
subconfluent monolayers on 75 cm2 culture flask with vent caps in Ham’s medium 
supplemented with 10 % fetal bovine serum (FBS) in a humidified incubator at 37 ºC 
with 5 % CO2.  Cells grown to subconfluence were enzymatically dissociated from the 
surface with trypsin and plated 2-3 days prior to the experiments in Lab-Tek two well 
chambered coverglass slides (Nunc).  
 
(b) Fluorescence microscopy  
Uptake and subcellular localization of the organic/McNeil nanoparticles were studied 
on living Clone 9 normal rat liver cells using a Zeiss 510 META NLO Multiphoton 
Microscope System consisting of an Axiovert 200 MOT microscope.  Throughout, 
digital images were captured with a 40x / 1.3 oil objective with the following filter sets:  
- for PFO nanoparticles: Excitation 740 nm; Emission BP 390-465 for the donor part ; 
Emission BP 565-615 for the acceptor part 
- for 70a nanoparticles: Excitation 740 nm; Emission BP 390-465 and BP 500-550 for 
the donor part and acceptor part, respectively 
 - for 70b nanoparticles: Excitation 740 nm; Emission BP 390-465 and BP 565-615 for 
the donor part and acceptor part, respectively 
- for 70c nanoparticles: Excitation 740 nm; Emission BP 390-465 and BP 565-615 for 
the donor part and acceptor part, respectively 
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- for 70d nanoparticles: Excitation 740 nm; Emission BP 390-465 and BP 650-710 for 
the donor part and acceptor part, respectively 
 
Clone 9 cells were incubated for 40 hrs at 37 ºC in Ham’s + 5 % FBS culture medium 
with 60 µL of 4 ppm nanoparticles solution.  After the incubation period, the cells were 
washed with serum free culture medium (ACAS) several times before imaging.  
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PFO
Exc. 740 nm, Emis. BP 390-465
70a
Exc. 740 nm, Emis. BP 500-550  
Cell 
autofluorescence
in acceptor
emission range
Nanoparticles
in acceptor
emission range
 
 321 
 
 
70b
Exc. 740 nm, Emis. BP 566-615
70c
Exc. 740 nm, Emis. BP 565-615  
Cell 
autofluorescence
in acceptor
emission range
Nanoparticles
in acceptor
emission range
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70d
Exc. 740 nm, Emis. BP 650-710  
Cell 
autofluorescence
in acceptor
emission range
Nanoparticles
in acceptor
emission range
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APPENDIX F 
EXPERIMENTAL DATA FOR CHAPTER V 
 
Photosensitizers 
The synthesis of many of the compounds studied here has already been reported 
elsewhere.  Compound A was prepared using a new method whereby 3,5-
dimethylpyrrole-2-carbaldehyde was treated with 1.2 equivalents of POCl3 followed by 
addition of BF3.OEt2.45  Compound B was prepared from condensation of 2,4-
dimethylpyrrole with 4-iodobenzene acid in POCl3, and reaction of the resultant 
dipyrromethene intermediate with BF3.OEt2.214  Compound C was prepared from 
compound A by using chlorosulphonic acid.86 
 324 
N
B
F2
N
I2, HIO3, EtOH
60 ºC, 20 min
I
N
B
F2
N
I
II
77B  
 
A mixture of B (107 mg, 0.238 mmol), I2 (151 mg, 0.476 mmol), HIO3 (84.0 mg, 0.476 
mmol) in 10 mL EtOH  was warmed to 60 oC for 20 min. The mixture was then cooled 
to room temperature.  The precipitate was filtered and washed thoroughly with MeOH to 
yield 135 mg (81 %) of product as an orange powder. 1H NMR (300 MHz, CDCl3) δ 
7.88 (d, J = 8.4 Hz, 2H), 7.02 (d, J = 8.4 Hz, 2H), 2.64 (s, 6H), 1.43 (s, 6H).  13C could 
not be obtained due to the tendency of the compound to crash out of solution during 
analysis. MS (APCI) calcd for C19H15BF2I3N2 {M-H}- 700.84, found 701.38. Rf = 0.29 
(49:1 hexanes/EtOAc).  Compound is photosensitive and should be stored over extended 
periods accordingly.  
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N
B
F2
N
ClO
Cl
Cl
N
H
(i) CH2Cl2, 25 ºC
30 min
(ii) TEA, BF3•OEt2
25 ºC, 17 h
79  
 
To a solution of 4-chlorobutanoyl chloride (0.99 mL, 8.8 mmol) in 20 mL of CH2Cl2 
was added 2,4-dimethylpyrrole (2.0 mL, 19 mmol) over 10 min at 0 ºC.  The reaction 
was stirred at 0 ºC for 30 min and then heated to 25 ºC and stirred for an additional 30 
min.  Triethylamine (3.7 mL, 26 mmol) was then added in small portions at 0 ºC and the 
mixture was stirred at 25 ºC for 10 min.  BF3•OEt2 (5.5 mL, 44 mmol) was then added in 
portions and the mixture was stirred at 25 ºC for 17 h.  The reaction was quenched with 
careful addition of 20 mL of H2O and the system was stirred vigorously for 15 min.  The 
layers were separated and the aqueous layer was extracted three times with 10 mL 
CH2Cl2.  The organic layers were combined and washed twice with 10 mL H2O and 10 
mL of brine.  The organic layer was dried over MgSO4, filtered, and the solvent was 
removed under reduced pressure.  The brown powder was dissolved in small amount of 
CH2Cl2 and filtered through a short plug of silica.  The solvent was removed under 
reduced pressure and the remaining powder was recrystalized from ethyl acetate to yield 
0.90 g (32 %) of 79 as a red needles.  1H NMR (300 MHz, CDCl3) δ 6.06 (s, 2H), 3.70 
(t, J = 6.0 Hz, 2H), 3.13 (t, J = 8.4 Hz, 2H), 2.52 (s, 6H), 2.43 (s, 6H), 2.08 (m, 2H).  13C 
(75 MHz, CDCl3) δ 154.5, 144.6, 140.4, 131.6, 122.0, 44.9, 34.2, 26.1, 16.7, 14.6.  MS 
(ESI) calcd for C16H21BClF2N2 {M+H}+ 325.14, found 325.47. 
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N
B
F2
N
Cl
79
NaN3, DMF
40 ºC, 36 h
N
B
F2
N
N3
80  
 
The a solution of 79 (200 mg, 0.62 mmol) in 12 mL of DMF was added sodium azide 
(80 mg, 1.2 mmol).  The mixture was stirred at 40 ºC for 24 h.  To the mixture was 
added 12 mL of water and the suspension was extracted three times with 24 mL of ethyl 
acetate.  The combined organic layers were washed three times with 24 mL H2O and 
finally 24 mL of brine.  The organic layer was dried over MgSO4, filtered and the 
solvent was removed under removed pressure to afford 200mg (99 %) of 80 as an orange 
powder. 1H NMR (300 MHz, CDCl3) δ 6.06 (s, 2H), 3.49 (t, J = 6.0 Hz, 2H), 3.03 (t, J = 
8.4 Hz, 2H), 2.51 (s, 6H), 2.42 (s, 6H), 1.86 (m, 2H).  13C (75 MHz, CDCl3) δ 154.4, 
144.7, 140.4, 131.4, 122.0, 51.6, 31.2, 25.7, 16.5, 14.6.  MS (ESI) calcd for C16H19BF2N5 
{M-H}- 330.17, found 330.28. 
 329 
 
 
 
N
B
F2
N
N3
 330 
N
B
F2
N
N3
80
I2, HIO3
MeOH, 60 ºC
20 min
N
B
F2
N
N3
II
81  
 
To a suspension of 80 (117 mg, 0.308 mmol) in 6 mL ethanol was added iodine (195 
mg, 0.770 mmol) and iodic acid (114 mg, 0.647 mmol).  The mixture was stirred at 60 
ºC for 30 min.  The mixture was cooled to 25 ºC and 12 mL of water was added.  The 
product was extracted three times with 24 mL CH2Cl2.  The combined organic layers 
were dried over MgSO4, filtered, and the solvent was removed under reduced pressure.  
The residue was purified by flash silica chromatography eluting with 3:1 to 2:1 
hexanes/CH2Cl2.  The solvent was removed under reduced pressure to yield 117 mg (65 
%) as a red powder.  1H NMR (500 MHz, CDCl3) δ 3.53 (t, J = 6.5 Hz, 2H), 3.11 (t, J = 
8.5 Hz, 2H), 2.62 (s, 6H), 2.49 (s, 6H), 1.85 (m, 2H).  13C (126 MHz, CDCl3) δ 156.0, 
144.5, 142.3, 131.4, 86.9, 51.5, 31.0, 26.6, 19.2, 16.3.  MS (ESI) calcd for C16H17BF2I2N5 
{M-H}- 581.96, found 582.09. 
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PPh3, THF, H2O
35 ºC, 24 h
PGA-78
N
B
F2
N
H2N
II
78
0.1 eq DCC
PGA-H, DMAP
DMF, 25 ºC
24 h
O
N
H
O ONa
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To BODIPY 81 (100 mg, 0.17 mmol) in 2 mL of 10:1 THF/H2O was added PPh3 (49 
mg, 0.19 mmol).  The reaction was stirred at 25 ºC for 24 h and the solvent was removed 
under reduced pressure.  Residue partially purified by flash silica chromatography 
eluting with 1 % to 3 % MeOH in CH2Cl2. 78. MS (ESI) calcd for C16H20BF2I2N3Na 
{M+Na}+ 579.97, found 579.53. 
In a flame dried flask was added PGA-H196 (33 mg, 0.26 mmol {-COOH}), DCC (11 
mg, 0.051 mmol), DMAP (catalytic) in 7 mL of DMF.  BODIPY-amine 78 (14 mg, 
0.039 mmol) was added and the mixture was stirred at 25 ºC for 24 h.  To the mixture 
was added 6 mL of 0.1 M NaHCO3 and the mixture was stirred for 5 min.  To the 
mixture was added 6 mL of CHCl3.  The layers were separated and the aqueous layer 
was washed twice with 6 mL of CHCl3.  The aqueous layer was dialysed in 5 L of H2O 
for 5 h, changing out the water every 1.5 h.  The pink solution was then lyophilized to 
yield 43 mg of PGA-78 as pink fibers. 
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Biological Assays 
Cells 
HL60 human promyelocytic leukemia cells were obtained from American Tissue 
Culture Collection (Virginia, USA) and maintained in RPMI 1640 medium 
supplemented with 10% FBS.  HSC2 oral cavity human squamous carcinoma cells were 
obtained from Health Science Research Resources Bank (Japan Health Sciences 
Foundation, Japan).  HK1 nasopharyngeal epithelial carcinoma cell-line is a gift from 
University of Hong Kong Culture Collection (University of Hong Kong, Hong Kong).  
Both cells were grown in MEM medium supplemented with 10% FBS.  
 
Photo-induced cytotoxicity assay 
Approximately 15 000 HL60 cells/well or 3 000 cells/well for HSC2 and HK1 cells in 
phenol red-free culture medium containing 10% fetal bovine serum were seeded in 96-
well plate. HSC2 and HK1 cells were allowed to adhere overnight before test 
compounds were introduced. Photosensitisers stock solution (10 mM in DMSO) was 
diluted with medium, and concentrations varying from 0.001-100.0 µM were tested on 
the cells. The control wells received 0.01 % of DMSO equivalent to the highest amount 
of DMSO used as vehicle in the compound-treated wells. Following 2 h of treatment, 
cells were irradiated with a light dose of 9.6 J/cm2 from a broad spectrum light source 
and were further incubated for 24 h before cell viability was assessed using MTT assay. 
Following incubation, 15 µl of MTT solution (5 mg/ml) was added into each well, and 
incubated for 4 h at 37 ºC. The medium was then removed and 100 µl of DMSO was 
H
N
O
OHN
n
N
BF2
N
I
I
O
N
H
O ONa
x
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added to dissolve the formazan crystal formed. Absorbance, as a measure of viable cell 
number was read at 570 nm with OpsysMR microplate spectrometer 
(ThermoLabsystems, Chantilly, Virginia, USA). The dark toxicity of each 
photosensitiser was also determined in every experiment. 
 
Comparative singlet-oxygen generation measurements 
A 8 ml of aerated isopropanol containing 50 µM of DPBF and photosensitiser (0.5 µM 
or 5 µM) in a 6-well plate was irradiated at 1.6 mW/cm2 of filtered light source of > 510 
nm wavelength with a Roscolux medium yellow #10 filter (Rosco, New York, USA) at 
room temperature for 1 h. Aliquots of 200 µl were removed from the mixture at various 
fixed intervals and the absorbance was measured at 410 nm. The rate of singlet oxygen 
production was determined from the reduction in intensity of absorbance recorded over 
time. Irradiation of DPBF-isopropanol solution in the absence of photosensitiser as a 
negative control and solution containing methylene blue as a comparative control were 
also carried out. The relative singlet oxygen generation rate for each of the 
photosensitisers was determined by using methylene blue as a reference. 
 
Cellular localisation  
HSC2 cells grown on round glass coverslips in 12-well plate were co-incubated with 
100 nM of photosensitiser together with organelle-specific fluorescence probes. The 
endoplasmic reticulum was labeled with 100 nM of ER-Tracker Blue-White DPX, the 
lysosomes were stained with 500 nM of LysoTracker Blue DND-22, and the 
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mitochrondria was tracked with 100 nM of Rh123 respectively for 15-30 min of 
incubation at room temperature. After incubation, cells were gently rinsed in PBS to 
remove free dyes, and the stained cells were observed using Olympus DSU spinning 
disk confocal microscope configured with a PlanApo ×63 oil objective (Olympus 
Optical Corp. Ltd., Tokyo, Japan) and iXon EM + digital camera (Andor Technology, 
South Windsor, Connecticut, USA). Fluorescent images of X-Y sections at 0.2 μm were 
collected sequentially using Olympus CellR software. Organelle-specific fluorescence 
probes were respectively excited at 330-385 nm wavelength to illuminate ER-tracker and 
LysoTracker, at 460-490 nm for Rh123 and at 520-550 nm for photosensitiser.   
 
AnnexinV-FITC apoptosis analysis 
HSC2 cells grown in 60-mm dishes at 50% confluency were treated with 0.5 µM of 
compound 5.  Following 2 h of incubation, cells were irradiated with 9.6 J/cm2 of broad 
spectrum light. At various treatment intervals, floating cells in the medium were pooled 
together with the adherent cells after trypsinisation and were washed twice with cold 
phosphate buffered saline (PBS).  The cells were resuspended with 1× binding buffer at 
1 × 106 cells/mL.  A 100 µL of cell suspension was transferred to a flow cytometry tube 
followed by 5 µL of AnnexinV-FITC and 5 µL of 200 µg/mL propidium iodide in PBS.  
The cells were gently mixed and incubated for 15 min at room temperature in the dark 
before analysed on a FACSCalibur flow cytometer equipped with 488 nm argon laser.  
The fluorescence data of 1 × 104 cells were collected with the FL1 detector with 530/30 
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band pass filter to collect Annexin-FITC fluorescence, and the FL3 detector with a 630 
nm long pass filter to collect propidium iodide fluorescence.   
 
Cell cycle analysis 
HSC2 cells were treated with 0.25 µM of compound 5 and collected as above.  Cells 
were then fixed in 70% ice-cold ethanol (v/v in PBS) overnight at 4 ºC.  Following 
fixation, the cells were washed twice in cold PBS.  The pellet was then resuspended in 
PBS solution containing 20 µg/ml RNase A and 1 µM SYTOX Green for 30 min.  The 
cells were analysed on a FACSCalibur flow cytometer with 488 nm argon laser.  The 
DNA-SYTOX Green fluorescence of 1 × 104 cells were collected with the FL1 detector 
with 530/30 band pass filter. 
 
PDT on CAM vasculature 
Freshly obtained fertilised chicken eggs were incubated with the narrow apex down in 
a 90 degree swinging incubator (Savimat MG 200, Chauffry, France) at 37 °C and 65% 
relative humidity.  On embryo development day (EDD) three, an opening on the 
eggshell, about 4 mm in diameter, was bored at the apex and sealed with adhesive tape 
to avoid contamination and desiccation of the egg contents.  The eggs were further 
incubated in stationary position with the apex upright until EDD-9. 
Microscopic observation of CAM vasculature and the light irradiation during PDT 
were performed with an epifluorescence Eclipse 600 FN microscope equipped with a 
CFI Achromat 4×/0.1 objective (Nikon, Japan).  Illumination was provided by a 100 W 
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mercury arc lamp. Light doses were adjusted with neutral density filters and measured 
with a calibrated Field-Master GS power analyser (Coherent, Santa Clara, USA).  For 
exciting and detecting compound 48, the microscope was equipped with a G-2A filter set 
(excitation, 510-560 nm) (Nikon, Japan).  For detecting FITC, a B-2E/C filter set 
(excitation, 465-495 nm) was used (Nikon, Japan).  Fluorescence images were acquired 
with an F-view II 12-bit monochrome Peltier-cooled digital CCD camera driven with 
analySIS® DOCU software from Soft Imaging System (Münster, Germany). 
On EDD-9, the egg opening was extended to ~30 mm in diameter. Embryo was 
intravenously administered with a single bolus of 3.5 to 7 nmol/embryo of 
photosensitisers in dosing vehicle (CrEL 5%, EtOH 5% in saline) at the CAM main 
vasculature. A minute after injection, site with vessels of diameter between 5-100 µm 
was irradiated at light dose of 20-40 J/cm2 filtered at 510-560 nm with an irradiation area 
of 0.02 cm2 and fluence rate of 40 mW/cm2.  The site was photographed at the beginning 
and at the end of irradiation.  Subsequently, the egg opening was sealed with parafilm 
and the embryo was further incubated for 24 h before assessing the PDT damage 
induced.  
Fluorescence angiographies were performed in order to assess the PDT-induced 
vasculature damage. Blood vessels were perfused with 10 µl of 25 mg/ml FITC – 
dextran followed by injection of Indian ink into the amnion cavity for better viewing 
contrast.  The vasculature network at the site of irradiation was illuminated by exciting 
the FITC at 465-495 nm on the fluorescence microscope.  The vasculature network was 
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imaged and the damage induced by PDT was scored according to the criteria as defined 
by Lange et al.  At least 10 embryos were assessed for each treatment group. 
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Design and Synthesis of Near-IR PDT Agents 
 
NH2
NO2
NH2
NO2IICl, CH2Cl2
reflux, 17 h
83  
 
To 2-nitroaniline (10.0 g, 72.4 mmol) in 75 mL CH2Cl2 was added ICl (12.9 g, 79.6 
mmol) in 10 mL CH2Cl2 over 30 min at 0 ºC.  The reaction was stirred at 25 ºC for 24 h.  
The reaction was cooled to 0 ºC and ca 75 mL of saturated Na2CO3 solution was slowly 
added to obtain a pH of 7.0.  The layers were separated and the aqueous layer was 
extracted three times with CH2Cl2.  The organic layers were combined and washed twice 
with 75 mL of saturated Na2CO3, twice with 75 mL of 1 M Na2SO3, and 75 mL of brine.  
The organic layer was dried over MgSO4, filtered, and the solvent was removed under 
reduced pressure.  The brown residue was digested in methanol, filtered and washed 
with warm methanol to yield 8.23 g (43 %) 83 as a dark red powder.  1H NMR (300 
MHz, CDCl3) δ 8.41 (d, J = 1.8 Hz, 1H), 7.56 (dd, J = 2.1 Hz, J = 8.7 Hz, 1H), 6.61 (d, J 
= 8.7 Hz, 1H), 6.12 (bs, 2H).  13C (75 MHz, CDCl3) δ 144.2, 143.8, 134.4, 120.7, 90.1, 
76.0.  HRMS (ESI) calcd for C6H4IN2O2 {M-H}- 262.9318, found 262.9323. 
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HCl, 70 ºC
3 h
83 84  
 
To a slurry of 83 (7.00 g, 26.5 mmol) in 250 mL concentrated HCl was added 
SnCl2•H2O (30.0 g, 133 mmol).  The reaction was stirred at reflux for 3 h.  Mixture was 
cooled to 0 ºC and slowly neutralized with Na2CO3 (note: this has been done with both 
solid and concentrated Na2CO3 solution, with the later proving more convenient though 
large volumes were required).  Once a basic pH was reached, the product was extracted 
three times with 250 mL ethyl acetate.  The combined organic layers were dried over 
MgSO4, filtered, and the solvent was removed under reduced pressure.  Diamine 84 was 
obtained as a brown powder in sufficient purity  1H NMR (300 MHz, CDCl3) δ 6.92 (m, 
2H), 6.39 (dd, J = 2.1 Hz, J = 7.5 Hz, 1H), 3.67 (bs, 4H).  13C (75 MHz, CDCl3) δ 136.3, 
134.2, 128.5, 124.6, 118.3, 81.2.  HRMS (ESI) calcd for C6H8IN2 {M+H}+ 234.9732, 
found 234.9745. 
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To a solution of 84 (5.92 g, 25.3 mmol) in methanol (60 mL) was added 50 % ethyl 
glyoxylate in toluene (5.06 mL, 25.6 mmol).  The reaction was heated to reflux for 2 h.  
The reaction was cooled to 25 ºC.  The precipitate was filtered and washed with copious 
amounts of methanol.  Product 85 (5.8 g, 86 %) was obtained as a white powder and 1:1 
regioisomeric mixture.  1H NMR (300 MHz, DMSO) δ 8.17-8.16 (2 overlapping 
singlets, 2H), 8.10 (d, J = 1.8 Hz, 1H), 7.83 (dd, J = 1.8 Hz, J = 8.4 Hz, 1H), 7.64 (d, J = 
1.8 Hz, 1H), 7.60 (dd, J = 1.8 Hz, J = 8.4 Hz, 1H), 7.52 (d, J = 8.4 Hz, 1H), 7.10 (d, J = 
8.4 Hz, 1H).  Compound solubility was unsuitable for routine 13C analysis.  HRMS (ESI) 
calcd for C8H6IN2O {M+H}+ 272.9525, found 272.9517. 
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Quinoxalinones 85 (5.00 g, 18.4 mmol) were suspended in POCl3 (75 mL) and brought 
to reflux.  After 3 h the solution was cooled to 25 ºC and the POCl3 was removed under 
reduced pressure.  The precipitate was dissolved in 75 mL ethyl acetate and washed 
three times with 75 mL of water and once with 75 mL of brine.  The organic layer was 
dried over MgSO4, filtered, and the solvent was removed under reduced pressure to yield 
isomeric mixture 86 as a white powder (5.1 g, 96 %). (Note: white powder darkens upon 
standing with no noticeable drop in purity by NMR).  1H NMR (300 MHz, CDCl3) δ 
8.78 (s, 1H), 8.75 (s, 1H), 8.49-8.40 (m, 2H), 8.05-8.00 (m, 2H), 7.81 (d, J = 10.5 Hz, 
1H), 7.73 (d, J = 9.0 Hz, 1H).  13C (75 MHz, CDCl3) δ 148.1, 147.9, 145.0, 144.7, 142.7, 
141.4, 140.7, 140.5, 139.7, 139.0, 137.7, 137.6, 129.7 (2C), 98.2, 96.6.  MS (ESI) calcd 
for C8H5ClIN2 {M+H}+ 290.92, found 291.63 
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In a flame dried flask was placed sodium hydride (60 % in oil, 1.03 g, 25.8 mmol) in 
THF at 0 ºC.  tbutyl 2-cyanoacetate (2.95 mL, 20.7 mmol) was added over 30 min and 
stirred at 0 ºC for an additional 15 min.  Mixture was warmed to 25 ºC and stirred for 30 
min.  In a separate flask, quinoxaline 86 (5.00 g, 17.2 mmol) was dissolved in 30 mL of 
THF and the quinoxaline solution was added to the cyanoacetate mixture over 15 min at 
0 ºC.  The mixture was warmed to 25 ºC and stirred for 17 h.  The reaction was carefully 
quenched with ice water (20 mL) and then glacial acetic acid was added until a 
suspension formed.  The product was extracted three times with 30 mL CH2Cl2 and the 
combined organic layers were washed three times with 40 mL of water and once with 
brine.  The red solution was dried over MgSO4, filtered, and the solvent was removed 
under reduced pressure.  The orange residue was digested in ca 100 mL of hexanes for 1 
h.  The orange precipitate was filtered and washed thoroughly with hexanes to afford 87 
as an orange powder (4.9 g, 72 %).  1H NMR (500 MHz, CDCl3) δ 13.03-13.00 (2 
overlapping broad singlets, 2H), 8.80-8.79 (m, 2H), 8.21 (d, J = 2 Hz, 1H), 7.82 (dd, J = 
2 Hz, J = 8.5 Hz, 1H), 7.71-7.68 (m, 2H), 7.54 (d, J = 8.5 Hz, 1H), 7.07 (d, J = 8.5 Hz, 
1H, 1.56 (2 overlapping singlets, 18H).  13C (126 MHz, CDCl3) δ 168.9 (2C), 148.4, 
147.9, 146.6, 140.5, 138.6, 136.5, 135.2, 134.9, 131.1, 129.3, 128.1, 125.4, 118.0, 116.4, 
 352 
116.3, 98.0, 88.8, 83.3 (2C), 71.8 (2C), 28.4, 28.3. (Note: 1 carbon is missing).  HRMS 
(ESI) calcd for C15H15IN3O2 {M+H}+ 396.0209, found 396.0226. 
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To a solution of 87 in 50 mL of CH2Cl2 was added trifluoroacetic acid.  The reaction 
was stirred at 25 ºC for 17 h.  The solution was washed three time with 50 mL of 
saturated Na2CO3 and once with 50 mL of brine.  The organic layer was dried over 
MgSO4, filtered, and the solvent was removed under reduced pressure.  The residue was 
purified by flash silica chromatography eluting with 4:1 to 3:1 hexanes/ethyl acetate.  
The first polar compound to elute was identified as 88a (692 mg, 21 %) and the second 
as 88b (650 mg, 19 %). 
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88a. 1H NMR (500 MHz, CDCl3) δ 8.91 (s, 1H), 8.57 (d, J = 2 Hz, 1H), 8.07 (dd, J = 
2 Hz, J = 9 Hz, 1H), 7.81 (d, J = 9 Hz, 1H), 4.15 (s, 2H).  HRMS (ESI) calcd for 
C10H7IN3 {M+H}+ 295.9685, found 295.9677. 
88b. 1H NMR (500 MHz, CDCl3) δ 8.93 (s, 1H), 8.53 (d, J = 1.5 Hz, 1H), 8.05 (dd, J 
= 2 Hz, J = 8.5 Hz, 1H), 7.84 (d, J = 8.5 Hz, 1H), 4.16 (s, 2H). 
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X-ray structure of 88a. 
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To a suspension of DPP dye 90 (222 mg, 0.407) was added either isomer of 88 (300 
mg, 1.02 mmol) and POCl3 (303 µL, 3.25 mmol).  The mixture was refluxed for 5 h.  
The mixture was cooled to 25 ºC and the solvent was removed under reduced pressure.  
The residue was digested in methanol, filtered, and washed with copious amounts of 
methanol to yield 91 in sufficient purity for chelation step, 336 mg of semi-pure 91a was 
obtained and 315 mg of 91b.  91a. MS (ESI) calcd for C54H51I2N8O2 {M-H}- 1097.22, 
found 1097.41. 
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To either isomer of 91 dissolved in CH2Cl2 was added Hunig’s base. The mixture was 
stirred at 25 ºC for 30 min and BF3•OEt2 was added.  The reaction was refluxed for 30 
min and then cooled to 25 ºC.  To the mixture was added 10 mL of water and the 
mixture was stirred vigorously for 10 min.  The layers were separated and the organic 
layer was washed twice with 10 mL water and once with 10 mL brine.  The organic 
layer was dried over MgSO4, filtered, and the solvent was removed under reduced 
pressure.  The residue was purified by flash silica chromatography eluting with CH2Cl2 
and the solvent was removed under reduced pressure to yield 82 as a reddish shiny 
residue, in the case of 82a 11 mg (3 % - 2 steps) was isolated, and 82b 12 mg (3 % - 2 
steps).  It is noteworthy that solubility of the products is poor, especially for 82b to the 
point that routine 1H was arduous (see text).  HPLC analysis performed on silica column, 
4.6 x 150 mm, eleuting with CH2Cl2 at 1 mL/min.  82a. 1H NMR (500 MHz, CDCl3) δ 
9.27 (s, 2H), 8.53 (m, 2H), 8.32 (d, J = 9.5 Hz, 2H), 8.02 (m, 2H), 7.71-7.64 (m, 4H), 
HN
NH
N
N
CN
CN
N N
C8H17O
OC8H17
I
I
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7.11-7.00 (m, 6H), 3.99 (t, J = 6.5 Hz, 4H), 1.78 (q, J = 8.0 Hz, 4H), 1.57-1.25 (m, 20H), 
0.88 (t, J = 7.0 Hz, 6H).  HRMS (MALDI) calcd for C54H51B2F4I2N8O2 {M+H}+ 
1195.2357, found 1195.2338. 
82b. HRMS (MALDI) calcd for C54H51B2F4I2N8O2 {M+H}+ 1195.2357, found 
1195.2369. 
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" 156,000 cm-1M-1
!em 823 nm
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82b 
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